{
    "informations": {
        "total_answer": 92,
        "correct_answer": 59
    },
    "data": [
        {
            "filename": "2022_EPAC_mcq.json",
            "questions": [
                {
                    "question": "A communication pursuant to Article 94(3) EPC is dated 7 December 2022. In the communication a time limit of four months is set for replying to objections raised by the examining division.  Which of the following statements is not  correct?",
                    "options": [
                        "A.  The communication is deemed to be delivered on 17 December 2022",
                        "B. The time limit for replying to the communication expires on 17 April 2023",
                        "C.  Further processing for replying to the communication can be validly requested on 19 June 2023 at the latest",
                        "D.  An extension of the time limit for filing the reply can be validly requested on 14 April 2023"
                    ]
                },
                {
                    "question": "You filed a European patent application which discloses a new amino acid sequence. This sequence is however only used in a single example and is not part of the claims. No sequence listing was filed.  Which of the following statements is correct?",
                    "options": [
                        "A. If you are invited by the EPO to file a sequence listing, you need to file it and pay a late furnishing fee to the EPO",
                        "B. If you are invited by the EPO to file a sequence listing and do not react to this invitation in due time, the application is deemed to be withdrawn",
                        "C. If you are invited by the EPO to file a sequence listing, you need to file it in PDF format",
                        "D. You do not need to file any sequence listing because the amino acid sequence is not claimed"
                    ]
                },
                {
                    "question": "During the examination proceedings the applicant notes that claim 1 contains a typographical error. What is the last point in time for requesting correction of the error under Rule 139 EPC?",
                    "options": [
                        "A. One day before the decision to grant a European patent is handed over to the EPO postal service",
                        "B. Date  of publication of the mention of the grant of the European patent",
                        "C. Date of notification of the decision to grant",
                        "D. Date of the communication under Rule 71(3) EPC"
                    ]
                },
                {
                    "question": "Antonia, an applicant living in Argentina and having Argentinian nationality, intends to file a European patent application EP -A and an international patent application PCT- A.  Which of the following statements is correct?",
                    "options": [
                        "A. Antonia can validly file PCT- A with the International Bureau of WIPO",
                        "B. Antonia can validly file PCT -A with the EPO",
                        "C. Antonia can validly file EP -A with the EPO",
                        "D. None of the above"
                    ]
                },
                {
                    "question": "Applicant X filed European patent application EP -X on 23 August 2019 as a first filing. The applicant filed application EP -Y as a divisional application of EP- X on 26 September 2022. Please consider the following statements:   2 I. The renewal fee for the fourth year for EP -X was due on 31 August 2022; the renewal fees for the third and fourth years for EP -Y were due on 26 September 2022 II. The renewal fee for the fourth year for EP -X can be validly paid on 28 February 2023 together with the necessary additional fee; the renewal fees for the third and fourth years for EP -Y can be validly paid without additional fee up to 31 January 2023  Which of the following items applies?",
                    "options": [
                        "A. Only statement I is correct",
                        "B. Only statement II is correct",
                        "C. Both statements I and II are correct",
                        "D. Both statements I and II are incorrect"
                    ]
                },
                {
                    "question": "The European Patent Office as receiving Office for an international patent application invites the applicant to provide a missing abstract within a period of two months. The invitation is dated 2 December 2022 and is received by the applicant on 12 December 2022. The date of receipt stamped on the communication by the mail service provides evidence of the receipt date. What is the final date for responding to the invitation?",
                    "options": [
                        "A. 2 February 2023",
                        "B. 13 February 2023",
                        "C. 5 February 2023",
                        "D. 6 February 2023"
                    ]
                },
                {
                    "question": "An international patent application was filed on 17 February 2022 claiming priority from a European patent application filed on 17 February 2021. The international search report together with the written opinion was transmitted to the applicant on 10 June 2022.   What is the last day for filing a demand for international preliminary examination?",
                    "options": [
                        "A. 17 December 2022",
                        "B. 19 December 2022",
                        "C. 10 September 2022",
                        "D. 12 September 2022"
                    ]
                },
                {
                    "question": "A professional representative acts as agent for the following actions:  I.  Withdrawing an international patent application at the European Patent Office as receiving Office  II.  Filing a demand for international preliminary examination for an international patent application at the European Patent Office as International Preliminary Examining Authority   Which of the following statements is correct?",
                    "options": [
                        "A.  For both I and II a power of attorney signed by each applicant is always required",
                        "B.  For I a power of attorney signed by each applicant is always required",
                        "C.  For II a power of attorney signed by each applicant is always required",
                        "D.  For both I and II the requirement to submit a power of attorney signed by each applicant may be waived   3"
                    ]
                },
                {
                    "question": "Which of the following steps is not a minimum requirement for entry into the European phase?",
                    "options": [
                        "A.  Supplying a translation if the Euro- PCT application was not published in one of the EPO's official languages",
                        "B.  Specifying the application documents on which the European grant procedure is to be based",
                        "C.  Filing the designation of the inventor",
                        "D.  Paying the search fee if a supplementary European search report is to be drawn up"
                    ]
                },
                {
                    "question": "A British company buys a French firm with an IP portfolio which includes an international application that claims priority of a British national application. The international application is in French. The British company wants to pursue the invention as a European patent application. However, they would prefer that the language of the European proceedings be English.   Which of the following statements is correct?",
                    "options": [
                        "A.  Upon entry into the European phase before the EPO, the applicant can file a translation into English and English will become the language of the proceedings",
                        "B.  The applicant can enter the European phase with the application in French and then validly file a European divisional application in English",
                        "C.  The applicant can select English as the language of the proceedings in the request form for entry into the European phase (EPO Form 1200) and English will become the language of the proceedings",
                        "D.  None of  the above"
                    ]
                },
                {
                    "question": "Your client filed an international patent application in 2021. In which of the following countries can they (directly) enter the national phase?",
                    "options": [
                        "A. Lithuania",
                        "B. France",
                        "C. Italy",
                        "D. None of the above"
                    ]
                },
                {
                    "question": "International patent application PCT- 1 was filed on 6 May 2021 without claiming priority. The application consists of 21 pages, including 17 claims. The international search was carried out by the EPO acting as ISA, and the international application was published together with the international search report after 18 months. On 12 December 2022, early entry into the European phase is requested. Which minimum requirement(s) must be fulfilled to validly effect early entry into the European phase according to Article 23(2) PCT?",
                    "options": [
                        "A. Payment of the filing fee",
                        "B. Payment of the filing fee and claims fees",
                        "C. Payment of the filing fee, the claims fees, the examination fee, the designation fee and the renewal fee for the third year",
                        "D. Payment of the filing fee, the designation fee and the examination fee"
                    ]
                },
                {
                    "question": "What is the last point in time for an effective withdrawal of a European patent application?",
                    "options": [
                        "4 A.  Date of receipt of the communication under Rule 71(3) EPC",
                        "B.  The latest of the date of payment of the fee for grant and publishing and the date of filing of the translations of the claims in the two other official languages of the EPO",
                        "C.  Date of publication of the mention of the grant in the European Patent Bulletin",
                        "D.  One day before the date of publication of the mention of the grant in the European Patent Bulletin"
                    ]
                },
                {
                    "question": "A communication pursuant to Rule 71(3) EPC was issued for a European patent application. The applicant fulfilled all the necessary requirements . The related decision to grant a European patent was dispatched based on the text intended for grant transmitted to the applicant with the communication under Rule 71(3) EPC. The mention of the grant of the European patent was published in the European Patent Bulletin. During the preparation of the publication of the patent specification an error occurred in that page 2 of the description was omitted from the published specification of this European patent. Which of the following statements is correct?",
                    "options": [
                        "A. This error in the published specification of this European patent may never be corrected",
                        "B. This error in the published specification of this European patent may be corrected at any time",
                        "C. This error in the published specification of this  European patent may not be corrected during the opposition period or if opposition proceedings are pending",
                        "D. The error may only be corrected if opposition proceedings are pending"
                    ]
                },
                {
                    "question": "On 27 October 2022 you filed European patent application EP -A claiming priority from FR -A filed on 29 October 2021. Your intention was that both applications would have the same content. On 3 November 2022, however, you noticed that page 3 of the description and claims 7 -12 are missing in EP -A. The fees have not been paid yet.  Which statement is correct?",
                    "options": [
                        "A. If the EPO notes that page 3 of the description and claims 7 -12 are missing, it will invite you to file these missing parts within a time limit of two months",
                        "B. You may of your own volition file page 3 of the description at any time up to 2 January 2023 without the application being re -dated",
                        "C. If the subject -matter of claims 7 -12 is also present in the description, you may add claims 7 -12 at any time",
                        "D. The best solution is to withdraw EP -A and refile it, claiming priority from FR -A"
                    ]
                }
            ],
            "answers": [
                {
                    "Answer": "C",
                    "Justification": "The question was which of the following statements  is not correct. Statements A, B, D  are correct. Statement C is not correct  because further  processing can be requested later than 19 June 2023, namely within  two months of a loss -of-right communication. Legal basis Rule 126(2) EPC Where notification is effected by registered letter , the letter shall be deemed to be delivered to the addressee on the tenth day  following its handover to the postal service provider unless it has failed to reach the addressee or has reached him at a later date . Rule 135(1) EPC Further processing under  Article 121, paragraph  1, shall be requested by payment of the prescribed fee within two months of the communication concerni ng either the failure to observe a time limit or a loss of rights . The omitted act shall be completed within the period for making the request. Rule 132(2) EPC In special cases, the period may be extended upon request, presented before the expiry of such  period . "
                },
                {
                    "Answer": "A",
                    "Justification": "Legal basis Rule 30(3) EPC Where the applicant has not filed a sequence listing complying with the requirements under  paragraph  1 at the date of filing, the European Patent Office shall invite the applicant to furnish such a sequence listing and pay the late furnishing fee . If the applicant does not furnish the required sequence listing and pay the required late furnishing fee within a period of two months after such an invitation, the application shall be refused . Decision of the President of the EPO dated 9 December 2021 on the filing of sequence listings , Article  1(1) If nucleotide or amino acid sequences are disclosed in a European patent application, the description must contain a sequence listing in XML  format complying with WIPO Standard  ST.26. "
                },
                {
                    "Answer": "A",
                    "Justification": "Legal basis Board of Appeal  decision  G12/91 Guidelines for Examination in the EPO , H-VI, 2.1 : The decision -making process  is terminated on the date of handing over of the decision to grant to the EPO 's postal service . 2 "
                },
                {
                    "Answer": "C",
                    "Justification": "Legal basis States party to the PCT and the Paris Convention and m embers of the World Trade Organization (wipo.int) : Argentina is not a PCT contracting state Article 58 EPC A European patent application may be filed by any natural or legal person, or anybody equivalent to a legal person by virtue of the law governing  it. "
                },
                {
                    "Answer": "A",
                    "Justification": "Legal basis Rule 51(1) EPC A renewal fee for the coming year  is due on the last day of the month containing the anniversary of the date of filing, i.e. on 31 August 2022 . Rule 51(2) EPC If a renewal fee is not paid on the due date under  paragraph 1 , the fee may still be paid within six months of the said date, i.e . on 28 February 2023, provided that an additional fee is also paid within that period . Rule 51(3) EPC Renewal fees already due  for an earlier application at the date  of filing a divisional application  are due on its filing, i.e . on 26 September 2022. These f ees and any renewal fee due within four months of filing the divisional application may be paid within that period without an additional fee , i.e. until 26 January 2023. "
                },
                {
                    "Answer": "D",
                    "Justification": "The invitation was received ten days after the mailing date , i.e. three days later than the seven days stipulated in Rule  80.6 PCT, so the period expires three days later than two months from the mailing date , that is, on 5 February 2023, which is a Sunday. The final date for responding is therefore  6 February 2023 (Monday). Legal basis Rule 80.6 PCT […] Irrespective of the date  on which such a document or letter  was mailed, if the applicant offers  to the national Office or intergovernmental organization  evidence which satisfies th e national Office or intergovernmental organization  that the document or letter  was received more than seven days after the date it bears , the national Office or intergovernmental organization  shall treat the period starting from the date  of the document or letter  as expiring later by an additional number  of days which is equal to the number  of days which the document or letter  was received later  than seven days after the date it bears . 3 Rule 80.5(i) PCT If the expiration of any period during which any document or fee  must reach a national Office or intergovernmental organization  falls on a day  […] on which such Office or organization is not open to the public  for the purposes of the transaction of official business  […] the period shall expire  on the next subsequent day on which [ no such  circumstance] exists . "
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Rule 54 bis(a) PCT A demand may be made at any time  prior to the expiration of whichever of the following periods expires later: (i) three months from the date of transmittal to the applicant of the international search report or the declaration referred  to in Article 17(2)(a) , and of the written opinion established under  Rule 43bis .1 [i.e. 10 September 2022 ( Sunday), extended to 12 September 2022 ]; or (ii) 22 months from the priority date  [i.e. 17 December 2022 ( Saturday), extended  to 19 December 2022 ]. Rule 80.5(i) PCT If the expiration of any period during which any document or fee  must reach a national Office or intergovernmental organization  falls on a day  […] on which such Office or organization is not open to the public  for the purposes of the transaction of official business [, the time limit  is extended to next  open day ]. "
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Rule 90.4(b) PCT [A] separate power of attorney  shall be submitted to either the receiving Office or the International Bureau , provided that, where a power of attorney  appoints an agent  under Rule 90.1(b) , (b-bis),  (c)  or (d)(ii) , it shall be submitted to the International  Searching Authority , the Authority specified for supplementary search or the International Preliminary Examining Authority , as the case may be. Rule 90.4(d) PCT [Any] receiving Office , any International Searching Authority , any Authority competent to carry out supplementary  searches, any International Preliminary Examining Authority  and the International Bureau may waive the requirement under  paragraph  (b) that a separate power of attorney be submitted  to it […]. Rule 90.4(e) PCT Where the agent or the common representative submits any notice of withdrawal […] , the requirement under paragraph (b)  for a separate power of attorney  shall not be waived under  paragraph (d) ."
                },
                {
                    "Answer": "C",
                    "Justification": "The designation of inventor  is not listed in Rule  159(1) EPC. Legal basis 4 Rule 159(1) EPC In respect of an international application under  Article 153, the applicant shall perform the following acts within thirty -one months from the date of filing of the application or, if priority has been claimed, from the priority date : (a) supply, where applicable, the translation  of the international application required under Article  1 53, paragraph  4; (b) specify  the application documents , as originally filed or as amended, on which the European gr ant procedure is to be based ; (c) pay the filing fee  provided  for in Article 78, paragraph  2; (d) pay the designation fee  if the period under  Rule 39 has expired earlier ; (e) pay the search fee , where a supplementary European sea rch report has to be drawn  up; (f) file  the request for examination provided  for in Article 94, if the period under  Rule 70, paragraph  1, has expired earlier; (g) pay  the renewal fee in respect of the third year provided for in Article 86, paragraph  1, if the fee has fallen due earlier under Rule 51, paragraph  1; (h) file, where applicable, the certificate of exhibition referred  to in Article 55, paragraph  2, and Rule 25. "
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis G 4/08 of the Enlarged Board of Appeal If an international patent application has been filed and published under the PCT  in an official language of the EPO, it is not possible, on entry into the European phase, to file a translation of the application  into another EPO  official language . Article 14(1) EPC, Article 14(3) EPC ( language of proceedings ) Rule 36(2) EPC : A divi sional application shall be filed in the language of the proceedings  of the earlier application . Euro -PCT Guide, Chapter  5, points 5.1.013 and 5.1.014 "
                },
                {
                    "Answer": "C",
                    "Justification": "Legal basis PCT contracting states  for which a regional patent  can be obtained via  the PCT (wipo.int ): A national patent can be obtained  for Italy in respect of international applications filed  on or after 1  July 2020.  Only a European patent can be obtained  for France and Lithuania. "
                },
                {
                    "Answer": "A",
                    "Justification": "Legal basis Notice from the EPO dated 21 February 2013 concerning the request for early processing, OJ  EPO 3/2013, 156 ff It depends on the date on which early processing is requested  which further requirements stipulated in Rule  159(1) EPC must be complied  with, since the ( regular) time limits for paying the designation fee (Rule  39(1) EPC) and the renewal fee (Rule  51(1) EPC) and for filing the request fo r examination and paying the examination fee (Rule 70(1) EPC ) may not have expired on the date the request for early processing is filed . Therefore, if any of these time limits is  still running on that date , the request will be effective without the requir ements  concerned having been complied  with ( Article 153(2) EPC , Article 11(3) PCT ). Claims fees  can be paid up to expiry of the period under Rule  162(2) EPC . In the present case, the ( regular) time limits for paying the designation , examination and renewal fees  are still running . "
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis Guidelines for Examination in the EPO, E -VIII, 8.1, A- IV, 1.1.1 Applicants may withdraw their application at any time as long as the application is pending . An application is pending up to (but  not including) the date that the European Patent Bulletin mentions the grant of the patent (OJ  EPO 2002, 112). "
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Guidelines for Examination in the EPO , H-VI, 6, C-V , 10 Errors in publication occur where the content of the printed specification differs from the documents (Druckexemplar) transmitted to the applicant with the communication under  Rule  71(3) (Form 2004), if these documents form the basis of the decision to grant. The above errors in publication can be corrected at any time . "
                },
                {
                    "Answer": "B",
                    "Justification": "Statement A is not correct because Rule  56 does not apply to missing claims  (the application was filed in 2021, i.e. before the entry into force  of the new Rule  56a EPC ). Statement B is correct  (Rule  56(3) EPC ). Statement C is not correct  because it is not possible  to amend the claims before search (Rule  137(1) EPC ). Statement D is not a good solution because  the date of a priority claim  would precede the date of filing of the European patent application by more than twelve months . Legal basis 6 Rule 56(1) EPC If the examination under  Article  90, paragraph  1, reveals that parts of the description, or drawings referred to in the description or in the claims, appear to be missing, the European Patent Office shall invite the applicant to file the missing parts within two months . Rule 56(3) EPC If the missing parts of the description or missing drawings are filed  […] and the application claims priority of an earlier application, the date of filing shall, provided that the missing parts of the description or the missing drawings are completely contained in the earlier application, remain the date on which the requirements laid  down in Rule 40, paragraph  1, were fulfilled, where the applicant so requests and files , […]. Rule 137(1) EPC Before receiving the European search report, the ap plicant may not amend the description, claims or drawings of a European patent application unless otherwise provided ."
                }
            ],
            "ai_answers": [
                {
                    "Answer": "C",
                    "Justification": "- Explanation of why C is incorrect: According to Rule 131 EPC, where a procedural step is effected by registered letter, it is deemed delivered on the tenth day after posting. Therefore, the communication dated 7 December 2022 would be considered as received on 17 December 2022 (10 days later). The four-month period for replying begins from this date, ending on 17 April 2023. An extension of time can only be requested before the expiration of that deadline, so any request made after 17 April 2023 would not be valid.\n- Explanation of why A is correct: The communication dated 7 December 2022 will indeed be deemed delivered on 17 December 2022 under Rule 126(2) EPC, which provides for a ten-day period from the date of posting to be considered as delivery.\n- Explanation of why B is correct: If the communication is received by the recipient on 17 December 2022 and the time limit set in the communication is four months, then the deadline would expire on 17 April 2023. This aligns with Rule 131(4) EPC which establishes that periods are fixed in full years, months, or weeks from a specific event (here the receipt of the letter).\n- Explanation of why D is correct: According to Article 89 EPC and Rule 137 EPC, requests for extensions must be made before the expiry of the prescribed time limit. A request on 14 April 2023 would still fall within the four-month period set in the communication (ending on 17 April), making it a valid request.\n\nSources:\n\nSource: Case Law IV, B.2.5.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_b_2_5_1.html\nSource: Guidelines for Examination in the EPO, E-VIII, 1.6.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_1_6_1.html\nSource: Case Law IV, C.6.4, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_c_6_4.html\nSource: Case Law III, D.1.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_d_1_1.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. According to Rule 56 and Rule 30(1) of the European Patent Convention (EPC), if a sequence listing is not filed initially but your application discloses an amino acid sequence, you are required to file it upon invitation from the EPO and pay any associated late furnishing fee.\n- Explanation of why B is incorrect. If you do not react in due time to the invitation by the EPO, the application will be considered abandoned (not deemed withdrawn), as per Rule 30(3).\n- Explanation of why C is incorrect. The sequence listing should comply with WIPO Standard ST.26 and can be filed electronically in a standard-compliant format such as FASTA or XML, not necessarily in PDF.\n- Explanation of why D is incorrect. Even though the amino acid sequence is only used in an example and not claimed, Rule 56 still mandates that if the application discloses it, you must file a sequence listing. The presence of sequences in examples means they are part of the description and thus need to be listed appropriately.\n\nSources:\n\nSource: EPC Rule 30, Url: https://www.epo.org/en/legal/epc/2020/r30.html\nSource: Case Law II, C.7.5, Url: https://www.epo.org/en/legal/case-law/2022/clr_ii_c_7_5.html\nSource: Guidelines for Examination in the EPO, A-IV, 5.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iv_5_3.html\nSource: Guidelines for Examination in the EPO, A-IV, 5.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iv_5_1.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. According to the Guidelines for Examination in the EPO and relevant case law, Rule 139 EPC allows correction of errors as long as proceedings are pending before the EPO. Specifically, corrections under Rule 139 can only be made up until the decision to grant a European patent is handed over to the EPO's internal postal service (Guidelines for Examination in the EPO, H-VI 2.1). Therefore, one day before this handover would still allow for corrections.\n- Explanation of why B is incorrect. The date of publication of the mention of the grant of the European patent occurs after the decision has been handed over to the postal service and thus is too late for making any corrections under Rule 139 EPC.\n- Explanation of why C is incorrect. The date of notification of the decision to grant also comes after the handover to the internal postal service, meaning that no further corrections can be made under Rule 139 at this point.\n- Explanation of why D is incorrect. The communication under Rule 71(3) EPC typically precedes the final decision and handing over to the postal service, but it does not define the latest possible time for correction requests under Rule 139; rather, corrections must be requested before the actual handover process begins.\n\nSources:\n\nSource: EPC Rule 139, Url: https://www.epo.org/en/legal/epc/2020/r139.html\nSource: Guidelines for Examination in the EPO, A-V, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_v_3.html\nSource: Guidelines for Examination in the EPO, H-VI, 3.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_vi_3_1.html\nSource: Case Law II, E.4, Url: https://www.epo.org/en/legal/case-law/2022/clr_ii_e_4.html"
                },
                {
                    "Answer": "C",
                    "Justification": "- **Explanation of why C is correct:** Antonia can validly file EP-A with the EPO because Article 58 EPC allows any natural or legal person, or anybody equivalent to a legal person by virtue of the law governing it, to file a European patent application. Since Antonia is a natural person and has Argentinian nationality, she meets this requirement.\n\n- **Explanation of why A is incorrect:** According to PCT Article 9(1), only residents or nationals of Contracting States (parties to the PCT) may file an international application. Argentina is not a PCT contracting state as per the provided legal basis. Therefore, Antonia cannot validly file PCT-A with the International Bureau of WIPO.\n\n- **Explanation of why B is incorrect:** Similar to option A, since Argentina is not a PCT contracting state, Antonia does not have the right to file a PCT application through any receiving Office, including the EPO. The EPO cannot act as a receiving Office for an applicant from a non-PCT member country.\n\n- **Explanation of why D is incorrect:** Option D states that none of the above are correct, but since Antonia can validly file EP-A with the EPO (Option C), this option is not accurate.\n\nSources:\n\nSource: PCT Article 9, Url: https://www.wipo.int/pct/en/texts//articles/a9.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_2.html\nSource: Guidelines for Examination in the EPO, A-III, 6.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_6_2.html\nSource: Case Law VI, 3.2.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_vi_3_2_2.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- Explanation of why B is correct:\n  - Statement I states that the renewal fee for the fourth year for EP-X was due on 31 August 2022, which is true based on the typical one-year cycle from the filing date. However, it incorrectly implies that the third and fourth years' renewal fees for EP-Y were due on its divisional application filing date of 26 September 2022. According to Rule 51(1) EPC, when a divisional application is filed, the renewal fee for the divisional must be paid up to the same due date as the parent application. Therefore, the third and fourth year renewal fees for EP-Y should be due on 31 August 2022.\n  \n- Explanation of why A, C, and D are incorrect:\n  - Statement II correctly notes that the renewal fee for the fourth year for EP-X can be validly paid up to six months past its due date (i.e., up to 28 February 2023) together with the necessary additional fee as per Rule 51(4). It also correctly states that the third and fourth year renewal fees for EP-Y must be paid without additional fee up to four months from its divisional application filing date of 26 September 2022, i.e., until 31 January 2023. Thus, only Statement II is correct.\n  \n- Therefore, option B (Only statement II is correct) is the accurate response.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-IV, 1.4.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iv_1_4_3.html\nSource: Guidelines for Examination in the EPO, A-X, 5.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_4.html\nSource: EPC Rule 51, Url: https://www.epo.org/en/legal/epc/2020/r51.html\nSource: Guidelines for Examination in the EPO, A-X, 5.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_4.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. According to Rule 17(2) and Article 4(c) of the PCT, a period of two months starts from the date of receipt of the communication by the applicant. The invitation was dated 2 December 2022 but received on 12 December 2022. Therefore, the deadline for responding is calculated as follows: 12 December + 60 days = 10 February 2023 (since January has 31 days). However, if this date falls on a non-working day or holiday in the receiving office, it would be extended to the next working day. The date provided by option A, which is 2 February 2023, does not account for these additional days but follows from the basic calculation and typical interpretations of deadlines.\n- Explanation of why B is incorrect. Option B suggests a deadline of 13 February 2023, which is one day after 12 February 2023 (which would be the correct date if we start counting from December 12). Since Rule 17(2) counts days precisely and not extended unnecessarily, 13 February does not align with starting from receipt.\n- Explanation of why C is incorrect. Option C suggests a deadline of 5 February 2023, which would be calculated incorrectly based on the actual receipt date (December 12). This option fails to account for the full two months after December 12.\n- Explanation of why D is incorrect. Option D suggests a deadline of 6 February 2023, similarly miscalculating from the correct start point and not accounting for the exact two-month period.\n\nSources:\n\nSource: EPC Rule 126, Url: https://www.epo.org/en/legal/epc/2020/r126.html\nSource: Case Law III, S.4, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_s_4.html\nSource: EPC Rule 134, Url: https://www.epo.org/en/legal/epc/2020/r134.html\nSource: EPC Rule 35, Url: https://www.epo.org/en/legal/epc/2020/r35.html\nSource: Guidelines for Examination in the EPO, A-II, 3.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_3_1.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- According to Rule 69.1(a) of the PCT Regulations, the demand for international preliminary examination must be filed with the International Preliminary Examining Authority (IPEA) within twenty-two months from the priority date or three months from the date on which the applicant received the international search report and written opinion, whichever is later. Here, the priority date is 17 February 2021, making the first deadline fall on 17 December 2022 (twenty-two months). However, the second condition states that the demand must also be filed within three months from receiving the international search report and written opinion, which was transmitted to the applicant on 10 June 2022. Three months from 10 June 2022 is 10 September 2022. Since this date is earlier than 17 December 2022, it becomes the relevant deadline for filing the demand. However, since 10 September 2022 falls on a Saturday, the filing deadline is extended to the next business day, which is Monday, 12 September 2022 (option D). But given the options provided and the context of extending deadlines in patent applications to the following business days, option B (19 December 2022) aligns with the twenty-two months from the priority date rule.\n\n- Option A (17 December 2022) is incorrect because it does not account for the extension to the next business day if the deadline falls on a weekend.\n- Option C (10 September 2022) is incorrect because it doesn't consider the extension to Monday if the date falls on a Saturday or Sunday.\n- Option D (12 September 2022) would be correct for the three-month rule but isn't provided as an option in this case, and we must adhere strictly to the options given.\n\nGiven these considerations, B is the correct answer based on the extended deadline of twenty-two months from the priority date.\n\nSources:\n\nSource: EPC Article 89, Url: https://www.epo.org/en/legal/epc/2020/a89.html\nSource: Case Law IV, B.1.2.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_b_1_2_2.html"
                },
                {
                    "Answer": "D",
                    "Justification": "- Explanation of why D is correct. According to the guidelines and legal provisions discussed in the case law and EPO regulations, for both withdrawing an international patent application at the European Patent Office as a receiving office (I) and filing a demand for international preliminary examination at the European Patent Office as International Preliminary Examining Authority (II), the requirement to submit a power of attorney signed by each applicant may be waived. This is aligned with the principle that such requirements can be waived under specific conditions, especially when professional representatives act on behalf of applicants or proprietors.\n\n- Explanation of why B and C are incorrect. Both options B and C incorrectly suggest that for one of the actions (withdrawal or filing a demand), a power of attorney signed by each applicant is always required. This conflicts with the waiver principle where the requirement can be waived under certain circumstances, such as when a professional representative acts on behalf of applicants.\n\n- Explanation of why A is incorrect. Option A states that for both actions, a power of attorney signed by each applicant is always required, which does not consider the possibility of waiving this requirement when a professional representative acts accordingly. Therefore, it incorrectly assumes an absolute necessity without acknowledging the waiver provisions mentioned in EPO regulations and case law.\n\nSources:\n\nSource: PCT Rule 90, Url: https://www.wipo.int/pct/en/texts//rules/r90.html\nSource: Case Law III, V.4.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_v_4_1.html\nSource: Guidelines for Examination in the EPO, A-VIII, 1.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_viii_1_4.html"
                },
                {
                    "Answer": "C",
                    "Justification": "- Explanation of why C is correct: According to the provided guidelines and legal bases, filing the designation of the inventor is not listed as a minimum requirement for entry into the European phase. The focus is on providing specific documents, translations (if required), fees related to searches, and application specifications.\n\n- Explanation of why A, B, and D are incorrect:\n  - A: Supplying a translation if the Euro-PCT application was not published in one of the EPO's official languages is explicitly listed as a requirement.\n  - B: Specifying the application documents on which the European grant procedure is to be based is also necessary per the guidelines provided.\n  - D: Paying the search fee when a supplementary European search report is requested is mandated for entry into the phase.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-IX, 2.1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_1_1.html\nSource: Guidelines for Examination in the EPO, G-IV, 5.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/g_iv_5_2.html\nSource: Case Law II, B.6.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_ii_b_6_2.html"
                },
                {
                    "Answer": "D",
                    "Justification": "- Explanation of why D is correct: According to Article 14(3) EPC and G 4/08 of the Enlarged Board of Appeal, once an international patent application has been filed and published under the PCT in one of the official languages of the EPO (French, in this case), it cannot be translated into another official language of the EPO upon entry into the European phase. Therefore, French will remain as the language of the proceedings for the European patent application.\n- Explanation of why A is incorrect: The applicant cannot simply file a translation into English upon entering the European phase; the language used in the published international application (French) must be retained throughout the European proceedings.\n- Explanation of why B is incorrect: Although it may seem possible to enter the European phase with the French version and then file a divisional application, according to Rule 36(2) EPC and A-VII 1.3 guidelines, the language of the divisional application must be in the same language as the earlier (parent) application's proceedings, which is French.\n- Explanation of why C is incorrect: The applicant cannot arbitrarily select a different language on the request form for entry into the European phase (EPO Form 1200). The language of the published international application determines the language of the proceedings.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-VII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_2.html\nSource: Guidelines for Examination in the EPO, A-VII, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_1_1.html\nSource: Guidelines for Examination in the EPO, A-X, 9.2.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_9_2_1.html\nSource: Guidelines for Examination in the EPO, A-VII, 1.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_1_3.html"
                },
                {
                    "Answer": "D",
                    "Justification": "- Explanation of why D is correct. According to the information provided and from general knowledge of international patent applications under the Patent Cooperation Treaty (PCT), entering the national phase directly involves countries that do not require an intermediary step via regional or supra-regional offices like the EPO for \"Euro-PCT\" designations. However, Lithuania, France, and Italy are all part of the European Union and typically enter their national phases through the Euro-PCT route processed by the EPO first before entering their respective national patent office.\n- Explanation of why A (Lithuania), B (France), and C (Italy) are incorrect. These countries are covered under the Euro-PCT system, meaning that after filing an international application under PCT designating \"EP,\" the applicant would typically enter the European phase at EPO before entering any individual national phase in these countries. Therefore, they cannot directly enter the national phases of Lithuania, France, or Italy without going through the European phase first.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-III, 6.12, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_6_12.html\nSource: Guidelines for Examination in the EPO, A-III, 12.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_12_1.html\nSource: Guidelines for Examination in the EPO, E-IX, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_1.html\nSource: Guidelines for Examination in the EPO, A-III, 6.12, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_6_12.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- Explanation of why B is correct. According to Article 23(2) PCT and relevant EPO guidelines (as detailed in A-III, 13.1), for early entry into the European phase, at least the filing fee and claims fees must be paid. The application has 21 pages with 17 claims, necessitating payment of both the basic filing fee and additional claim fees.\n\n- Explanation of why B, C, and D are incorrect.\n    - **A (Payment of the filing fee):** This is insufficient because claims fees for 17 claims must also be paid as per Art. 85(3) PCT and EPO guidelines.\n    - **C (Payment of the filing fee, the claims fees, the examination fee, the designation fee, and the renewal fee for the third year):** This is incorrect because according to Article 23(2) PCT, only the filing and claims fees are mandatory for early entry. The examination fee, designation fee, and renewal fee for the third year are not required at this stage.\n    - **D (Payment of the filing fee, the designation fee, and the examination fee):** This is incorrect because while the filing fee must be paid, neither the designation fee nor the examination fee is necessary to effect early entry into the European phase. The claims fees, however, are essential.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-IX, 2.1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_1_1.html\nSource: Guidelines for Examination in the EPO, A-X, 5.2.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_1.html\nSource: Guidelines for Examination in the EPO, A-III, 11.3.9, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_11_3_9.html\nSource: Guidelines for Examination in the EPO, A-III, 13.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_13_1.html\nSource: Guidelines for Examination in the EPO, A-III, 11.2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_11_2_5.html"
                },
                {
                    "Answer": "D",
                    "Justification": "- Explanation of why D is correct. According to the guidelines for examination in the EPO, an effective withdrawal can be made up until one day before the date of publication of the mention of grant in the European Patent Bulletin, as the applicant can still make it subject to the proviso that the content not be made public if publication has not yet been finalized.\n\n- Explanation of why B is incorrect. The latest dates for payment of fees and filing translations are procedural requirements but do not define the last point of withdrawal; they are related to the formalities of granting a patent, not its withdrawal.\n\n- Explanation of why C is incorrect. Once an application is published with the mention of grant in the European Patent Bulletin, it has already been made public and cannot be withdrawn effectively as the content would have become part of the public domain.\n\n- Explanation of why A is incorrect. The receipt of communication under Rule 71(3) EPC pertains to formalities post-granting and does not mark the last point for withdrawal.\n\nSources:\n\nSource: Case Law III, K.4.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_k_4_1.html\nSource: EPC Rule 15, Url: https://www.epo.org/en/legal/epc/2020/r15.html\nSource: EPC Rule 160, Url: https://www.epo.org/en/legal/epc/2020/r160.html\nSource: EPC Rule 155, Url: https://www.epo.org/en/legal/epc/2020/r155.html\nSource: Guidelines for Examination in the EPO, A-VI, 1.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vi_1_2.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- Explanation of why B is correct. According to the Guidelines for Examination, mistakes in the published specification of a European patent can be corrected by means of a note in the European Patent Bulletin and publication of a corrigendum if discovered (see Rule 143(2) EPC). This correction aims to bring the specification into line with the content on which the decision to grant was based. Since the error here is purely printing, it can be corrected at any time after its discovery.\n- Explanation of why A is incorrect. The statement suggests that no corrections are possible, but this contradicts Rule 143(2) EPC and the Guidelines for Examination, which allow for such corrections to align with the original decision to grant.\n- Explanation of why C is incorrect. There is no restriction on correcting errors in the published specification during the opposition period or if opposition proceedings are pending. The guidelines do not impose such a limitation; hence, corrections can be made irrespective of whether opposition proceedings are ongoing.\n- Explanation of why D is incorrect. This statement incorrectly limits the correction to when opposition proceedings are pending, while Rule 143(2) EPC and the Guidelines for Examination state that such errors can be corrected at any time without this condition.\n\nSources:\n\nSource: Case Law III, L.5, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_l_5.html\nSource: Guidelines for Examination in the EPO, H-VI, 6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_vi_6.html\nSource: Guidelines for Examination in the EPO, H-VI, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_vi_3.html\nSource: Guidelines for Examination in the EPO, C-V, 10, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_v_10.html\nSource: Guidelines for Examination in the EPO, H-VI, 3.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_vi_3_1.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. According to EPC Rule 56 and the Guidelines for Examination, if page 3 of the description and claims 7-12 are missing from EP-A, the Receiving Section will invite you to file these missing parts within a time limit of two months. The fees have not been paid yet, which means there is still an opportunity to rectify the defect without re-dating the application.\n\n- Explanation of why B is incorrect. Although it might seem that you can file page 3 of the description at any time up to January 2023, Rule 56 specifies that you must file missing parts within two months from notification by the EPO or else the application will be re-dated. Thus, simply filing the missing pages without a specific invitation could lead to an unwanted change in the date of filing.\n\n- Explanation of why C is incorrect. You cannot add claims at any time if they were originally missing and not filed within the given time frame by the EPO's rules (Rule 56). If you attempt to add them outside this period, it would be considered a new application or an amendment that could re-date your application.\n\n- Explanation of why D is incorrect. Refiling EP-A and claiming priority from FR-A would not be optimal because it introduces unnecessary complications and risks losing the original filing date (27 October 2022). It also involves additional costs and time without guaranteeing the desired outcome, whereas following the EPO’s procedures to file missing parts can maintain the original application's date.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-II, 4.1.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_4_1_4.html\nSource: Guidelines for Examination in the EPO, A-III, 15, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_15.html\nSource: EPC Rule 56, Url: https://www.epo.org/en/legal/epc/2020/r56.html\nSource: Guidelines for Examination in the EPO, A-III, 6.6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_6_6.html"
                }
            ]
        },
        {
            "filename": "2023_EPAC_mcq.json",
            "questions": [
                {
                    "question": "A European patent was granted to a German company on 4  January 2023. No opposition was filed. Mr Li and Ms Smith were designated as inventors. On 12 October 2023,  the patent proprietor not ices that Ms Smith was erroneously designated as inventor and that Mr Li is the sole inventor.  Which of the following statements is correct?",
                    "options": [
                        "A. Ms Smith will be deleted as inventor if the patent proprietor requests this in writing .",
                        "B. Ms Smith can no longer  be deleted as inventor because no proceedings are pending before the EPO .",
                        "C. The patent proprietor can request that  Ms Smith be deleted as inventor but needs Mr Li 's consent  for this .",
                        "D. Ms Smith can only be deleted as inventor with her consent ."
                    ]
                },
                {
                    "question": "On 10 October 2021, European patent attorney X filed European patent application EP -A with the EPO on the applicant's behalf. Application EP -A was published on 12 April 2023, together  with the extended European search report. On 6  October 2023, the applicant contacts a new European patent attorney  Y to replace X as representative and issues Y with its instructions to reply to the extended European search report. The applicant did not inform X that he would be replaced.  What are the steps necessary to validly appoint representative Y and to avoid any loss of rights for European patent application EP -A?",
                    "options": [
                        "A. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 12 October 2023 at the latest and files in good time an authorisation signed by the applicant .",
                        "B. New representative Y requests a change of representative and files a response to the extended European search report with  the EPO by 12 October 2023 at the latest .",
                        "C. New representative Y requests a change of representative and files a response to the extended European search report with the EPO by 23 October 2023 at the latest.",
                        "D. New representative Y requests a change of representative, files a response to the extended European search report with the EPO by 23 October 2023 at the latest and files in good time an authorisation signed by the applicant ."
                    ]
                },
                {
                    "question": "EP-1 is a regular European patent application (Euro -direct application) .  Which one of the following missed time limits can be remedied for EP -1 before the EPO by requesting re- establishment of rights ?",
                    "options": [
                        "A. T ime limit for pay ing the designation fee",
                        "B. T ime limit for requesting examination",
                        "C. T ime limit for filing the application within the priority period",
                        "D. T ime limit for paying the fee for re- establishment of rights"
                    ]
                },
                {
                    "question": "Last week Greta validly filed the international patent application PCT -G with the German Patent and Trade mark Office ( DPMA ) and appointed Hassan to represent her. Hassan is entitled to act before the DPMA  but he is not a European patent attorney. Greta and Hassan are resident in Germany.  Which of the following statements is not correct?",
                    "options": [
                        "A. Hassan can represent Greta before the EPO acting as the International Searching Authority for PCT -G.",
                        "B. In order for Hassan to be able to act before the EPO acting as the International Searching Authority , he needs to submit a power of attorney signed by Greta.",
                        "C. According to the provisions of the PCT, it is mandatory that the d emand for international preliminary examination is signed by Greta or Hassan.",
                        "D. According to the provisions of the PCT, an international application can only be withdrawn by the applicant or an agent appointed by a power of attorney."
                    ]
                },
                {
                    "question": "In which of the following cases is the applicant entitled to a reduction of the filing fee  under Rule  6 EPC ? A declaration of such entitlement has  been made by crossing the relevant box on Form  1001.",
                    "options": [
                        "A. A Spanish European patent attorney files a European patent application in Spanish for a natural person who is resident in Andorra and of Andorra n nationality .",
                        "B. A firm whose principal place of business is in Germany and a natural person who is resident in Germany  and of Dutch nationality  jointly file a European patent application in Dutch. The German firm employs 200 people with an annual turnover of EUR 60 million.",
                        "C. A natural person resident in the USA and of Belgian nationality files a European patent application in French.",
                        "D. A natural person resident in the USA and of Swiss nationality files a European patent application in Italian."
                    ]
                },
                {
                    "question": "Mr Van Holland is a Dutch citizen resident in the Netherlands. He filed a European patent application EP -parent in Dutch, together with  a translation into English. Whil e EP-parent was pending, Mr Van Holland filed a divisional application EP -div in Dutch and requested examination in Dutch. He paid all fees due for EP -div. He has not filed an English translation of EP -div. The Receiving Section has now issued a noting of l oss of rights.  Which of the following statements is correct?",
                    "options": [
                        "A. The deficiency cannot be remedied.",
                        "B. Mr Van Holland can remedy the deficiency by filing an English translation of EP -div within two months of notification of the communication  under Rule 112(1) EPC .",
                        "C. Mr Van Holland needs to file an English translation of EP -div together with a request for f urther processing.",
                        "D. Mr Van Holland needs to file an English translation of EP -div together with a request for re- establishment of rights."
                    ]
                },
                {
                    "question": "On 16  November 2020, you filed a European patent application EP -A, which did not claim priority. Today, 12  October 2023, you receive a communication from the EPO entitled \" Decision to grant a European patent pursuant to Article  97(1) EPC \". This communication state s that the mention of the grant You wish to validate the patent in only two contracting states  to the EPC . Which of the following statements is correct?",
                    "options": [
                        "A. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 16 November 2023.",
                        "B. The renewal fee for the fourth year must be paid centrally to the EPO. The due date is 30 November 2023.",
                        "C. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 9 January 2024 at the latest .",
                        "D. The renewal fee for the fourth year must be paid separately in each state where the patent is validated. The renewal fee for the fourth year can be validly paid without any additional fee until 16 January 2024 at the latest ."
                    ]
                },
                {
                    "question": "During oral proceedings, the opposition division decided to maintain the patent in amended form on the basis of a request in which the description contains a paragraph with handwritten amendments.  Which of the following statements is correct ?",
                    "options": [
                        "A. Upon request the patent proprietor must  pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the entire description.",
                        "B. If a party files an appeal, the patent proprietor will not be invited to pay the fee for publishing a new specification, file translations of the claims or file a formally compliant version of the amended paragraph  while the appeal proceedings are still pending.",
                        "C. Together with the interlocutory decision, the patent proprietor will receive an invitation to pay the fee for publishing a new specification, file translations of the claims and file a formally compliant version of the amended paragraph.",
                        "D. If no appeal is filed, the patent proprietor must, upon request, pay the fee for publishing a new specification, file translations of the claims and file a typed version of the amended paragraph within four months."
                    ]
                },
                {
                    "question": "Under the PCT, what is the time limit for filing a request for rectification of an obvious mistake made in the international application?",
                    "options": [
                        "A. 18 months from the earliest priority date",
                        "B. 30 months from the earliest priority date",
                        "C. 22 months from the earliest priority date",
                        "D. 26 months from the earliest priority date"
                    ]
                },
                {
                    "question": "After receipt of a negative written opinion issued by the EPO acting as ISA, amendments under Art icle 19 PCT were filed during the international phase. No request for international preliminary examination was filed. Form  1200 was used,  and no further amendments were filed with the EPO upon entry into the regional phase.   What communication under Rules  161/162 EPC will be received in the regional phase?",
                    "options": [
                        "A. Form 1226AA ;  if you do not reply to it in time, the application will be deemed to be withdrawn",
                        "B. Form 1226BB offering the opportunity to comment and file amendments",
                        "C. Form 1226CC offering the opportunity to file amendments before the supplementary European search report is drawn up",
                        "D. Form 1226AC stating that the examination has started"
                    ]
                },
                {
                    "question": "Company M, which has  its principal place of business in Tijuana, Mexico, validly filed an international patent application PCT -M with the Mexican Institute of Industrial Property. The application was filed in Spanish. A few days later, the applicant files an English translati on of the application.  Which of the following statements is correct?",
                    "options": [
                        "A. The applicant can choose the EPO as ISA and the USPTO as IPEA.",
                        "B. The applicant can choose the USPTO as ISA and the EPO as IPEA.",
                        "C. The applicant can choose the Austrian Patent Offic e as ISA and the",
                        "EPO as IPEA.",
                        "D. The applicant can choose the EPO as ISA and the Intellectual Property",
                        "Office of Singapore as IPEA."
                    ]
                },
                {
                    "question": "On 20  June 2023, applicant P validly filed an international patent application PCT-P, claiming priority from European patent application EP -I filed on 7 July 2022. Today, 12 October 2023, he discovers that he should also have claimed priority from EP -II filed on 3 July 2022. Can the missing priority claim still be validly added?",
                    "options": [
                        "A. Yes, the time  limit for adding the priority claim expires on 3  November 2023.",
                        "B. Yes, the time limit for adding the priority claim expires on 7  November 2023.",
                        "C. Yes, the time  limit for adding the priority claim expires on 20 October 2023.",
                        "D. No, the time  limit for adding the priority claim expired on 3 July 2023."
                    ]
                },
                {
                    "question": "The opposition division revoked European patent EP -B1. The patent proprietor filed an appeal  in time . The b oard of appeal forwarded a copy of the appeal to the o pponent/ respondent with a communication dated 1 June 2023 giving it an opportunity to file comments within a period of four  months.  The opponent/respondent files comments today, 12 October 2023. What further action has to be taken ?",
                    "options": [
                        "A. The opponent/ respondent needs  to request an extension of the period for comment.",
                        "B. The opponent/respondent needs to pay a fee for further processing.",
                        "C. The opponent/respondent needs to file a substantiated request for reestablishment of rights and pay the associated fee.",
                        "D. None of the above."
                    ]
                },
                {
                    "question": "A European patent application was filed on 20 March 2020. Proceedings were interrupted under  Rule 142 EPC on 10  March 2022. The applicant was informed that proceedings would be resumed today, 12 October 2023. No renewal fee has been paid so far . Which of the following statements is correct?",
                    "options": [
                        "A. As no renewal fees have been paid, the application is deemed to be withdrawn .",
                        "B. The renewal fees for the third and fourth years can be validly paid without any additional fee on 12 October 2023 at the latest .",
                        "C. The renewal fees for the third and fourth years can be validly paid with an additional  fee by 30  April 2024 at the latest .",
                        "D. The renewal fees for the third and fourth years can be validly paid without any additional fee by 31  October 2023 at the latest ."
                    ]
                }
            ],
            "answers": [
                {
                    "Answer": "D",
                    "Justification": "Legal basis A n incorrect designation of inventor shall be rectiﬁed upon request and only with the consent of the wrongly designated person and, where such a request is ﬁled by a third party, the consent of the applicant for or proprietor of the patent (R. 21(1) EPC)."
                },
                {
                    "Answer": "A",
                    "Justification": "Legal basis R epresentative X is a representative according to article 134.1 EPC and is already registered as representative for the European patent application EP -A, so any registration of change in representation by a new European patent atorney necessitates an authorization for representation signed by the applicant to be validly registered by the EPO. According to rule 152(1) EPC, The President of the European Patent Offi ce shall determine the cases in which a signed authorization shall be ﬁled by representatives acting before the European Patent Office. In decision of the President of the EPO of 12.07.2007 on the ﬁling of authorizations (Special edition No. 3, OJ EPO 2 007, L.1), (2) If the European Patent Office is informed of a change of representative involving professional representatives who are not members of the same association, without being notiﬁed that the previous representative's authorization has terminate d, the new representative must ﬁle, together with the notiﬁcation of his appointment, an individual authorization (original and one copy) or a reference to a general authorization already on ﬁle If an authorization for representation is not provided, an y acts done by the “new” representative will be deemed to never have occurred by the EPO. R 152(6) Representative Y shall ﬁle a change in representation with form 5060 to register before the EPO as the new representative, an authorization of representatio n signed by the applicant for the change in representation to be valid and a response to the writen opinion before the EPO before: T ime limit to respond to the negative search opinion: publication  date  of the EESR: 12 April 2023 + 6 months (R 70a(1) + R  70(1) EPC) = 12 October 2023  (Tuesday) 2"
                },
                {
                    "Answer": "C",
                    "Justification": "Legal basis Ac cording to Art. 122 EPC and Rule 136(1) EPC it is possible to obtain re -establishment of rights in respect of the priority period (twelve months according to Art. 87(1)  EPC). A : Rule 136(3) EPC: Further processing is available B: Rule 136(3) EPC: Further processing is available D: Article 122(4) EPC Re -establishment of rights shall be ruled out in respect of the time limit for requesting re-establishment of rights Question 4 : B Legal basis Rule 90.4(d) PCT Subject to paragraph (e), any r eceiving Office,  any International Searching Authorit y, any Authority c ompetent to carry o ut supplementary s earches,  any I nternation al Preliminary Examining Authority a nd the International Bureau may waive the requ irement under paragraph (b) tha t a separate power o f atorney be submited to it, in which case paragraph (c) shall not appl y. Question 5 : D Legal b asis Art. 14(4) EPC: “Natural or legal persons having their residence or princip al place of business within a Contracting State  having a language othe r than English, French or German as an offic ial language, and nationals of that State  who are resident abroad, may ﬁle documents which have to be ﬁled within a time limit in an offic ial language of that State .” Article 14(1) RFees : 30% reduction of the application fee; Rule 6 RFees A-X, 9.2.1; A-X, 9.2.2 A-X, 9.2.1 Conditions - Guidelines for Examinatio n (epo.org) A-X, 9.2.2 Reduction o f the ﬁ ling f ee - Guidelines for Examination (epo.org) Notice from t he EPO date d 10 January 2014 concerning amended Rule  6 EPC an d Article 14(1 ) RFees ( EPO - Notice f rom t he E PO d ated 1 0 January 2014 concerning amended Rule 6 EPC and Article 14(1 ) RFees ) A. Not c orrect ( Andorra i s not an EPC contracting state); A rt. 14(4) E PC relates t o the applicant and not to his representative) 3 B. Not correct (the German company is not considered as SME - R. 6(4)a, R. 6(7) // Notice from the EPO dated 10 January 2014 concerning amended Rule 6 EPC and Art. 14(1) RFEES) C. Not correct (French is an official language of the EPO  Art. 14(1) EPC ) D. Correct (applicant of an EPC contracting state with resident abroad; Italian is official language of Switzerland ; natural person is entitled to the reduction )"
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Rule 90.4(d) PCT Subject to paragraph (e), any receiving Office, any International Searching Authority, any Authority competent to carry out supplementary searches, any International Preliminary Examining Authority and the International Bureau may waive the requirement under paragraph (b) that a separate power of attorney be submitted to it, in which case paragraph (c) shall not apply."
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis Art. 14(4) EPC: “Natural or legal persons having their residence or principal place of business within a Contracting State having a language other than English, French or German as an official language, and nationals of that State who are resident abroad, may file documents which have to be filed within a time limit in an official language of that State.”"
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis R36(2), R135(2) EPC The English translation of the application documents must  be ﬁled within 2 months of ﬁling the DA. If the English translation is not ﬁled: The EPO will issue  a communication pursuant to  Rule 58 EPC seting a time limit of further 2 months for ﬁling the  translation. If the English translation is not ﬁled within the time limit set by the communication pursuant Rule 58 EPC: a loss of rights communication is issued: f urther processing is ruled out for  the missing 2 -month time limit of Rule 58 EPC  -> re-establishment of rights ."
                },
                {
                    "Answer": "C",
                    "Justification": "Legal basis Art 86 EPC, Rule 51 EPC, Art 141 EPC Due date of the renewal fee: 30 November 2023 = atier grant of the patent renewal fee must be paid to the national offices. Time limit: 2 months of publication of grant in the European Patent Bulletin: 8 January 2014"
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Guidelines D- VI, 7.2.3 A: incorrect because of the entire description B: correct C: incorrect ; the invitation  is not  issued  together  with  the interlocutory  decision , but atier the interlocutory  decision  has become  ﬁnal and can no longer  be appealed D: incorrect: 3 months is correct Rule 82(2)  EPC 4"
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis R 91.2 PCT : the time limit for ﬁling a request for rectiﬁcation of an obvious mistake is 26 months from the earliest priority date"
                },
                {
                    "Answer": "C",
                    "Justification": "(the most correct answer), D (also possible) Legal basis A rt. 121(1) (2), Rule 135(1) and (3) EPC, Art. 2(1), item 12 RFees Guidelines for Examination E -VIII, 2 (Further processing) and E -VIII, 3.1.3 E-IX, 2.3.1 (Representation, address for correspondence) Comment: A good paralegal will perform all acts of C, including  the appointment of the representative. H owever , formally/grammatically D can also be considered as a correct answer to the question,  because the appointment of the professional representative can be done later (if the translation is supplied and the fees are paid, but no professional representative has been appointed, the JP applicant may be invited to appoint a professional representative under R 163(5) EPC. The procedural acts of requesting examination and filing the translation could also be c onsidered as unsigned documents, because the JP applicant is not entitled to sign.   He might receive an invitation under R 50(3) EPC to supply a missing signature, which can be fulfilled by appointing a professional representative."
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis G uide for applicants: PCT procedure before the EPO (Euro -PCT Guide) - 5.4 Amending the application - Rule 161/162 communication G uidelines for examination GL E -IX, 2.1.1 ( 2.1.1 Requirements for entry into the European phase (epo.org) ) E-IX, 3.3.1 ( htps://www.epo.org/law -p ractice/legal- texts/html/guidelines/e/e_ix_3_3_1.htm ) 5 “A reply to the communication under Rule 161(1)  may not be necessary … If the applicant ﬁled amendments according to Art. 19  and/or 34 PCT  in the international phase, and if the EPO prepared the WO -ISA or SISR but no IPER (either because the applicant did not demand PCT Chapter II  or because the IPEA was an office other than the EPO), then these amendments are considered to constitute a response to the WO -ISA or SISR, provided that the applicant has indicated on entry into the European phase that these amendments are maintained…”"
                },
                {
                    "Answer": "C",
                    "Justification": "Legal basis Explanation: Applicant's Guide - MX - Annex C - Receiving Office PCT Applicant's Guide Mexico - Valid as from 13 Apr 2023 (wipo. int) Competent International Searching Authority: AT, CL, EP , ES, KR, SE, SG, US Competent International Preliminary Examining Authority: AT, CL*, EP**, ES, KR, SE, SG*, US* * The Office is competent only if the international search is or has been carried out by that Office. ** The Office is competent only if the international search is or has been carried out by that Office, the Austrian Patent Office, the Spanish Patent and Trademark Office or the Swedish Intellectual Property Office (PRV)."
                },
                {
                    "Answer": "A",
                    "Justification": "Legal basis PCT Rule 26 bis.1 (a), stating : “The applicant may correct a priority claim or add a priority claim to the request by a notice submited to the receiving Office or the International Bureau within a time limit of 16 months from the priority date or, where the correction or addition would  cause a change in the priority date, 16 months from the priority date as so changed, whichever 16 -month period expires ﬁrst, provided that such a notice may be submited until the expiration of four months from the international ﬁling date.” 6 Questio n 14: D Legal basis A n extension must be requested before expiry of the period for responding not the case here. Further processing is only available to applicants (and thus before grant). The non- observance of the time limit to ﬁle comments does not have the direct consequence demanded for re -establishment of rights in Art 122(1). [see G1/90] Therefore, only D can be correct,  and the Board will exercise its discretion. The Opponent/Respon dent should thus submit reasons for submiting them late."
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis An extension must be requested before expiry of the period for responding not the case here. Further processing is only available to applicants (and thus before grant). The non-observance of the time limit to file comments does not have the direct consequence demanded for re-establishment of rights in Art 122(1). [see G1/90] Therefore, only D can be correct, and the Board will exercise its discretion. The Opponent/Respondent should thus submit reasons for submiting them late."
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Guidelines, E -Vii.1.5 Concerning renewal fees falling due during the period of interruption, Rule 142(4) has to be interpreted as deferring the due date for their payment until the date the proceedings are resumed (J 902/87). Thus, such renewal fees may be paid without additional fee at the date of resumption and in the amounts applicable on that date. They may also be paid within six months of said date, provided that an additional fee is also paid within said period (Rule 51(2))."
                }
            ],
            "ai_answers": [
                {
                    "Answer": "D",
                    "Justification": "- Explanation of why D is correct:\n  According to Rule 21(1) EPC and the Guidelines for Examination (A-III, 5.5), an incorrect designation may be rectified only with the consent of the wrongly designated person (in this case, Ms Smith). Therefore, Ms Smith must give her consent before she can be deleted as inventor.\n\n- Explanation of why B is incorrect:\n  There is no rule that precludes deleting a wrongly designated inventor simply because there are no pending proceedings. Even if no opposition was filed or other proceedings were ongoing, the EPO still allows for rectification with proper consent.\n\n- Explanation of why C is incorrect:\n  The requirement under Rule 21(1) EPC and Guidelines (A-III, 5.5) explicitly states that only Ms Smith's consent is needed to remove her name from the designation as inventor. Mr Li’s consent is not required for this action.\n\n- Explanation of why A is incorrect:\n  Simply requesting in writing is insufficient without Ms Smith’s consent. Rule 21(1) EPC mandates her consent for the rectification process to proceed, hence a written request alone would not be enough to remove Ms Smith as inventor.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-III, 5.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_5_5.html\nSource: Guidelines for Examination in the EPO, D-VIII, 1.2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_viii_1_2_5.html\nSource: Case Law IV, A.6.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_a_6_2.html\nSource: Guidelines for Examination in the EPO, D-VI, 2.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_vi_2_2.html\nSource: EPC Rule 21, Url: https://www.epo.org/en/legal/epc/2020/r21.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. According to the case law and guidelines provided, European patent attorney Y must request a change of representative, file a response to the extended European search report by 12 October 2023 at the latest (since the response deadline for an extended European search report is two months from the publication date), and file in good time an authorisation signed by the applicant. The authorization ensures that Y has valid authority to act on behalf of the applicant.\n\n- Explanation of why B, C, and D are incorrect.\n  - Option B: While it mentions requesting a change of representative and filing a response within the deadline (12 October 2023), it fails to mention the necessity of filing an authorisation signed by the applicant. Without this authorization, Y's actions may be considered invalid or unauthorized.\n\n  - Option C: This option only requests a change of representative but extends the deadline for responding beyond 12 October 2023 (which is incorrect). The extended European search report response must still be filed within two months from publication (by 12 October 2023 at the latest).\n\n  - Option D: While this option mentions all necessary steps, including filing an authorisation signed by the applicant and requesting a change of representative, it incorrectly extends the deadline for responding to 23 October 2023. The response must still be filed by 12 October 2023 at the latest to avoid any loss of rights.\n\nTherefore, Option A is the only correct answer as it includes all necessary actions and adheres to the deadlines specified.\n\nSources:\n\nSource: Case Law III, V.4.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_v_4_1.html\nSource: Guidelines for Examination in the EPO, A-VIII, 1.8, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_viii_1_8.html\nSource: Guidelines for Examination in the EPO, D-VIII, 1.2.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_viii_1_2_3.html\nSource: Guidelines for Examination in the EPO, A-VIII, 1.7, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_viii_1_7.html"
                },
                {
                    "Answer": "C",
                    "Justification": "- Explanation of why C is correct. According to Article 122(4) EPC, re-establishment of rights can be requested for missed time limits such as filing an application within the priority period (Art. 87 EPC). Therefore, if the time limit for filing the application within the priority period was missed, a request for re-establishment of rights is admissible.\n\n- Explanation of why A and B are incorrect: The Implementing Regulations rule out re-establishment of rights for certain specific time limits, including paying designation fees (Art. 123(4) RPBA) and requesting examination (Rule 57(2)(b) EPC). Hence, missing the time limit for these actions cannot be remedied through a request for re-establishment.\n\n- Explanation of why D is incorrect: Article 122(4) explicitly states that re-establishment of rights shall be ruled out in respect of the time limit for requesting re-establishment itself. Therefore, if one misses the time limit to pay the fee for re-establishment of rights, it cannot be remedied by another request for re-establishment.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-VIII, 3.1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_3_1_1.html\nSource: Case Law III, E.3.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_e_3_2.html\nSource: Guidelines for Examination in the EPO, E-VIII, 3.1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_3_1_1.html\nSource: EPC Article 122, Url: https://www.epo.org/en/legal/epc/2020/a122.html\nSource: Case Law III, E.4.1.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_e_4_1_2.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. Hassan can represent Greta before the DPMA and under PCT rules, agents who are entitled to act before a receiving office (such as DPMA) can also act on behalf of applicants in international patent procedures up until certain points. However, this does not extend automatically to representation before the European Patent Office acting as an International Searching Authority without further authorization.\n\n- Explanation of why B is incorrect. Hassan needs to submit a power of attorney signed by Greta only if he is supposed to represent her beyond what his current entitlements allow under PCT rules. Since Hassan is already entitled to act on behalf of Greta before the DPMA, and the question does not specify that further authorization is required for acting before EPO as ISA, this statement would imply an unnecessary step.\n\n- Explanation of why C is incorrect. According to Article 39(2) of the PCT Regulations, demands for international preliminary examination must be signed by the applicant or their representative. Hence, Hassan, as Greta's appointed representative, can sign the demand on her behalf without any issues.\n\n- Explanation of why D is incorrect. The provisions under Article 17(b)(iii) of the PCT state that an international application may only be withdrawn with the consent of all applicants, and this withdrawal must be carried out in writing by the applicant or their authorized representative (who must submit a power of attorney). Thus, Hassan can withdraw the application as long as he has a valid power of attorney from Greta.\n\nSources:\n\nSource: Case Law III, D.4.6, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_d_4_6.html\nSource: PCT Article 49, Url: https://www.wipo.int/pct/en/texts//articles/a49.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.3.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_3_1.html\nSource: PCT Article 16, Url: https://www.wipo.int/pct/en/texts//articles/a16.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. According to Rule 6(3) EPC and Article 14(2), an applicant entitled to a fee reduction must be either resident or have their principal place of business in a contracting state with the language of filing as its official language, or be a national of such a contracting state. In option A, the natural person is of Spanish nationality (an admissible non-EPO language) and files the application in Spanish, meeting these criteria.\n- Explanation of why B is incorrect. The firm in Germany does not meet the eligibility criteria for fee reduction since it employs more than 100 people with an annual turnover exceeding EUR 10 million (Rule 6(3)(a)). Additionally, even though one co-applicant has Dutch nationality and files in Dutch, this alone doesn’t suffice to qualify under Rule 6(3) EPC.\n- Explanation of why C is incorrect. The applicant in the USA filing a European patent application in French does not meet the criteria for fee reduction as per Article 14(2). French is an official EPO language and hence no reduction applies.\n- Explanation of why D is incorrect. Although the natural person is Swiss, Italian is not an official language of Switzerland. Therefore, filing in Italian does not qualify under Rule 6(3) since it fails to meet the requirement for admissible non-EPO languages (i.e., a contracting state having that language as its official language).\n\nSources:\n\nSource: Case Law III, F.6.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_f_6_1.html\nSource: Case Law III, F.4, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_f_4.html\nSource: Guidelines for Examination in the EPO, A-X, 9.2.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_9_2_2.html\nSource: Guidelines for Examination in the EPO, A-X, 9.2.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_9_2_1.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct: According to Rule 36(2) and relevant guidelines, if a European patent application (EP-parent) was filed in Dutch with an English translation provided, any subsequent divisional applications must also be filed in the language of the earlier parent application's proceedings. In this case, the parent application was pending in English, so Mr Van Holland should have filed the EP-div in English or at least submitted an English translation within two months as required under Rule 36(2). Since he did not file a translation and the Receiving Section has already issued a noting of loss of rights (Rule 112(1) EPC), it implies that the deficiency is irreversible according to standard procedural rules.\n\n- Explanation of why B, C, and D are incorrect:\n    - Option B: Once the Receiving Section issues a notification under Rule 112(1), which results in loss of rights if not remedied within the time frame, there typically isn't an automatic right to remedy the deficiency by merely filing a translation afterward.\n    - Option C: A request for further processing would usually require a prior failure to comply with specific procedural rules. The noting of loss of rights indicates that any such requests are already too late and insufficient to remedy the situation.\n    - Option D: Requesting re-establishment of rights (Rule 134) is typically only applicable when there was fault on the part of the EPO or if it can be demonstrated that a deficiency was due to circumstances beyond Mr Van Holland's control, neither of which are suggested by the given facts.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-III, 14, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_14.html\nSource: Case Law II, F.3.3, Url: https://www.epo.org/en/legal/case-law/2022/clr_ii_f_3_3.html\nSource: Guidelines for Examination in the EPO, A-III, 6.8.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_6_8_3.html\nSource: Case Law III, A.4.2.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_a_4_2_1.html\nSource: Guidelines for Examination in the EPO, A-VII, 1.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_1_3.html"
                },
                {
                    "Answer": "D",
                    "Justification": "- Explanation of why D is correct: According to the provided information and EPC rules, when an application reaches the grant stage (communicated by the EPO as per Article 97(1) EPC), the obligation to pay renewal fees centrally to the EPO ends. The last renewal fee due before validation in contracting states would be for the year following the third anniversary of the filing date (i.e., the fourth year). Therefore, after receiving the grant communication on 12 October 2023, you must validate the patent in two contracting states and pay the renewal fees to these states. The due date is generally four months from the last day of the month following the third anniversary of the filing date, which is 16 November 2020 + 3 years = 16 November 2023. Four months after that is until 16 January 2024 at the latest without any additional fee.\n  \n- Explanation of why B and C are incorrect: Options B and C incorrectly state the due date or the method of payment (i.e., central payment to the EPO for the fourth year). The renewal fees for validating in contracting states must be paid separately, not centrally.\n\n- Explanation of why A is incorrect: Option A incorrectly indicates that the fee can be paid centrally to the EPO and specifies an incorrect due date. After grant communication, the responsibility shifts to paying renewal fees directly in each contracting state where validation is sought.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-X, 5.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_4.html\nSource: Guidelines for Examination in the EPO, A-X, 5.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_4.html\nSource: EPC Rule 51, Url: https://www.epo.org/en/legal/epc/2020/r51.html\nSource: Guidelines for Examination in the EPO, A-X, 5.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_4.html"
                },
                {
                    "Answer": "C",
                    "Justification": "- Explanation of why C is correct: According to R. 82(2) EPC and related guidelines, when an interlocutory decision is issued during oral proceedings for maintaining a patent in amended form with handwritten amendments, the formalities officer will invite the patent proprietor to file a formally compliant version of the text passages under Rule 82(2). This also includes paying the fee for publishing a new specification and filing translations of the claims as necessary.\n\n- Explanation of why B is incorrect: If an appeal is filed against the interlocutory decision, it does not prevent the formalities officer from requesting compliance with Rule 82(2) regarding the payment of fees and submission of formally compliant versions. The patent proprietor will still need to comply regardless of pending appeal proceedings.\n\n- Explanation of why A is incorrect: The statement implies that the patent proprietor must pay all required fees and file translations immediately upon request, without providing a specific time frame or context (like receiving an invitation with the interlocutory decision).\n\n- Explanation of why D is incorrect: While it mentions the necessity to comply if no appeal is filed, this option incorrectly specifies a four-month timeframe which does not align with the standard procedure that involves sending an explicit invitation after issuing the interlocutory decision. The exact timing for compliance can vary and should be clearly stated in the official communication from the formalities officer.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, D-VI, 7.2.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_vi_7_2_3.html\nSource: Guidelines for Examination in the EPO, E-III, 8.7.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_iii_8_7_3.html\nSource: Guidelines for Examination in the EPO, D-VI, 7.2.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_vi_7_2_1.html\nSource: Case Law IV, C.8.2.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_c_8_2_2.html\nSource: Guidelines for Examination in the EPO, E-XII, 9, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_xii_9.html"
                },
                {
                    "Answer": "D",
                    "Justification": "- Explanation of why D is correct. According to Legal basis R 91.2 PCT, the time limit for filing a request for rectification of an obvious mistake made in the international application is 26 months from the earliest priority date.\n\n- Explanation of why B, C, and D are incorrect.\n  - Option A (18 months) is incorrect because it does not align with the specific time frame outlined in R 91.2 PCT for rectification purposes.\n  - Option B (30 months) is incorrect as the legal basis clearly specifies a different period for rectification that does not extend to 30 months.\n  - Option C (22 months) is also incorrect because it falls short of the specified time limit set by R 91.2 PCT, which allows up to 26 months from the earliest priority date.\n\nSources:\n\nSource: PCT Rule 30, Url: https://www.wipo.int/pct/en/texts//rules/r30.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. According to E-IX 3.3.1(ii), if amendments under Article 19 PCT have been filed during the international phase and no request for an International Preliminary Examination Report (IPER) has been made, these amendments are considered a response to the written opinion issued by the ISA/EPO. However, since Form 1200 was used upon entry into the regional phase without further amendments or comments, the EPO will issue a communication under Rule 161(1), which is typically Form 1226AA. Failure to respond timely will lead to the application being deemed withdrawn.\n\n- Explanation of why B, C, and D are incorrect.\n    - Option B (Form 1226BB) offers the opportunity to comment and file amendments but would not be issued if there was already a valid response in place from the international phase. Since no further action was taken upon entry into the regional phase, Form 1226BB is not applicable.\n    - Option C (Form 1226CC) offers an opportunity to file amendments before the supplementary European search report but would only be issued if there were no valid response from the international phase. Since Article 19 PCT amendments have already been considered a valid response, this form will not be issued.\n    - Option D (Form 1226AC stating that examination has started) does not align with the scenario since no further action was taken upon entry into the regional phase and a formal reply is still required to confirm these amendments. The examination process cannot start without a valid response from the applicant acknowledging the previously filed amendments or filing new ones.\n\nThus, Form 1226AA will be issued as the communication under Rule 161(1), and if not responded to in time, the application will be deemed withdrawn.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-IX, 3.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_3_4.html\nSource: Guidelines for Examination in the EPO, C-III, 2.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_iii_2_2.html\nSource: Guidelines for Examination in the EPO, C-II, 3.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_ii_3_2.html\nSource: Guidelines for Examination in the EPO, E-IX, 3.3.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_3_3_1.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. According to the Patent Cooperation Treaty (PCT) regulations, applicants can choose any International Searching Authority (ISA) and International Preliminary Examining Authority (IPEA) from a list of authorized offices as long as they are different entities. The EPO is an ISA, and the USPTO is both an ISA and IPEA. Since the applicant's principal place of business is in Mexico, which allows them to file in Spanish initially with their national office, it means they can select any other designated authority for further processing stages.\n- Explanation of why B is incorrect. According to PCT rules, the ISA and IPEA must be different entities. The USPTO cannot serve both as the ISA and IPEA for a single application.\n- Explanation of why C is incorrect. The Austrian Patent Office (APO) can act as an ISA but not as an IPEA. Additionally, the EPO cannot be selected if APO serves as ISA because they must be from different countries.\n- Explanation of why D is incorrect. While the Intellectual Property Office of Singapore (IPOS) can function as an IPEA, it is not listed as a recognized ISA under PCT rules. Therefore, this combination does not comply with PCT regulations.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-IX, 2.5.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_5_1.html\nSource: Guidelines for Examination in the EPO, A-VII, 7, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_7.html\nSource: Guidelines for Examination in the EPO, A-X, 9.2.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_9_2_1.html\nSource: Case Law II, E.1.2.3, Url: https://www.epo.org/en/legal/case-law/2022/clr_ii_e_1_2_3.html"
                },
                {
                    "Answer": "D",
                    "Justification": "- Explanation of why D is correct. According to Rule 52(2) of the European Patent Convention (EPC), a priority claim can be added within 16 months from the filing date of the earlier application, unless it has already been filed as an international or regional patent application. Here, EP-II was filed on 3 July 2022 and PCT-P on 20 June 2023 is well beyond the 16-month deadline (which would have expired on 3 January 2024). However, under Rule 59 EPC, if a priority claim has not been made at all within this period, it cannot be added later. Since PCT-P already includes another priority claim from EP-I and the time limit to add additional claims (16 months after the filing date of the earlier application) has passed without adding the missing priority claim, the time limit for adding a new priority claim expired on 3 July 2023.\n\n- Explanation of why A, B, and C are incorrect.\n    - Option A suggests that the deadline is 3 November 2023. This would imply that there was still an open period to add a priority claim after the 16-month limit from EP-II's filing date had expired, which is not correct according to Rule 59 EPC.\n    - Option B implies a deadline of 7 November 2023, which similarly fails to account for the fact that the time limit for adding new priority claims expired when the filing date of PCT-P exceeded the 16-month window from EP-II's filing date.\n    - Option C indicates an expiration on 20 October 2023, which is also incorrect as it suggests there was still a period to add a priority claim despite already exceeding the critical 16-month timeframe.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-III, 6.6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_6_6.html\nSource: Guidelines for Examination in the EPO, A-III, 6.5.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_6_5_3.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct: According to the given scenario, the opponent/respondent filed their comments on 12 October 2023, which is beyond the deadline of four months from the communication date (1 June 2023). The appropriate course of action in this situation would be for the opponent/respondent to request an extension of the period for filing comments. \n\n- Explanation of why B is incorrect: There is no indication that a fee needs to be paid for further processing at this stage, as the specific nature of payment required has not been detailed or mandated by any regulation provided in the context.\n\n- Explanation of why C is incorrect: Reestablishment of rights typically applies when there was an unreasonable delay due to unforeseen circumstances. The scenario does not indicate such conditions were met here, and thus filing a substantiated request for re-establishment of rights would be unnecessary unless there are extenuating circumstances that warrant it.\n\n- Explanation of why D is incorrect: Given the late submission of comments, some action needs to be taken to address the delay; \"none of the above\" does not account for the need to rectify the tardiness in filing.\n\nSources:\n\nSource: EPC Article 108, Url: https://www.epo.org/en/legal/epc/2020/a108.html\nSource: Guidelines for Examination in the EPO, E-X, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_x_2.html\nSource: EPC Rule 81, Url: https://www.epo.org/en/legal/epc/2020/r81.html\nSource: Guidelines for Examination in the EPO, D-VII, 6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_vii_6.html\nSource: Case Law III, Q.1.2.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_q_1_2_1.html"
                },
                {
                    "Answer": "D",
                    "Justification": "- Explanation of why D is correct. According to Rule 51(1) EPC, renewal fees for a European patent application must be paid annually by the last day of the month containing the anniversary of the date of filing (20 March). Thus, the third-year fee was due on 31 March 2023 and the fourth-year fee will be due on 31 March 2024. Given that proceedings were interrupted from 10 March 2022 to today (12 October 2023), according to Rule 51(2) EPC, renewal fees can still be paid within six months of their respective due dates with an additional fee. However, since the application was not abandoned and proceedings have now resumed on 12 October 2023, the third-year renewal fee (due on 31 March 2023) falls under Rule 51(2), meaning it can still be paid without any additional fee by 31 October 2023.\n\n- Explanation of why A is incorrect. The application has not been deemed to be withdrawn as no fees have yet expired beyond the six-month grace period, and the renewal fees can still be paid within that timeframe according to Rule 51(2).\n\n- Explanation of why B is incorrect. According to Rule 51(2) EPC, the third-year fee (due on 31 March 2023) must be paid with an additional fee if it has not been paid within six months from its due date (i.e., by 30 September 2023). Therefore, paying without any additional fees is only possible before the expiration of this period.\n\n- Explanation of why C is incorrect. The fourth-year renewal fee (due on 31 March 2024) can be paid with an additional fee within six months from its due date, i.e., by 30 September 2024. However, it must be noted that the third-year fee requires payment without any additional fees only if it is done before 31 October 2023.\n\nSources:\n\nSource: Case Law III, D.4.8, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_d_4_8.html\nSource: Case Law III, D.4.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_d_4_1.html\nSource: EPC Rule 51, Url: https://www.epo.org/en/legal/epc/2020/r51.html\nSource: EPC Rule 51, Url: https://www.epo.org/en/legal/epc/2020/r51.html"
                }
            ]
        },
        {
            "filename": "2024_EPAC_mcq.json",
            "questions": [
                {
                    "question": "An international application is published , together  with the search report drawn up by the CNIPA , 18 m onths + 1 day after the filing date (no priority claimed). The application has no more than 35 pages and 15 claims. Which statement reflects all actions the CN  applicant  needs to take for entry into the EP phase 25 months  after the filing date ? A request for early processing has been filed.",
                    "options": [
                        "A. Complete and file Form 1200 and pay the filing fee and the search fee",
                        "B. Complete and file Form 1200 and pay the filing fee, the search fee and the renewal fee for the third year",
                        "C. Complete and file Form 1200, pay the filing fee and the search fee and appoint a representative",
                        "D. None of the above statements"
                    ]
                },
                {
                    "question": "A European patent application was filed on 6 February 2023. The search, filing and designation fees were paid within a month of the date of filing. What is the latest point in time for withdrawing the application, if the applicant wishes to obtain a refund of the designation fee?",
                    "options": [
                        "A. Six months after the date of mention of the publication of the European search report",
                        "B. Date of mention of the publication of the European search report",
                        "C. The designation fee was validly paid and can no longer be refunded",
                        "D. Date of the start of substantive examination"
                    ]
                },
                {
                    "question": "On 10 October 2024, an applicant files a request for entry into the European phase, together with a debit order, according to which the filing fee, the designation fee, the examination fee and the renewal fee for the third year are to be debited from the applicant's deposit account. It is specified that the debit order is to be executed on 18 October 2024. On the evening of 10 October 2024, the applicant notices that the renewal fee is not yet due and should not be debited from the deposit account. What is the latest point in time for revoking the order to debit the renewal fee in Central Fee Payment (CFP)?",
                    "options": [
                        "A. 10 October 2024",
                        "B. 17 October 2024",
                        "C. 18 October 2024",
                        "D. A debit order cannot be revoked in part"
                    ]
                },
                {
                    "question": "The applicant received a communication pursuant to Article 90(3) EPC and Rule  60 EPC, requesting them to file a designation of inventor but missed the time limit for filing a response. After expiry of the time limit, the Receiving Section issued a decision to refuse the European patent application, dated 10  October 2024. What can the applicant do to remedy the situation?",
                    "options": [
                        "A. File a notice of appeal against the decision within four months of notification of the decision",
                        "B. File a request for further processing within two months of notification of the decision",
                        "C. File, within two months of notification of the decision, a request for re-establishment of rights in respect of the time limit for filing the designation of inventor",
                        "D. A, B and C are correct"
                    ]
                },
                {
                    "question": "Which of the following statements about filing third- party observations is correct?",
                    "options": [
                        "A. The person that filed third- party observations will be a party to the proceedings before the EPO, and the applicant is obliged to respond to third- party observations",
                        "B. Third -party observations must be filed in writing and may not be filed anonymously",
                        "C. Third -party observations are considered by the examining division only if they include a statement of the grounds on which they are based, and an official fee is paid",
                        "D. Third -party observations can be filed after the publication of a European patent application and must be filed in an official language of the EPO"
                    ]
                },
                {
                    "question": "You filed an international patent application on 6 June 2024, claiming the priority of a European patent application filed on 7  July 2023. You received a communication dated 25 September 2024 from the EPO acting as International Searching Authority (ISA), stating that the requirement of unity of invention has not been complied with. The ISA identifies three inventions. You are invited to pay two additional search fees. Which of the following statements is correct?",
                    "options": [
                        "A. You must pay two additional search fees by 25 October 2024",
                        "B. You do not need to file a response to the provisional opinion accompanying the partial search results",
                        "C. If you pay two additional search fees under protest, you must pay two protest fees within the time limit",
                        "D. If you do not pay any additional search fees within the time limit, the international patent application will be deemed to be withdrawn"
                    ]
                },
                {
                    "question": "An international patent application filed with the EPO as receiving Office on 10 September 2024, claims the priority of a Luxembourg patent application filed on 11 October 2023. No certified copy of the Luxembourg patent application was filed at the time of filing of the international patent application. Which of the following actions can be taken to file a certified copy of the Luxembourg patent application for this international patent application?",
                    "options": [
                        "A. Request the Luxembourg Intellectual Property Office to prepare and send a certified copy of the Luxembourg patent application to the EPO",
                        "B. Submit a valid DAS code (Digital Access Service) to the International Bureau to enable it to obtain a certified copy of the Luxembourg patent application",
                        "C. File an electronic certified copy of the Luxembourg patent application with the EPO",
                        "D. File a certified copy of the Luxembourg patent application with the International Bureau"
                    ]
                },
                {
                    "question": "Firm A owns a European patent, EP . Firm B filed an opposition against EP, requesting its revocation. Firm B argued that the subject -matter of the granted claims was not new in view of document D1. During the opposition proceedings, firm C filed observations under Art.  115 EPC, arguing that the subject -matter of the granted claims was not new in view of document D2. Firm A requested maintenance of the patent as granted, or maintenance in amended Which of the following statements is correct?",
                    "options": [
                        "A. At the end of the opposition proceedings, the opposition division decided to revoke the patent. Firm B is entitled to file an appeal against the opposition division's decision.",
                        "B. At the end of the opposition proceedings, the opposition division decided to and firm B are entitled to file an appeal against the opposition division's decision.",
                        "C. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm C is entitled to file an appeal against the opposition division's decision.",
                        "D. During the opposition proceedings, firm B withdrew its opposition. At the end of the opposition proceedings, the opposition division decided to maintain the patent as granted. Firm B is entitled to file an appeal against the opposition division's decision."
                    ]
                },
                {
                    "question": "European patent application EP -X was filed on 1  October 2020, claiming the priority of a Belgian application filed on 16 October 2019. The mention of the grant of European patent EP -X was published on 2  October 2024. The proprietor filed a request for unitary effect and was informed by communication dated 10  October 2024, that unitary effect had been registered for EP -X-C0 on the same date. Which of the following statements is correct?",
                    "options": [
                        "A. A renewal fee still has to be paid by 31 October 2024 in respect of the 5th year for EP -X",
                        "B. A renewal fee is due on 31 October 2024 in respect of the 5th year for EP -X-C0",
                        "C. A renewal fee is due on 31 October 2024 in respect of the 6th year for EP -X-C0",
                        "D. No renewal fee has to be paid on 31 October 2024"
                    ]
                },
                {
                    "question": "A communication under Article 94(3) EPC, setting a four -month time limit for reply is dated 12 September 2024. The applicant receives the letter on 21 September 2024, as evidenced by the postal receipt signed by him.  What is the last day for replying to the communication?",
                    "options": [
                        "A. 13 January 2025",
                        "B. 12 January 2025",
                        "C. 22 January 2025",
                        "D. 14 January 2025"
                    ]
                },
                {
                    "question": "Which functionalities or services can be accessed directly from MyEPO Portfolio?",
                    "options": [
                        "A. A shared area with examiners, European Patent Register, filing via the EPO's online filing software eOLF",
                        "B. Mailbox, a shared area with examiners, replying to a communication under Article  94(3) EPC",
                        "C. Mailbox, patent search via publication server, a shared area with examiners",
                        "D. Filing via the EPO's Online Filing 2.0, patent search via publication server, Mailbox"
                    ]
                },
                {
                    "question": "In which of the following situations does the EPO recommend using the EPO Contingency Upload Service?",
                    "options": [
                        "A. When you submit documents after business hours",
                        "B. When the EPO filing systems are functioning correctly, but you encounter a technical issue at your end",
                        "C. When there is a system outage at the EPO that prevents document submission via the standard filing systems",
                        "D. When the EPO is closed due to an official holiday"
                    ]
                },
                {
                    "question": "Applicant Korhonen is a Finnish national resident in Finland. He filed a European patent application in Finnish and provided an English translation in time. In response to the extended European search report (EESR), Korhonen wishes to file amended claims t ogether with a request for examination. Which of the following statements is correct?",
                    "options": [
                        "A. Korhonen must file the amended claims in Finnish and must then  provide a translation into English, in time",
                        "B. Korhonen is allowed to file the amended claims in Finnish if he then provides a",
                        "translation into any official language of the EPO, in time C. Korhonen is allowed to file the amended claims in Finnish if he then provides a translation into English, in time",
                        "D. Korhonen is not allowed to file the amended claims in Finnish"
                    ]
                },
                {
                    "question": "Applicants may request processing of their international application under PCT Direct by filing a letter (\"PCT Direct letter\") containing informal comments, aimed at overcoming objections raised in the search opinion established by the EPO for the priority application.  Which of the following statements is NOT  correct?",
                    "options": [
                        "A. PCT Direct is available if the priority application is a Belgian application filed in French, which has been searched and the international application is filed in French, using ePCT -Filing",
                        "B. PCT Direct is available if the priority application is an EP application filed in French, which has been searched and the international application is filed in English, using Online Filing 2.0",
                        "C. PCT Direct is available if the priority application is an international application filed with the EPO in English, which has been searched by the EPO and the subsequent international application is filed in English, using Online Filing 2.0",
                        "D. PCT Direct is available on condition that amended claims are filed with the PCT Direct letter, in a single PDF document"
                    ]
                },
                {
                    "question": "Mr Linguist filed a European patent application in Dutch and used English as language of the proceedings. When requesting unitary effect on 10 October 2024, Mr Linguist must provide a translation of the specification. Mr Linguist would like to obtain immediate registration of the unitary effect. Which of the following statements is correct?",
                    "options": [
                        "A. Mr Linguist must provide a translation of the specification into Dutch",
                        "B. Mr Linguist must provide a translation of the specification into an official language of any of the 18 states to which the unitary effect extends",
                        "C. Mr Linguist must provide a translation of the specification into an official language of any of the 24 states that have signed the UPCA",
                        "D. Mr Linguist may provide a translation of the specification into Spanish"
                    ]
                }
            ],
            "answers": [
                {
                    "Answer": "D",
                    "Justification": "Legal basis Rule 159(1) EPC The examination fee and designation fee must also be paid ( six months  after publication of search report ; payment cannot be postponed to 31 m onths  if there is a wish to enter into the European phase at 25 months )."
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Guidelines for Examination in the EPO, A-X, 5.2.2 “The designation fee falls due upon publication of the mention of the European search report. It may be paid within six months of the mentioned date of publication (Rules 39(1) , 17(3)  and 36(4) ). Where paid before the due date, e.g. upon filing of the application, the designation fee will however be retained by the EPO. These payments will only be considered valid as from the due date, provided that the amount paid corresponds to the amount payable on the due date (…)”"
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis OJ EPO  2024, Supplementary Publication 2,  Arrangements for deposit accounts (ADA), 13.2 “13.2: A debit order with a deferred payment date (…) may be revoked in whole or in part in Central Fee Payment until one day before the date specified as the execution date at the latest. ”"
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Articles 106 and 108 EPC ; Article 121(1) EPC ; Guidelines for Examination in the EPO, E-VIII, 2 A notice of appeal could also be filed within two months of  notification of the decision; re-establishment of rights is excluded because further processing is available."
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis Article 115 EPC, R ule 114 EPC ; Guidelines for E xamination in the EPO,  E-VI.3 2 A. Incorrect: a third party filing observations concerning the patentability of an application or patent is not a party to the proceedings; the  applicant may respond to third- party observations but is not obliged to do so B. Incorrect: third- party observations may be filed anonymously C. Incorrect: there is no official fee when filing third- party observations D. Correct"
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Rule 40 PCT A. Incorrect: may be paid but not must be paid B. Correct C. Incorrect: only one protest fee is due (Rule 40.2(e) PCT) D. Incorrect: if the applicant does not pay any additional search fees, the information appearing in the invitation to pay additional fees will be considered to be  the result of the international search and will be included as such in the international search report"
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis PCT Applicant's Guide 5.070. ; Guidelines for Examination in the EPO  A-III, 6.7; PCT Applicant's Guide LU-Luxembourg A. Only available if the priority application and the PCT application are filed with the same p atent office B. Incorrect: the LPTO does not use the DAS  access code C. Incorrect: the LPTO does not issue electronic priority document s D. Correct"
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis Article 107 EPC A. Incorrect: B is not adversely a ffected B. Correct: both parties A and B are adversely affected C. Incorrect: third  parties are no t parties to  the proc eedings D. Incorrect:  withdrew its opposition; no longer a party to the proceedings"
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis 3 Guidelines for Examination in the EPO, A- X, 5.2.4 The renewal fee that would have been due on 31 October had to be paid for the decision to grant to be issued (this is one of the warnings in the communication under Rule 71(3)  EPC)."
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis Rule 126(2) EPC The document was delivered to the addressee nine days after the date it bears, so the period expires later by the number of days by which the seven days were exceeded, i.e. 12 January 2025 + two  days. E vidence of late receipt needs to be filed with the response."
                },
                {
                    "Answer": "B",
                    "Justification": "Legal basis https://www.epo.org/en/applying/myepo- services/interact A. Incorrect : it is neither  possible  to access the European Patent Register n or to file using  the EPO's legacy O nline Filing software (eOLF)  via MyEPO Portfolio B. Correct C. Incorrect : it is not possible to access  the European P ublication Server via MyEPO Portfolio D. Incorrect : it is neither  possible to access the European P ublication Server nor to file using the EPO's Online Filing 2.0  via MyEPO Portfolio"
                },
                {
                    "Answer": "C",
                    "Justification": "Legal basis OJ EPO 2023, A50 , point  20; Contingency Upload Service | epo.org"
                },
                {
                    "Answer": "C",
                    "Justification": "Legal basis Guidelines for Examination in the EPO, A-VII, 3.2; Rule 3(2) EPC Since the response with the amendments has to be filed within  a time limit, the Finnish applicant is entitled to file the amended claims  in Finnish. A translation of a document filed in an admissible non- EPO language into an official language of the EPO must be filed within a non- extendable period of one month (Rule  6(2) EPC). This means that a translation of the amended claims must be filed in the language of proceedings , English  in this case  (Rule 3(2) EPC ). 4"
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis PCT-EPO  Guidelines , B-IV, 1.2 . Comment s are required but not amendments."
                },
                {
                    "Answer": "D",
                    "Justification": "Legal basis Article 6(1) Regulation (EU) No 1260/2012; R ule 6(2)(d) UPR; Unitary Patent Guide, para. 65 The translation may be in any of the 24 official languages of the EU, except English, irrespective of the language in which the application was filed or the geographical extent of the unitary effect."
                }
            ],
            "ai_answers": [
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. Given that a request for early processing has been filed 25 months after the filing date (which is before the standard 31-month deadline), and because the application contains no more than 35 pages, only the filing fee and search fee need to be paid upon entry into the EP phase. Additionally, completing and filing Form 1200 is necessary to specify the documents that will form part of the European patent application.\n  \n- Explanation of why B is incorrect. The renewal fee for the third year (the so-called \"maintenance fee\") would only be due after the 30-month deadline for entering the EP phase, which does not apply in this context since the applicant has requested early processing and will enter within the designated timeline.\n\n- Explanation of why C is incorrect. Appointing a representative is not mandatory upon entry into the European phase but can be done at any time later if needed by the applicant.\n\n- Explanation of why D is incorrect. The statement \"None of the above statements\" does not hold true because option A correctly reflects the necessary actions required for entry into the EP phase given the context provided.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-III, 13.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_13_2.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.8, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_8.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. According to Rule 39 EPC as amended from April 1, 2009, the designation fee must be paid within six months of the date on which the European Patent Bulletin mentions the publication of the European search report. If this fee is not paid in due time, the application will be deemed withdrawn and the applicant would typically receive a refund for the designation fee.\n\n- Explanation of why B is incorrect. The date of mention of the publication of the European search report (B) is too early because it doesn’t account for the six-month grace period to pay the designation fee without losing eligibility for a refund.\n\n- Explanation of why C is incorrect. C suggests that the designation fee cannot be refunded, which is not accurate if the application has been withdrawn before substantive examination begins and within the specified timeframe (six months from mention of publication).\n\n- Explanation of why D is incorrect. The date of the start of substantive examination (D) comes after the six-month window for withdrawal to obtain a refund on the designation fee, thus making it too late for a refund under this regulation.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-X, 10.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_10_2_4.html\nSource: EPC Rule 17, Url: https://www.epo.org/en/legal/epc/2020/r17.html\nSource: Case Law IV, A.7.2.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_a_7_2_1.html\nSource: EPC RFees 11, Url: https://www.epo.org/en/legal/epc/2020/f11.html\nSource: EPC RFees 9, Url: https://www.epo.org/en/legal/epc/2020/f9.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- According to the ADA point 10.2, if a debit order specifies that payment should be executed on a date later than its submission (i.e., an automatic or future execution), it can still be revoked before the specified execution date. In this scenario, the applicant has until the evening of October 17th, which is the day before the debit order's specified execution date (October 18th). Therefore, B is correct.\n\n- Option A (10 October 2024) is incorrect because it does not allow enough time for the revocation process to be completed. Revocation must occur by the evening of the day preceding the scheduled debiting date.\n\n- Option C (18 October 2024) is incorrect because by this date, the debit order would have already been executed, and thus any attempts at revocation would be too late.\n\n- Option D (A debit order cannot be revoked in part) is incorrect. The ADA allows for partial revocations of a debit order if specific fees need to be excluded from debiting. Hence, it is possible to revoke the order only for the renewal fee while keeping other fees intact.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-X, 4.2.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_4_2_3.html\nSource: Guidelines for Examination in the EPO, A-X, 5.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_4.html\nSource: Case Law III, U.2.2.7, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_u_2_2_7.html\nSource: Guidelines for Examination in the EPO, A-X, 5.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_4.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. According to Article 90(3) EPC and Rule 60 EPC, if an applicant fails to file a designation of inventor within the given time limit, the Receiving Section can issue a decision refusing the application. The applicant can appeal against this refusal within four months of notification of the decision according to Rule 142 EPC.\n\n- Explanation of why B is incorrect. A request for further processing under Article 90(3) and Rule 60 EPC would not be applicable after the time limit has expired and a decision refusing the application has been issued. The option to file such a request only applies during the period when the applicant can still remedy deficiencies, not after refusal.\n\n- Explanation of why C is incorrect. Requesting re-establishment of rights (Rule 134 EPC) in respect of the time limit for filing the designation of inventor would not be applicable post-refusal decision and cannot directly address the situation where a formal refusal has already been issued by the Receiving Section.\n\n- Explanation of why D is incorrect. Since B and C are incorrect, option D (which includes A, B, and C) cannot be correct. The only valid action in this scenario is to file an appeal within four months as per Rule 142 EPC.\n\nSources:\n\nSource: EPC Rule 60, Url: https://www.epo.org/en/legal/epc/2020/r60.html\nSource: Case Law IV, A.6, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_a_6.html\nSource: Guidelines for Examination in the EPO, A-III, 5.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_5_4.html\nSource: EPC Rule 163, Url: https://www.epo.org/en/legal/epc/2020/r163.html\nSource: Guidelines for Examination in the EPO, E-VIII, 8.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_8_1.html"
                },
                {
                    "Answer": "D",
                    "Justification": "- Explanation of why D is correct. According to Article 115 EPC and R. 114(1) EPC, third-party observations can indeed be filed after the publication of a European patent application and must be in an official language of the EPO.\n- Explanation of why B, C, and A are incorrect:\n    - Option A is incorrect because the person that files third-party observations will not become a party to the proceedings before the EPO. The applicant also does not have an obligation to respond directly to these observations; instead, they may be considered during examination or opposition.\n    - Option B is incorrect as third-party observations can indeed be filed anonymously (though identification becomes important in certain contexts). There's no requirement that they must always be signed for consideration.\n    - Option C is incorrect because while the observations should include a statement of grounds, an official fee is not required to file them. According to R. 114 EPC and Art. 115 EPC, there are no fees associated with filing third-party observations.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-VI, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_vi_3.html\nSource: Guidelines for Examination in the EPO, E-VI, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_vi_3.html\nSource: Case Law III, N.2.4, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_n_2_4.html\nSource: Case Law III, N.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_n_1.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- Explanation of why B is correct: According to the guidelines and rules stated, specifically under Rule 64(1) and Point 6.1 AAD, the provisional opinion on patentability accompanying partial search results is for information only, and the applicant does not need to respond to it.\n  \n- Explanation of why A is incorrect: The time limit mentioned in option A (25 October 2024) is arbitrary and not specified by any particular rule or regulation. Additionally, Rule 64(1) does not specify a precise deadline for paying additional search fees beyond the general requirements set forth by the PCT.\n  \n- Explanation of why C is incorrect: Paying protest fees under international patent application procedures has specific rules, usually tied to how the protest was filed and the procedural context. Under Rule 64(1), there’s no explicit requirement that two additional protest fees must be paid within a certain time limit if paying additional search fees under protest.\n  \n- Explanation of why D is incorrect: If you do not pay any additional search fees, it will result in the EPO acting as ISA only searching for unity with respect to one invention. However, the international patent application itself would not be deemed withdrawn; rather, the remaining inventions are considered unsearched.\n\nSources:\n\nSource: Case Law II, B.6, Url: https://www.epo.org/en/legal/case-law/2022/clr_ii_b_6.html\nSource: Guidelines for Examination in the EPO, B-II, 4.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_ii_4_5.html\nSource: Guidelines for Examination in the EPO, F-V, 7.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/f_v_7_1.html\nSource: Guidelines for Examination in the EPO, C-III, 3.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_iii_3_4.html\nSource: Guidelines for Examination in the EPO, B-VII, 1.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_vii_1_2.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. According to the Guidelines for Examination in the EPO and the rules regarding priority documents, a certified copy can be requested from the original filing office (Luxembourg Intellectual Property Office), which will then send it directly to the receiving Office (EPO). This process ensures that the document is properly certified and meets all formal requirements.\n  \n- Explanation of why B, C, and D are incorrect. Option B mentions using a valid DAS code with the International Bureau, but this would only be applicable if both offices participate in the WIPO Digital Access Service and if the Luxembourg office has provided such access for the document. There is no indication that either condition is met here. Option C suggests filing an electronic certified copy directly with the EPO, which is not a standard procedure for obtaining certified priority documents from another jurisdiction. Option D incorrectly identifies the International Bureau as the recipient of the certified copy; in this scenario, the certified copy should be sent to the receiving Office (EPO).\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-XI, 5.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_xi_5_2.html\nSource: Guidelines for Examination in the EPO, A-III, 6.7, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_6_7.html\nSource: Guidelines for Examination in the EPO, F-VI, 3.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/f_vi_3_3.html\nSource: Guidelines for Examination in the EPO, A-XI, 5.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_xi_5_2.html"
                },
                {
                    "Answer": "C",
                    "Justification": "- Explanation of why C is correct. According to Article 108 EPC, any party to the proceedings can file an appeal against a decision rendered by the opposition division. Since Firm C filed observations under Article 115 EPC, it became a party to the opposition proceedings and therefore has standing to appeal a decision that maintains the patent as granted.\n- Explanation of why B is incorrect. The statement in option B is incomplete (\"decided to and firm B...\"), making it unclear and thus invalid.\n- Explanation of why A is incorrect. If Firm B's request for revocation was denied by the opposition division, then Firm B would not be able to appeal a decision that maintains the patent. An appellant must have a legal interest in overturning the decision being appealed, which would not apply if their request was granted.\n- Explanation of why D is incorrect. Once Firm B withdrew its opposition, it no longer has standing as an opponent and thus cannot file an appeal against the decision to maintain the patent.\n\nSources:\n\nSource: EPC Article 101, Url: https://www.epo.org/en/legal/epc/2020/a101.html\nSource: Case Law III, Q.1.2.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_q_1_2_2.html\nSource: Guidelines for Examination in the EPO, D-VI, 7.2.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_vi_7_2_2.html\nSource: Guidelines for Examination in the EPO, H-III, 3.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_iii_3_4.html\nSource: Guidelines for Examination in the EPO, D-VIII, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_viii_1_1.html"
                },
                {
                    "Answer": "D",
                    "Justification": "- Explanation of why D is correct: According to Art. 86(2) and Rule 134, once a mention of grant is published, the obligation to pay renewal fees to the EPO terminates with the payment of the renewal fee due in respect of the year in which the mention of the grant was published. The mention of grant for EP -X was published on 2 October 2024, and hence no further renewal fees need to be paid to the EPO for this application after that date.\n\n- Explanation of why A is incorrect: No additional renewal fee needs to be paid by the proprietor as the obligation to pay renewal fees terminates with the payment of the renewal fee due in respect of the year in which the mention of grant was published. Since the publication of the mention of grant occurred on 2 October 2024, no further payment is required.\n\n- Explanation of why B is incorrect: The unitary effect registered for EP -X-C0 does not affect the payment of renewal fees to the EPO because such payments cease with the publication of the mention of grant. Therefore, no new fee is due on 31 October 2024 in respect of the 5th year.\n\n- Explanation of why C is incorrect: The unitary patent (EP -X-C0) does not affect payment of renewal fees to the EPO as these obligations terminate with the publication of the mention of grant. Thus, no fee for the 6th year or any subsequent year needs to be paid on 31 October 2024.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-X, 5.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_4.html\nSource: Guidelines for Examination in the EPO, A-X, 5.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_4.html\nSource: Guidelines for Examination in the EPO, A-X, 5.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_4.html\nSource: EPC Rule 51, Url: https://www.epo.org/en/legal/epc/2020/r51.html\nSource: Guidelines for Examination in the EPO, A-X, 5.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_4.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- According to Rule 126(2) EPC, if an applicant receives a document later than expected, the period for reply is extended by the number of days the receipt exceeded the standard delivery time. The communication was dated 12 September 2024 and set a four-month time limit for reply. Normally, without any delay in receipt, the reply would be due on 12 January 2025 (four months after 12 September). However, the applicant received it 9 days later than expected (on 21 September instead of within 7-8 days). Therefore, the period is extended by these 9 extra days. Thus, adding 9 days to 12 January 2025 gives us 21 January 2025. However, since only options are given and option A (13 January) seems to be the closest reasonable adjustment for a potential discrepancy in counting or other procedural considerations.\n\n- Option B (12 January 2025) is incorrect because it doesn't account for the delay in receipt.\n- Option C (22 January 2025) extends beyond the period by more than necessary based on standard interpretation and provided options.\n- Option D (14 January 2025) also does not correctly reflect the extension based on Rule 126(2).\n\nSources:\n\nSource: Case Law III, D.1.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_d_1_1.html\nSource: Case Law IV, B.2.5.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_b_2_5_1.html\nSource: Case Law IV, C.6.4, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_c_6_4.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- Explanation of why B is correct. According to the provided information, MyEPO Portfolio can be used for functionalities such as a mailbox and a shared area with examiners. Additionally, replying to communications under Article 94(3) EPC can also be done via these functionalities.\n\n- Explanation of why A is incorrect. The European Patent Register cannot be accessed directly from MyEPO Portfolio, and filing via the EPO's online filing software eOLF is not a listed functionality for MyEPO Portfolio.\n\n- Explanation of why C is incorrect. While the mailbox and shared area with examiners are correct functionalities of MyEPO Portfolio, patent search via publication server is not accessible directly through this service.\n\n- Explanation of why D is incorrect. Filing via the EPO's Online Filing 2.0 and patent search via the publication server cannot be accessed from within the MyEPO Portfolio; these services are separate functionalities.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-II, 1.1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_1_1_1.html\nSource: Guidelines for Examination in the EPO, A-VIII, 2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_viii_2_5.html\nSource: Guidelines for Examination in the EPO, A-VIII, 2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_viii_2_5.html\nSource: Guidelines for Examination in the EPO, A-II, 1.1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_1_1_1.html"
                },
                {
                    "Answer": "C",
                    "Justification": "- Explanation of why C is correct. The EPO Contingency Upload Service is recommended for use when there is a system outage at the EPO that prevents document submission via the standard filing systems, as this service acts as an alternative means to ensure documents can still be submitted during such disruptions.\n\n- Explanation of why A, B, and D are incorrect.\n  - Option A: The EPO Contingency Upload Service does not serve a purpose for submissions after business hours. Regular electronic filing methods or fax services would typically suffice in such cases.\n  - Option B: When the EPO filing systems are functioning correctly but you encounter a technical issue at your end, it is more appropriate to resolve the personal technical issue rather than using the contingency service, which is intended specifically for system outages at the EPO’s end.\n  - Option D: The Contingency Upload Service would not be needed if the EPO were closed due to an official holiday as submissions can typically still be made via regular means or will be accepted during normal business hours when offices reopen.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-VIII, 1.6.2.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_1_6_2_1.html\nSource: Guidelines for Examination in the EPO, A-VIII, 2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_viii_2_5.html\nSource: Guidelines for Examination in the EPO, C-VII, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_vii_3.html\nSource: Guidelines for Examination in the EPO, A-VIII, 2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_viii_2_5.html"
                },
                {
                    "Answer": "D",
                    "Justification": "- Explanation of why D is correct. According to Article 14(1) and Rule 3 of the European Patent Convention (EPC), all procedural documents must be filed in one of the official languages of the EPO, which are English, French, or German. Since Korhonen has already provided an English translation of his original application, he is required to file any further amendments, such as amended claims and request for examination, also in an official language of the EPO.\n\n- Explanation of why B is incorrect. Option B suggests that Korhonen can file the amended claims in Finnish and then provide a translation into any official language of the EPO. This would not comply with Article 14(1) since it requires that all procedural documents be filed directly in an official language from the beginning.\n\n- Explanation of why C is incorrect. Option C implies that Korhonen can file amended claims in Finnish and then provide a translation into English. However, this approach would still violate the requirement to use an EPO official language for filing amendments immediately. It is not acceptable under the rules to initially file documents in a non-official language.\n\n- Explanation of why A is incorrect. Option A suggests that Korhonen must first file amended claims in Finnish and then provide an English translation, which would contradict Article 14(1) as it requires all procedural acts to be performed directly in one of the official languages from the start.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-VII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_2.html\nSource: Guidelines for Examination in the EPO, A-VII, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_1_1.html\nSource: Guidelines for Examination in the EPO, A-VII, 5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_5.html\nSource: Guidelines for Examination in the EPO, A-X, 9.2.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_9_2_1.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct: PCT Direct requires that the search for the priority application be conducted by the EPO and not a national office like Belgium, thus making statement A incorrect. The language consistency and filing method do not override this requirement.\n- Explanation of why B, C, and D are incorrect:\n  - B is incorrect because it states an accurate scenario under PCT Direct conditions: if the priority application was an EP application (searched by EPO) filed in French and the international application is filed in English using Online Filing 2.0, this meets PCT Direct criteria.\n  - C is incorrect as it also fits within PCT Direct conditions: both applications are searched by the EPO and all requirements regarding language and filing method are met.\n  - D is incorrect because the condition mentioned (filing amended claims with a single PDF document) does not violate any rules of PCT Direct, which only requires that informal comments be provided in an effort to address search objections.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-IX, 2.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_2.html\nSource: Guidelines for Examination in the EPO, G-IV, 5.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/g_iv_5_2.html\nSource: Case Law III, F.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_f_2.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.9.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_9_1.html"
                },
                {
                    "Answer": "D",
                    "Justification": "- Explanation of why D is correct: According to Article 14(2) EPC and relevant regulations under the Unified Patent Court Agreement (UPCA), if a European patent application is filed in Dutch or any non-official language, it must be translated into one of the official languages of the EPO (English, French, or German). In this scenario, Spanish can be used since it is an official language. Therefore, Mr Linguist may provide a translation into Spanish.\n\n- Explanation of why B and C are incorrect: The UPCA specifies that translations must adhere to the official languages of the European Patent Office (EPO), which are English, French, or German. It does not allow for any official language from all 24 states that have signed the UPCA or specifically only those 18 states to which the unitary effect extends.\n\n- Explanation of why A is incorrect: The specification must be translated into an EPO official language (English, French, or German), and Dutch is not one of them. Hence, a translation into Dutch would not satisfy the requirements for obtaining immediate registration of the unitary effect.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-X, 9.2.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_9_2_1.html\nSource: EPC Article 14, Url: https://www.epo.org/en/legal/epc/2020/a14.html\nSource: Guidelines for Examination in the EPO, A-VII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_2.html\nSource: Case Law III, F.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_f_1.html"
                }
            ]
        },
        {
            "filename": "OEB_SUP_mcq.json",
            "questions": [
                {
                    "question": "You represent an individual applicant from Spain who has filed a European patent application in Spanish and satisfied all the requirements for filing. Examination was requested in Spanish at the time of filing the application. The examination and designation fees are due by 7 November 2023 and the applicant has asked you whether he is entitled to a reduction of 20% in the examination fee. What is the correct answer?",
                    "options": [
                        "A. The applicant is entitled to a reduction of 20% in the examination fee under Rule 6(3) EPC and Article 14(1) RFees.",
                        "B. The applicant is entitled to a reduction in the examination fee under Rule 6(3)EPC and Article 14(1) RFees, but the reduction is not 20%."
                    ]
                },
                {
                    "question": "Is the following statement true or false?\n\nWhen proceedings for grant of a European patent application are stayed following the institution of entitlement proceedings, renewal fees which fall due during the period of stay can be paid up to the date of resumption of the proceedings for grant.",
                    "options": [
                        "A. True",
                        "B. False"
                    ]
                },
                {
                    "question": "You represent a client whose European patent has been opposed. The opposition division decides to maintain the patent in amended form. The invitation with the three-month time limit under Rule 82(2) EPC is sent on 16 August 2021, but proceedings are interrupted under Rule 142 EPC on 20 October 2021. The problems are resolved and the proceedings resume on 16 January 2022. When does the time limit under Rule 82(2)EPC end?",
                    "options": [
                        "A. 19 April 2022",
                        "B. 30 April 2022"
                    ]
                },
                {
                    "question": "You are informed that one of the inventors named in an international application is incorrect. The application names Mr Y, but the correct inventor is Mrs Z. What should you do?",
                    "options": [
                        "A. Obtain the consent of Mr Y to rectification of the inventor before filing a request at the International Bureau with details of the correct inventor.",
                        "B. File a request for rectification at the International Bureau with details of the correct inventor."
                    ]
                },
                {
                    "question": "Your Client, A Inc, is a sub-licensee under European patent application EP-1. Can the sub-licence be recorded in the European Patent Register?",
                    "options": [
                        "A. No, it is not possible to record sub-licences in the European Patent Register.",
                        "B. Yes, any sub-licence can be recorded in the European Patent Register.",
                        "C. Yes, provided the licensee granting the sub-licence has recorded its licence in the European Patent Register."
                    ]
                },
                {
                    "question": "Company C files a European patent application for an invention which has been displayed at an officially recognised international exhibition. The exhibition closes two weeks after the invention was first displayed. Rule 25(d) EPC states that a suitable certificate must be filed within four months of the filing of the European patent application. Three months after filing the application, the applicant approaches the authority responsible for the protection of industrial property at the exhibition and obtains a certificate stating the information required according to Rule 25 EPC. The certificate is filed within the four-month period together with the authenticated identification of the invention. Will the certificate be accepted by the EPO?",
                    "options": [
                        "A. No, the certificate was not issued at the exhibition.",
                        "B. Yes, the certificate was filed within the specified four-month period."
                    ]
                },
                {
                    "question": "The time limit for paying the examination fee for a European patent application ends on 18 August 2023. The applicant wishes to pay by bank transfer and wants to make absolutely sure that no additional fees have to be paid even if the payment is delayed due to unforeseen circumstances. What can he do?",
                    "options": [
                        "A. Nothing. If the payment is received too late by the EPO it will be considered not to have been made.",
                        "B. Effect the payment no later than 13 August 2023.",
                        "C. Effect the payment no later than 8 August 2023.",
                        "D. It is sufficient to effect the payment on the last day for payment, that is on 18 August 2023."
                    ]
                },
                {
                    "question": "A European patent application EP-A is refused in a decision dated 1 June 2023. Today is 15 July 2023. Is it still possible to file a divisional application from EP-A?",
                    "options": [
                        "A. Yes.",
                        "B. No.",
                        "C. Only if the decision to refuse the application is appealed."
                    ]
                },
                {
                    "question": "Most fees for European patent applications cannot be paid before their due date. One exception is renewal fees, which can always be paid up to:",
                    "options": [
                        "A. Three months before the due date.",
                        "B. Six months before the due date.",
                        "C. One year before the due date."
                    ]
                },
                {
                    "question": "Today is 28 March 2023. Following national proceedings for entitlement of European patent application EP-1, the successful party has elected to file a new application under Article 61(1)(b) EPC. EP-1 was filed on 12 April 2019 and the new application, EP-2, was filed on 10 January 2023.  What is the last day for paying the first renewal fee that is payable for the new application, without surcharge (i.e. not including the fees for past renewals)?",
                    "options": [
                        "A. 31 January 2023.",
                        "B. 2 May 2023."
                    ]
                },
                {
                    "question": "You file a European patent application EP-1 in February 2023 on behalf of the applicant. In October 2023 you are informed that EP-1 should have claimed priority from United States patent application US-1 filed in March 2022. Is it possible to add the priority declaration to EP-1?",
                    "options": [
                        "A. No. More than 16 months have elapsed since the filing of US-1.",
                        "B. Yes. EP-1 was filed within 12 months of US-1, so is entitled to claim priority."
                    ]
                },
                {
                    "question": "What is the legal effect of failing to file a priority document for a European patent application? The right of priority will be lost if a priority document is not filed within 16 months of the earliest priority date (or any additional period permitted by the EPO).",
                    "options": [
                        "A. None. The priority document can be filed at any time.",
                        "B. The European patent application will be deemed withdrawn if a priority document is not filed within 16 months of the earliest priority date (or any additional period permitted by the EPO)."
                    ]
                },
                {
                    "question": "European patent application EP-1 is filed on 10 December 2020, but the inventor is not designated. The designation of the inventor is filed on 25 February 2022. Will the application be refused?",
                    "options": [
                        "A. No. The designation of the inventor was filed in due time.",
                        "B. Yes. The designation of the inventor was not filed in due time."
                    ]
                },
                {
                    "question": "In response to an opposition, the patentee introduces the features of claim 12 as granted into claim 1. Claim 12 was dependent on claim 1 and is phrased as a result to be achieved. The opponent argues that the amendment introduces a lack of clarity. Will the opposition division agree with the opponent?",
                    "options": [
                        "A. Yes. A claim feature may not be phrased as a result to be achieved.",
                        "B. Perhaps. It depends on whether or not the feature phrased as a result to be achieved is considered to be clear.",
                        "C. No. Since the feature was already in the claims set the amendment does not introduce a lack of clarity."
                    ]
                },
                {
                    "question": "Why might an opposition be filed even if the European patent has been surrendered, or has lapsed, in all the designated contracting states (Rule 75 EPC)?",
                    "options": [
                        "A. In the case of surrender or lapse the rights acquired with the patent remain in existence in the period up to surrender or lapse and claims arising from those rights may subsist after the date of grant.",
                        "B. There is no reason to oppose a patent that has been surrendered or has lapsed.",
                        "C. The effect of surrender or lapse is ex nunc, while the effect of revocation is ex tunc."
                    ]
                },
                {
                    "question": "In opposition proceedings a patent proprietor has proposed amendments to claims 1, 3 and 4 of its patent to overcome issues of novelty and inventive step. The proprietor has also noted a problem with the clarity of claim 2 and has additionally proposed an amendment to this claim. Is the amendment of claim 2 permitted?",
                    "options": [
                        "A. Yes",
                        "B. No"
                    ]
                },
                {
                    "question": "Where an assumed infringer intervenes in opposition appeal proceedings, which of the following fees are payable?",
                    "options": [
                        "A. The opposition fee.",
                        "B. The appeal fee.",
                        "C. The opposition fee and the appeal fee.",
                        "D. The assumed infringer must pay the opposition fee and may choose whether to pay the appeal fee."
                    ]
                },
                {
                    "question": "During proceedings before the opposition division there is a valid intervention under Article 105 EPC. At the conclusion of the proceedings the patent is maintained in amended form. Is the assumed infringer permitted to appeal?",
                    "options": [
                        "A. Yes",
                        "B. No"
                    ]
                },
                {
                    "question": "A patent proprietor requests revocation under Article 105a EPC of its European patent EP-B, which has been validated in Germany, France and Spain. It has an exclusive licensee in Germany. Will the request for revocation be considered to be admissible?",
                    "options": [
                        "A. No, the patent proprietor must file evidence that it is entitled to act on behalf of the exclusive licensee.",
                        "B. Yes, the existence of an exclusive licensee has no bearing on the admissibility of the request for revocation."
                    ]
                },
                {
                    "question": "The applicant for European patent application EP-1 has granted an exclusive license under the application. The exclusive licensee wishes to make its rights known by recording the license in the European Patent Register. \nIs it possible to record the exclusive license?",
                    "options": [
                        "A. No, exclusive licenses cannot be recorded in the European Patent Register.",
                        "B. Yes, exclusive licenses can be recorded in the European Patent Register at the joint request of both the applicant and the licensee.",
                        "C. Yes, exclusive licenses can be recorded in the European Patent Register, but only by the applicant.",
                        "D. Yes, exclusive licences can be recorded in the European Patent Register by either the applicant or the licensee."
                    ]
                },
                {
                    "question": "A European patent application is filed on 13.01.2023, not claiming priority. After receiving the EESR, the applicant wishes to proceed as soon as possible with examination and therefore pays the examination fee, responds to the search opinion and files by fax a request for accelerated examination under PACE. Will the EPO start examination as soon as possible? And will examination be accelerated?",
                    "options": [
                        "A. Examination will start but will not be accelerated.",
                        "B. Examination will not start until the time limit for requesting examination but then it will be accelerated.",
                        "C. Examination will start early and will be accelerated.",
                        "D. No."
                    ]
                },
                {
                    "question": "It is permitted to file observations under Article 115 EPC in respect of a patent undergoing limitation proceedings. However, there is no provision under Article 105b EPC or Rule 95 EPC for examination as to patentability, \nand Article 115 EPC specifically refers to observations concerning patentability. \nIs there any reason why a third party might nevertheless file observations under Article 115 EPC in respect of a patent undergoing limitation proceedings?",
                    "options": [
                        "A. Yes, the examining division may be persuaded to consider patentability as part of the limitation proceedings.",
                        "B. Yes, patentability can be considered in the broader sense as including issues relating to Articles 84 and 123(2) EPC.",
                        "C. No, there is no point in filing observations on patentability because they will not be taken into consideration."
                    ]
                },
                {
                    "question": "In response to a Rule 71(3) communication you have filed, on the 2 April 2023, the required translations of the claims and paid the grant fee. Today, the 3 May 2023, you receive the decision to grant, dated 28 April 2023. The decision states that the mention of the grant will be published on the 24 May 2023. What is/was the last day a divisional application may be filed?",
                    "options": [
                        "A. 2 April 2023",
                        "B. 28 April 2023",
                        "C. 8 May 2023",
                        "D. 23 May 2023",
                        "E. 24 May 2023"
                    ]
                },
                {
                    "question": "In the case of applicants entitled to a fee reduction under Rule 6(3) EPC, does the fee reduction include the additional fee for pages in excess of 35?",
                    "options": [
                        "A. Yes",
                        "B. No"
                    ]
                },
                {
                    "question": "Claim 1 of European patent application EP-1 originally defines a polymer blend XY containing, as a filler, graphite, talc, asbestos or silica. \nThe European search report identifies prior art disclosing a polymer blend XY containing asbestos. Is it permissible under Article 123(2) EPC to restrict the list of fillers by simply omitting asbestos, i.e., to claim a polymer blend XY containing, as a filler, graphite, talc or silica?",
                    "options": [
                        "A. Yes",
                        "B. No"
                    ]
                },
                {
                    "question": "Errors and mistakes in any document filed with the European Patent Office may be corrected on request under Rule 139 EPC. What is the last date in written proceedings prior to grant that such a request can be made?",
                    "options": [
                        "A. Up to the time the decision to grant has been received by the applicant or their representative.",
                        "B. Up to the time the decision to grant has been handed over to the EPO internal postal service.",
                        "C. Up to the expiry of the time limit for replying to the communication under Rule 71(3) EPC."
                    ]
                },
                {
                    "question": "On receipt of the decision to grant its European patent application EP-1 under Rule 71a(1) EPC the applicant realizes that they have made a significant typographical error in claim 1. \nWhat action can they take before the EPO to correct the error?",
                    "options": [
                        "A. None",
                        "B. Seek correction under Rule 140 EPC",
                        "C. Seek correction under Rule 139 EPC"
                    ]
                },
                {
                    "question": "Company X wishes to file an opposition to European patent EP-B, which was recently granted to its main competitor, company Y. To avoid retaliation, company X would prefer not to file the opposition in its own name. It therefore asks a European patent attorney to file the opposition in her name. Will the EPO accept this?",
                    "options": [
                        "A. Yes",
                        "B. No",
                        "C. Only if the patentee does not object"
                    ]
                },
                {
                    "question": "European patent EP-B is granted with a claim directed to a method of operating a heart pacemaker in dependence upon the required cardiac output while a person is exercising, the pacemaker including a pressure sensing means mounted on a pacing lead and adapted to be implanted in a heart and used to sense the right ventricular systolic pressure, which pressure is used to control the pacer rate. Is it permissible in opposition or opposition appeal proceedings to amend the claim to be directed to a heart pacemaker in order to address problems relating to Article 53(c) EPC?",
                    "options": [
                        "A. Yes, a change in claim category is permitted.",
                        "B. No, a change in claim category would contravene Article 123(3) EPC."
                    ]
                },
                {
                    "question": "The first communication from the examining division concerning a European patent application is unexpectedly negative. The applicant decides not to proceed further with the application. Can the applicant get a refund of fees in this situation?",
                    "options": [
                        "A. Yes",
                        "B. No"
                    ]
                },
                {
                    "question": "You file an international application for an applicant on 6 November 2023, but do not pay the fees because the applicant wishes to delay paying them as long as possible. The fees are due by 6 December 2023, but are not paid until 11 December 2023. What is the most likely outcome?",
                    "options": [
                        "A. The international application will be considered to be withdrawn.",
                        "B. The fees will be accepted as if they had been paid within the one-month period.",
                        "C. The applicant will be sent an invitation to pay a late payment fee of 50% of the fees due."
                    ]
                },
                {
                    "question": "Two applicants resident in Germany jointly file an international application with the EPO as receiving office. No agent or common representative is appointed. Following receipt of the international search report, the applicants both agree that the international application should be withdrawn, so the first-named applicant on Form PCT/RO/101 sends a letter, signed by him, to the EPO as receiving office specifically withdrawing the international application. Will the application be withdrawn?",
                    "options": [
                        "A. No",
                        "B. Yes"
                    ]
                },
                {
                    "question": "The applicant for international application PCT-1 wishes to prevent publication of the application. What is the last day for withdrawing the application and \npreventing publication?",
                    "options": [
                        "A. The 15th day prior to the date of publication.",
                        "B. Any time prior to the date of publication.",
                        "C. The end of the day five weeks before the end of the 18th month from the priority or filing date as appropriate."
                    ]
                },
                {
                    "question": "You are the agent for international application PCT-1. Shortly before the end of the international phase the applicant informs you that they wish to continue only with the regional phase before the EPO and additionally that there was an error in the details of the inventor and that the correct inventor is Ms White and not Mr Black. They ask you whether it would be better to wait until entry \ninto the EPO regional phase rather than to rush correction of the inventorship details in the international phase. What is your advice?",
                    "options": [
                        "A. Inventorship should be corrected if at all possible in the international phase.",
                        "B. It would be better to wait until after entry into the EPO regional phase.",
                        "C. There is no difference between the two options."
                    ]
                },
                {
                    "question": "You are monitoring the progress of an international application and on reviewing the details of the international search report you realize that you know of relevant prior art that has not been cited in the search report, but which is likely to be novelty-destroying in respect of at least some of the claims. \nYou believe that the international application will enter the national or regional phase in a significant number of countries or regions and it would therefore be time-consuming and costly to file separate observations in respect of each of \nthe national or regional applications. What can you do?",
                    "options": [
                        "A. File observations online using ePCT.",
                        "B. Send a letter with your observations to the receiving office or the International Bureau.",
                        "C. File observations by letter.",
                        "D. It is not possible to file observations on international applications."
                    ]
                },
                {
                    "question": "The EPO as receiving office issues an invitation to the applicant to remedy certain defects in an international application within a time limit of two months from the date of invitation. The invitation is dated as being mailed on 22 September 2023 and is received by the applicant on 2 October 2023. What is the final date for responding to the invitation?",
                    "options": [
                        "A. 22 November 2023",
                        "B. 27 November 2023",
                        "C. 3 December 2023",
                        "D. 4 December 2023"
                    ]
                },
                {
                    "question": "International application PCT-1 is filed on 31 October 2023. It seeks to claim priority from European patent application EP-1 filed on 27 October 2022. Can the claim to priority be restored in the international phase so as to be effective in a subsequent EPO regional phase?",
                    "options": [
                        "A. No, the 12-month period has expired.",
                        "B. Yes, the applicant can request further processing.",
                        "C. Yes, the applicant can restore the priority claim provided that they can show that the date was missed unintentionally.",
                        "D. Yes, the applicant can restore the priority date provided that they \ncan show that they were unable, despite taking all due care, to meet the time limit for claiming priority."
                    ]
                },
                {
                    "question": "You receive an email on 30 October 2023 from a United States patent attorney asking you to enter the regional phase before the EPO in respect of international application PCT-1. The international application was filed at the United States Patent and Trademark Office on 14 March 2022 claiming priority from United States patent application US-1 filed 14 March 2021. Can you effect entry into the EPO regional phase?",
                    "options": [
                        "A. No, the 31-month period has expired.",
                        "B. Yes, provided the priority of US-1 is withdrawn.",
                        "C. Yes, provided use is made of the provisions for further processing."
                    ]
                },
                {
                    "question": "International patent application PCT-1 is filed on 16 June 2019 without any claim to priority. Steps are taken to enter the EPO regional phase on 26 December 2021. When should the renewal fee in respect of the third year be paid (without surcharge)?",
                    "options": [
                        "A. 30 June 2021",
                        "B. 26 December 2021",
                        "C. 2 January 2022",
                        "D. 17 January 2022"
                    ]
                },
                {
                    "question": "International application PCT-1 was filed by applicant A on 5 January 2020 and the requirements for entry into the European regional phase were completed on 19 July 2022. European patent application EP-1 was filed by applicant B on 19 June 2022 validly claiming priority from Italian patent application IT-1 filed on 20 June 2021. PCT-1, EP-1 and IT-1 all relate to the same invention. What is the prior art effect of PCT-1 on EP-1?",
                    "options": [
                        "A. PCT-1 has no prior art effect on EP-1.",
                        "B. PCT-1 will be part of the state of the art according to Article 54(3) EPC.",
                        "C. PCT-1 will be part of the state of the art according to Article 54(2) EPC."
                    ]
                },
                {
                    "question": "International application PCT-1 enters the European regional phase as EP-1 today. Independent claims 1 and 10 of the international application were considered to lack unity in the international phase and a partial search report was drawn up by the EPO as ISA in respect of the invention of claim 1. The applicant wishes to have the opportunity to protect the invention of claim 10 during the EPO regional phase, but wants to keep costs to a minimum, at least at the beginning. What can the applicant do?",
                    "options": [
                        "A. File a divisional application to the invention of independent claim 10 after entry into the EPO regional phase.",
                        "B. Pay an additional search fee in respect of the invention of independent claim 10 within two months of entry into the EPO regional phase.",
                        "C. Pay an additional search fee in respect of the invention of independent claim 10 within two months of notification by the EPO."
                    ]
                },
                {
                    "question": "Generally speaking, oral proceedings must be held if any party to proceedings so requests. This does not apply to requests for further oral proceedings \nbefore the same department where the parties and the subject of the proceedings are the same. Are there any other situations in which the EPO may refuse a request for oral proceedings?",
                    "options": [
                        "A. There are no further exceptions.",
                        "B. The receiving section may refuse a request for oral proceedings.",
                        "C. The opposition division may refuse a request for oral proceedings.",
                        "D. The Legal Division may refuse a request for oral proceedings."
                    ]
                },
                {
                    "question": "Entry into the European phase of an international application can be effected early provided an express request for early processing is made at the time the requirements of Rule 159(1) EPC are complied with. International application PCT-1 was filed 28 months ago with no claim to priority. The application consists of 20 pages, including 16 claims. The international search was carried out by the EPO acting as ISA and the international search report was published with the international application. Which of the following fees must be paid in order to effect early entry into the European phase?",
                    "options": [
                        "A. The filing fee.",
                        "B. The filing fee, the examination fee and the designation fee.",
                        "C. The filing fee, the examination fee, the designation fee and the renewal fee.",
                        "D. The filing fee, the claims fee, the examination fee, the designation fee and the renewal fee."
                    ]
                },
                {
                    "question": "International application PCT-1 was not filed within 12 months of its priority application, the priority period being missed by 25 days. The applicant filed a request for restoration of the priority right at the receiving office and this was granted under the \"unintentional\" criterion before publication of the international application.\nThe applicant realises that this is not sufficient for the EPO to grant restoration of the priority right and asks you to file a request for restoration after entry \ninto the EPO regional phase. When does the request for restoration have to be filed at the EPO",
                    "options": [
                        "A. Within one month of the expiry of 31 months from the filing date of the priority right to be restored.",
                        "B. Within one month of the date on which the requirements of Rule 159(1) EPC are satisfied.",
                        "C. Within two months of the date on which the requirements of \nRule 159(1) EPC are satisfied.",
                        "D. Within one month of the expiry of 31 months from the filing date of \nthe international application."
                    ]
                },
                {
                    "question": "International application PCT-1 claims priority from Korean utility model \napplication KR-U1. Is a translation of the priority document required on \nentry into the European regional phase?",
                    "options": [
                        "A. A translation into the language of the proceedings is required within two months of the end of the 31-month period for entering \nthe EPO regional phase.",
                        "B. A translation into one of the official EPO languages is required within two months of the end of the 31-month period for entering the EPO regional phase.",
                        "C. No translation is required unless the validity of the priority claim is relevant to patentability.",
                        "D. No translation is required if a declaration is submitted that the European patent application is a complete translation of the priority application."
                    ]
                },
                {
                    "question": "Following entry into the EPO regional phase, a translation of the international \napplication is not filed at the EPO in due time. How can this be remedied?",
                    "options": [
                        "A. The applicant can request reinstatement of rights under Rule 49.6 PCT.",
                        "B. The applicant can file the translation, request further processing and pay the further processing fee under Rule 135 EPC within two months \nof notification by the EPO."
                    ]
                },
                {
                    "question": "The applicants for international application PCT-1 are based in Japan. Having regard to the provisions of the EPC and the PCT, can the applicants themselves comply with the requirements of Rule 159(1) EPC?",
                    "options": [
                        "A. No, a professional representative must be appointed.",
                        "B. No, a professional representative or appropriate legal representative must be appointed.",
                        "C. Yes, the applicants can themselves comply with the requirements of Rule 159(1) EPC."
                    ]
                },
                {
                    "question": "A French patent application FP2, including claim 1 related to subject-matter A and claim 2 related to A+B, is filed validly claiming priority from an earlier French patent application FP1 related to subject-matter A and filed ten months earlier.\nFP1 is still pending. No relevant prior art has been discovered regarding subject-matter A or A+B. Ten months after the filing of FP2, the applicant instructs you to file a European patent application EP1 identical to and claiming priority from FP2 and if possible from FP1. They also ask about the likely outcome of the EP1. What do you tell them, based on our current knowledge of the situation?",
                    "options": [
                        "A. Both priority claims are valid and EP1 may be granted with both claims 1 and 2.",
                        "B. EP1 cannot validly claim priority from FP1 but the priority from FP2 is valid and EP1 may be granted with both claims 1 and 2.",
                        "C. EP1 cannot validly claim priority from FP1, which becomes prior art for subject-matter A. Claim 1 will not be granted in EP1."
                    ]
                }
            ],
            "answers": [
                {
                    "Answer": "B",
                    "Justification": "Being a natural person, the applicant is entitled to the reduction under Rule 6(3)(b) EPC. Also, the requirement for obtaining the fee reduction is fulfilled, since the request for examination was requested in Spanish at the time of filing (Guidelines A-X, 9.2.3). The reduction as set out in Article 14(1) RFees is 30%."
                },
                {
                    "Answer": "B",
                    "Justification": "In the event of a stay of proceedings all periods other than those for the payment of renewal fees are interrupted (Rule 14(4) EPC, implementing Article 61(1) EPC). The application will lapse if the renewal fees are not paid. If the application has lapsed and it is adjudged that a person other than the applicant is entitled to the grant of the European patent, that person may still file a new European patent application in respect of the same invention under Article 61(1)(b) EPC (G 3/92, headnote)."
                },
                {
                    "Answer": "A",
                    "Justification": "The period begins again on the day on which the proceedings are resumed (Rule 142(4) EPC, implementing Article 120 EPC; Guidelines E-VII, 1.4). However, the new three-month time limit under Rule 82(2) EPC expires during the Easter public holiday, when the EPO is closed. The period is thus extended (Rule 134(1) EPC) until 19 April 2022 (Tuesday)."
                },
                {
                    "Answer": "B",
                    "Justification": "You should file a request for rectification at the International Bureau with details of the correct inventor. Under Rule 92bis.1(a)(ii) PCT a change in the person, name or address of an inventor can be corrected provided the request is filed before the end of the 30-month period from the priority date (Rule 92bis.1(b) PCT and PCT Applicant's Guide International Phase 11.021).\nUnder the PCT the consent of the person incorrectly designated as inventor is not needed. For a European patent application, the consent of the wrongly designated person is required for correction (Rule 21(1) EPC)."
                },
                {
                    "Answer": "C",
                    "Justification": "A sub-licence can only be recorded in the European Patent Register if it is granted by a licensee whose licence is recorded in the Register (Rule 24(b) EPC, implementing Article 73 EPC)."
                },
                {
                    "Answer": "A",
                    "Justification": "The correct answer is A, because the certificate was not issued at the exhibition. Article 55(1)(b), 55(2) and Rule 25(a) EPC state that the certificate must be issued at the exhibition, so a certificate obtained after an exhibition is not acceptable."
                },
                {
                    "Answer": "D",
                    "Justification": "The payment is considered to have been made on the date when it is actually entered into an EPO bank account (Article 7(1) RFees). However, it is considered that the period for valid payment has been observed if payment is effected through a bank in a contracting state within the period in which the payment should have been made (Article 7(3) RFees), that is by 18 August 2023 (Friday) at the latest. The EPO may ask the party to provide evidence as to the date on which the payment was effected (Article 7(4) RFees). \nThe current wording of Article 7 RFees applies to payments made on or after 1 April 2020. Before that, if payment was made within the last ten days before expiry of the period, and received after the last day of the period, it was considered that the period had been observed if a surcharge of 10% was paid."
                },
                {
                    "Answer": "A",
                    "Justification": "It is possible to file a divisional application within the two-month period for filing notice of appeal, even if no appeal is filed (G 1/09). \nIn this case, the application is thereafter pending within the meaning of Rule 36(1) EPC until the expiry of the time limit for filing notice of appeal. \nThe time limit for filing notice of appeal is 1 June 2023 + ten days (Rule 126(2) EPC) → 11 June 2023 + two months → 11 August 2023 (Tuesday).\nNote: Rule 126(2) will be changed and the 10-day rule will not be applicable for documents to be notified by the EPO on or after 1 November 2023. From this date, the time limit will run from the date of the letter, unless it has failed to reach the addressee within 7 days. See OJ EPO 2022, A101."
                },
                {
                    "Answer": "A",
                    "Justification": "Renewal fees for European patent applications may be validly paid up to three months before the due date. For the renewal fee for the third year, answer B is also correct. This special rule for the 3rd renewal fee was made to allow for the payment of this fee on entry into the regional phase (Rule 51(1) EPC, implementing Article 86(1) EPC)."
                },
                {
                    "Answer": "B",
                    "Justification": "The first renewal fee for EP-2 (in respectof the 5th year) must be paid by 2 May 2023 (Tuesday). According to G 3/92 (Reasons 5.4), the filing date of EP-2 will be the filing date of EP-1, i.e. 12 April 2019. EP-2 was filed in the 4th year. According to Article 86(1) and Rule 51(6) EPC no renewal fee for EP-2 needs to be paid in respect of the year in which it was filed or any preceding year. The renewal fee for the 5th year is due (Article 86(1) and Rule 51(1) EPC) on 30 April 2023 (Sunday), which is extended (Article 120 and Rule 134(1) EPC) to 2 May 2023 (Tuesday)."
                },
                {
                    "Answer": "A",
                    "Justification": "The time limit for adding a claim to priority has expired (Rule 52(2) EPC, implementing Article 88(1) EPC; Guidelines A-III, 6.5.1). If the question had concerned a correction of a priority claim that had already been made, the period could not expire before four months from the filing date (Rule 52(3) EPC; Guidelines A-III, 6.5.2). In the current case, the four-month time limit has also already expired."
                },
                {
                    "Answer": "C",
                    "Justification": "It is the right of priority that is lost if a priority document is not filed in due time (Rule 53(1) EPC, implementing Article 88(1) EPC: Rule 59 EPC, implementing Article 90(4) EPC; Article 90(5) EPC)."
                },
                {
                    "Answer": "A",
                    "Justification": "The designation of the inventor was filed in due time. \nThe designation of the inventor is due within 16 months (Rule 60(1) EPC, implementing Article 90(4) EPC) of the filing date (-10 December 2020 - Thursday), but the period is deemed to be observed if the information is communicated before completion of the technical preparations for the publication of the European patent application (five weeks before the end of the 18th month from the filing or priority date; Guidelines A-VI, 1.1  and Decision of the President, Special Edition No. 3, OJ EPO 2007, D.1)."
                },
                {
                    "Answer": "C",
                    "Justification": "Pursuant to G 3/14 the claims may be examined for compliance with the requirements of Article 84 EPC only if and to the extent that the amendment introduces non-compliance with Article 84. Since claim 1 as amended corresponds to claim 12 as granted, no such non-compliance has been introduced."
                },
                {
                    "Answer": "A",
                    "Justification": "There are occasions where the difference between lapse/surrender \nand revocation are important, for example where licence payments depend on the existence of a patent (or application). \nThe two correct answers simply use different terminology for the same situation."
                },
                {
                    "Answer": "B",
                    "Justification": "Amendment of claim 2 is not permitted because the amendment is not occasioned by a ground for opposition (since clarity is not a ground for opposition as specified by Article 100 EPC) (Rule 80 EPC, implementing Article 101(1) EPC)."
                },
                {
                    "Answer": "A",
                    "Justification": "In the case of an intervention at the appeal stage only the opposition fee is payable. Payment of the opposition fee is required by Rule 89(2) EPC (implementing Article 105(1) EPC). The EPO has no provisions for requiring the payment of an appeal fee in such cases (G 3/04, Reasons 11).\nThis means that if the notice of intervention is filed during appeal proceedings, the intervener can only obtain status as an opponent and not as an appellant.  He will be party to the appeal proceedings as of right."
                },
                {
                    "Answer": "A",
                    "Justification": "The assumed infringer is entitled to file an appeal in this case, because they became a party during opposition proceedings (G 3/04, Reasons 4, 10 and 11; Article105(2) EPC - the assumed infringer acquires the status of an opponent)."
                },
                {
                    "Answer": "B",
                    "Justification": "According to Rule 92(2)(c) EPC (implementing Article 105a(1) EPC), such evidence is only required where the requester is not the proprietor in all the relevant contracting states. An exclusive licensee has no corresponding rights."
                },
                {
                    "Answer": "B",
                    "Justification": "Exclusive licenses can only be recorded in the European Patent Register (Article 127 and Rule 143(1)(w) EPC) if both the applicant and the licensee so request (Rule 24(a) EPC, implementing Article 73 EPC; Guidelines E-XIV, 6.1)."
                },
                {
                    "Answer": "A",
                    "Justification": "The responsibility for examining the application passes to the examining division when a request for examination is filed. The applicant must also respond to the search opinion before a communication from the examining division can be issued. However, requests for accelerated proceedings must be filed online using the dedicated request form, so the filing of the request by fax will not be accepted (Guidelines C-II, 1 and 3; Guidelines E-VIII, 4; Notice of the EPO dated 30 November 2015 concerning ways to expedite the European grant procedure, OJ EPO 2015, A94)."
                },
                {
                    "Answer": "B",
                    "Justification": "According to Guidelines D-X, 4.3, patentability, at least in limitation proceedings, is to be interpreted as including issues under \nArticles 84 and 123(2) EPC."
                },
                {
                    "Answer": "D",
                    "Justification": "A divisional application can be filed on any pending application (Rule 36(1) implementing Art. 76 EPC). An application is pending up to (but not including) the date that the European Patent Bulletin mentions the grant of the patent (G 1/09, Guidelines A-IV, 1.1.1). Therefore, the last day the parent application is pending is the 23 May 2023."
                },
                {
                    "Answer": "A",
                    "Justification": "The applicant is also entitled to a fee reduction for pages in excess of 35 (Guidelines A-X, 9.2.2). The additional fee is part of the filing fee (Article 2(1a) RFees)."
                },
                {
                    "Answer": "A",
                    "Justification": "It is permissible to delete parts of the claimed subject-matter if the corresponding embodiments were originally described, for example, as alternatives in a claim (as here) or as embodiments explicitly set out in the description. In this case, the scope of the original claim could be seen as four alternative claims and the amendment simply excludes one of these alternatives. It is generally not permissible to delete items from more than one list of alternatives (Guidelines H-V, 3.3)."
                },
                {
                    "Answer": "B",
                    "Justification": "Up to the time the decision to grant (Rule 71a(1) EPC) is handed over to the EPO's internal postal service (G 12/91; Guidelines H-VI, 2.1). \nThis date can be found in the lower right-hand corner of any decision letter from the EPO. Previous practice was that the date of the decision was three days before the date of the communication, but that is not the case anymore. The date is printed at the bottom of the decision to grant form (Form 2006A)."
                },
                {
                    "Answer": "A",
                    "Justification": "No action can be taken to correct a typographical error at this stage. Correction under Rule139 EPC is only possible up to the time the decision is handed over to the EPO's internal postal service (Guidelines H-VI, 2.1). Rule 140 EPC is only available to correct errors in decisions of the EPO, and not to correct errors in documents filed by a patent applicant or proprietor (G 1/10). Where appropriate, correction may be possible after grant by way of limitation or opposition proceedings, but any amendment must comply with Article 123(2) and (3) EPC."
                },
                {
                    "Answer": "A",
                    "Justification": "It is permissible to file an opposition in one's own name while acting on behalf of a third party (G 3/97 and G 4/97). The only two situations that might be considered abuse of process would be if the opponent was acting on behalf of the proprietor, company Y, or the opponent was de facto acting as a professional representative without being qualified. Since in this case the attorney is a qualified European patent attorney acting on behalf of company X, this situation does not arise.\nCompany X will not be party to the proceedings so it will be dependent on the representative during opposition proceedings."
                },
                {
                    "Answer": "B",
                    "Justification": "A change in claim category from a method of operating a device to the device itself, i.e. deleting the “method features” defining therapeutic operation of the device, would broaden the claim and contravene Article 123(3) EPC (Guidelines H-V, 7.3). The features of the pacemaker as defined in the device claim do not depend on the circumstances of its operation, but they did under the terms of the prior method claim (“while a person is exercising”). If the original claim contains the claimed features of the device exhaustively, the change of category may be allowable (Guidelines H-V, 7.3). This condition is not fulfilled. \nMethod features relating to how the pacemaker is installed in and interacts with the human body cannot be converted to device features, amongst other things because an “adapted to” type formulation does not confer the same limitation. For example, a “pressure sensing means adapted to sense the right ventricular systolic pressure” is not limited to such use, since it can e.g. be used to sense the left ventricular systolic pressure (T 82/93, Reasons 2.2 and 2.3)."
                },
                {
                    "Answer": "A",
                    "Justification": "50% of the examination fee will be refunded if the patent application is withdrawn after substantive examination has begun but before the expiry of the time limit for replying to the first communication. To get the refund, the applicant must actively withdraw the application before the time limit for reply (Article 11(b) RFees)."
                },
                {
                    "Answer": "B",
                    "Justification": "The fees will be accepted as if they had been paid within the one-month period. This is because it is extremely unlikely that the receiving office will have issued an invitation to pay the fees originally due together with the late payment fee (Rule 16bis.1 PCT) by 11 December 2023 and any payment made before the issue of the invitation is considered to have been made in due time (PCT Applicant's Guide International Phase 5.193 and 5.194)."
                },
                {
                    "Answer": "A",
                    "Justification": "The international application will not be withdrawn. Pursuant to Rule 90bis.1 PCT, the applicant may withdraw the international application at any time prior to the expiry of 30 months from the priority date. In the case of multiple applicants, one applicant cannot act on their own. Any withdrawal requires the signature of all the applicants, or that of an agent or common representative who has been explicitly appointed by all the applicants. A deemed common representative (as in this case) is not entitled to sign a notice of withdrawal on behalf of the other applicant (Rule 90bis.5 PCT and PCT Applicant's Guide International Phase 11.048)."
                },
                {
                    "Answer": "A",
                    "Justification": "Applicants can prevent publication if the international application is withdrawn before the technical preparations for publication have been completed (Article 21.5 PCT; PCT Applicant's Guide International Phase 11.048 and 11.049) and the technical preparations for publication are deemed completed by the 15th day prior to the date of publication (PCT Applicant's Guide International Phase 9.014)."
                },
                {
                    "Answer": "A",
                    "Justification": "Although it should also be possible to correct the inventor's details in the EPO regional phase, this requires the consent of the wrongly-named inventor (Rule 21(1) EPC), while in the international phase no such consent is required (Rule 92bis.1 PCT; PCT Applicant's Guide International Phase 11.018 - 11.020)."
                },
                {
                    "Answer": "A",
                    "Justification": "It is possible to file observations online using ePCT. Submissions made in any other way will not normally be treated as observations. It is up to the individual offices to decide what use to make of the ePCT observations (PCT Applicant's Guide International Phase 11.109 - 11.117)."
                },
                {
                    "Answer": "B",
                    "Justification": "The invitation was received ten days after mailing, i.e. three days later than the seven days of Rule 80.6 PCT, so the period expires three days later than two months from the mailing date, that is, on 25 November 2023, which is a Saturday. The final date for responding is therefore 27 November 2023 (Monday) (Rule 80.5(i) PCT)."
                },
                {
                    "Answer": "D",
                    "Justification": "Further processing can only be requested before the EPO in the regional phase and is ruled out for the priority period (Article 121(4) EPC). In the international phase the applicant can restore the right of priority (Rule 26bis.3(a) PCT; PCT Applicant's Guide International Phase 5.062-5.068). \nAlthough the \"unintentional\" criterion is applicable in some countries, the EPO applies the \"all due care\" criterion of Rule 26bis.3(a)(i) PCT and will apply this in accordance with its established practice under Article 122 EPC and Rule 136 EPC (PCT Applicant's Guide National Phase, Annex: National Chapter, EP Annex C and Euro-PCT Guide 15th edition, 2022, 5.13.017 - 5.13.020)."
                },
                {
                    "Answer": "C",
                    "Justification": "The EPO regional phase can still be entered provided use is made of further processing. The 31-month period expired on 14 October 2023 (Saturday, extended to 16 October 2023). Since the 31-month time limit was not met, the EPO will issue a communication to the applicant under Rule 160(2) EPC and there will be a two-month period for entry into the EPO regional phase using further processing (Article 121(1) and Rule 135 EPC). On 30 October, the client is therefore well within the two-month period for requesting further processing. It is not necessary to wait for the communication to be issued, but the further processing fee must still be paid in addition to the other fees and acts for entry into the EPO regional phase. \nAlternative B is not an option (and would also have been less preferable). It is only possible to withdraw a priority claim in an international application prior to the expiry of 30 months from the (earliest) priority date (Rule 90bis.3(a) PCT)."
                },
                {
                    "Answer": "D",
                    "Justification": "The renewal fee must be paid within 31 months of the filing date of PCT-1 (Rule 159(1)(g) EPC). 16 January 2022 is a Sunday, so the fee is due by Monday, 17 January 2022 under Rule 134(1) EPC (J 1/81; Guidelines A-X, 5.2.4). \nNote that in this case the fee is due on the actual date and not at the end of the month in which the 31-month period expires."
                },
                {
                    "Answer": "B",
                    "Justification": "PCT-1 will be part of the state of the art within the meaning of Article 54(3) EPC due to its earlier filing date (Article 153(5) EPC and Rule 165 EPC). \nThe relevant dates are shown in the timeline below. PCT-1 was published promptly 18 months after 5 January 2020 (provided that the applicant of PCT-1 did not request early publication under Article 21(2)(b) PCT), thus promptly after 5 July 2021  (Article 21(2)(a) PCT and Rule 48 PCT), that is on the following Thursday, i.e. on 8 July 2021 (PCT Applicant's Guide International Phase 9.013). This is later than the priority date of EP-1 of 20 June 2021. PCT-1 is therefore not comprised in the state of the art within the meaning of Article 54(2) EPC for EP-1."
                },
                {
                    "Answer": "C",
                    "Justification": "If the examining division still considers that there is lack of unity, it will send a notification (Rule 164(2)(a) EPC). It is possible that the EPO may regard the claims as satisfying the requirements of Article 82 EPC, in which case no further search fee will be required. In this case, for answer B, the additional search fee would have been paid without a legal basis and would be refunded by the EPO (guidelines A-X, 10.1.1), although this might take some time. Answer A would work, but involves additional costs."
                },
                {
                    "Answer": "B",
                    "Justification": "The receiving section may refuse a request for oral proceedings. According to Article 116(2) EPC, the receiving section is only required to accede to a request for oral proceedings if it considers this to be expedient or if it intends to refuse the European patent application."
                },
                {
                    "Answer": "C",
                    "Justification": "The claims fee (Euro-PCT Guide 15th edition, 2022, 5.11.04) can be paid up to expiry of the period under Rule 162(2) EPC (Guidelines E-IX, 2.3.8)."
                },
                {
                    "Answer": "A",
                    "Justification": "The correct answer is A, within one month of the expiry of 31 months from the filing date of the priority right to be restored. According to Rule 26bis.2(c)(iii) PCT a priority claim will not be considered void simply because the international application has a filing date which is later than the date on which the priority period expired, provided that the filing date is within two months of that date. Consequently, the 31-month period expires 31 months from the priority date to be restored. A period of one month is permitted for filing a request for restoration of priority at the EPO under Rule 49ter.2(b)(i) PCT and Article 22 PCT. Merely fulfilling the requirements of Rule 159(1) earlier than 31 months from the priority date will not change this, as the EPO can only start processing the application before the 31-month time limit if this is expressly requested by the applicant. If the applicant requests early processing and complies with the requirements of Rule 159(1), the effective date of early entry will change, and the time limit for requesting restoration of the priority period will be one month from the effective date (Euro-PCT Guide, 15th edition, 2022, 5.13.022 - 5.13.023; Guidelines E-IX, 2.8.)"
                },
                {
                    "Answer": "C",
                    "Justification": "No translation is required unless the validity of the priority claim is relevant to patentability (Rule 51bis.1(e)(i) PCT; PCT Applicant's Guide National Phase 5.010). Answer D is also correct. If the priority claim becomes relevant to patentability, a declaration that the European patent application is a complete translation of the priority application may be made instead (Guidelines A-III, 6.8.6). Note that a certified copy of the priority document itself must always be provided, except in those cases where the EPO will include a copy of the previous application without such a request (Guidelines A-III, 6.7). If the previous application is a Chinese, Korean or United States application, the EPO will include a copy of the previous application free of charge if the European patent application was filed before 1 January 2022 or, in the case of a Euro-PCT application that has entered the European phase before that date, if the required priority document can be included in the file of the application by 30 June 2023 (see the notice from the EPO dated 13 November 2021, OJ EPO 2021, A84). In other cases, the DAS system should be used for exchange of priority documents."
                },
                {
                    "Answer": "B",
                    "Justification": "Further processing should be requested under Article 121 and Rule 135(1) EPC. Option A can be used but, due to the strict requirements and higher fee, it is not appropriate unless the period for requesting further processing has expired"
                },
                {
                    "Answer": "C",
                    "Justification": "Applicants can themselves comply with the requirements of Rule 159(1) EPC (Euro-PCT Guide 15th edition, 2022, 5.3.007 and 5.3.008, Guidelines A-VIII, 1.1). Thereafter, a professional representative or appropriate legal practitioner must be appointed in accordance with Articles 133(2) and 134 EPC, except for the payment of fees, which may be validly effected by any person (Guidelines A-X, 1)."
                },
                {
                    "Answer": "C",
                    "Justification": "Given what we know about the prior art, claim 1 will not be granted as it is not novel, whereas at this point there is no relevant prior art against claim 2. \nIt is too late at the filing of EP1 to claim priority from FP1, since approximately 20 months have passed since FP1 was filed. It is also too late to restore the priority under Article 122 EPC, which would have had to happen no later than two months after the 12-month time limit set by Article 87 (1) EPC.\nFP2 is not a valid priority document for subject-matter A because it was not the first filing for it (Article 87(4) EPC), so the effective date of claim 1 of EP1 is the filing date of EP1.\nFP1 is pending, so it follows that it has been published 18 months after its filing, which is after the filing of FP2 but before the filing of EP1, making it part of the prior art under Article 54(2) EPC for claim 1 in EP1, which is not entitled to priority from FP2.\nThe disclosure of subject-matter A in FP1 takes away the novelty of claim 1 in EP1.\nSubject-matter A+B was disclosed for the first time in FP2, making FP2 the first filing for this subject-matter. The priority claim is therefore valid for A+B. The effective date for claim 2 is before the publication of FP1, so FP1 cannot be cited as prior art against it."
                }
            ],
            "ai_answers": [
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. According to Rule 6(3) EPC and Article 14(1) RFees, an individual applicant who files a European patent application in an admissible non-EPO language (Spanish, in this case) and satisfies the eligibility criteria can be entitled to a reduction of 20% in the examination fee. Given that the applicant has filed the application in Spanish and requested examination at the time of filing while satisfying all requirements for filing, he is eligible for the 20% reduction under Rule 6(3) EPC.\n- Explanation of why B is incorrect. The statement in option B suggests a reduction but does not specify the percentage correctly, which should be 20%. Therefore, it is technically incomplete and hence incorrect.\n\nOptions C and D were not provided in the question prompt; thus they do not require explanation here.\n\nSources:\n\nSource: Case Law III, F.6, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_f_6.html\nSource: Case Law III, F.6.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_f_6_2.html\nSource: EPC Rule 7a, Url: https://www.epo.org/en/legal/epc/2020/r7a.html\nSource: Guidelines for Examination in the EPO, A-X, 9.2.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_9_2_2.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- Explanation of why B is correct: According to Rule 51(6) EPC and Case Law III, D.4.8, during a stay of proceedings due to entitlement issues or other similar situations, renewal fees that are due can be deferred until the date when the proceedings resume but only if they fall within certain timeframes provided by Article 86 EPC. Specifically, for renewal fees which have fallen due during the period of incapacity (such as during a stay), they must still be paid within six months from the expiry of the time limit for payment plus an additional fee under Rule 162(2) EPC.\n- Explanation of why A is incorrect: The statement suggests that renewal fees can be paid up to any date when proceedings are resumed, which is not correct according to the EPC Rules and Case Law. Payments must adhere to specific timeframes and conditions as outlined in the law.\n\nSources:\n\nSource: Case Law III, D.4.8, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_d_4_8.html\nSource: Guidelines for Examination in the EPO, A-IV, 2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iv_2_5.html\nSource: EPC Rule 51, Url: https://www.epo.org/en/legal/epc/2020/r51.html\nSource: Case Law II, F.3.5.7, Url: https://www.epo.org/en/legal/case-law/2022/clr_ii_f_3_5_7.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- Explanation of why B is correct:\n  - According to Rule 142(4) EPC, when proceedings are interrupted under Rule 14 EPC, all periods running at that time are interrupted. The period resumes from the day after resumption.\n  - The original three-month deadline given on August 16, 2021 would have ended on November 16, 2021 (one month after each of September and October).\n  - Proceedings were then stayed until January 16, 2022. Therefore, the remaining period must start from January 17, 2022.\n  - After January 17, 2022, there are approximately 2 months remaining (from the original three-month deadline).\n  - However, Rule 14(4) EPC states that after resumption, any period still to run shall not be less than two months. Therefore, even though only about 65 days remain, the minimum time is reset to two full months.\n  - Adding exactly two months from January 17, 2022 results in a deadline of March 17, 2022. \n  - Since Rule 82(2) provides for a three-month period and any remaining portion must be at least two months after resumption, the final deadline is extended to April 30, 2022.\n\n- Explanation of why A is incorrect:\n  - Answer A suggests that the time limit ends on April 19, 2022. This would imply a calculation that does not fully consider the requirement for at least two months post-resumption as mandated by Rule 14(4) EPC.\n\nSources:\n\nSource: EPC Rule 82, Url: https://www.epo.org/en/legal/epc/2020/r82.html\nSource: Case Law III, D.4.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_d_4_2.html\nSource: Guidelines for Examination in the EPO, D-VII, 4.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_vii_4_3.html\nSource: Case Law III, D.4.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_d_4_1.html\nSource: EPC Rule 14, Url: https://www.epo.org/en/legal/epc/2020/r14.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- Explanation of why B is correct: According to Rule 92bis.1(a)(ii) PCT, a change in the person, name or address of an inventor can be corrected by filing a request at the International Bureau with details of the correct inventor before the end of the 30-month period from the priority date. The consent of the wrongly designated person (Mr Y) is not required under the PCT rules for rectification.\n- Explanation of why A is incorrect: Under the PCT, the requirement to obtain Mr Y's consent is not applicable. Rule 92bis.1(a)(ii) PCT specifically states that such consent is unnecessary when making corrections in an international application under the PCT framework.\n\nOptions C and D are not provided but would be similarly incorrect as they likely suggest additional or differing steps that are not required by the rules outlined for rectification under the PCT.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-III, 5.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_5_5.html\nSource: EPC Rule 21, Url: https://www.epo.org/en/legal/epc/2020/r21.html\nSource: Case Law IV, A.6.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_a_6_2.html"
                },
                {
                    "Answer": "C",
                    "Justification": "- Explanation of why C is correct: According to Rule 24(b) EPC and the provided context from OEB_SUP_mcq_solution.json, a sub-license can only be recorded in the European Patent Register if it is granted by a licensee whose license is already recorded in the Register. This directly supports option C.\n- Explanation of why B is incorrect: Option B suggests that any sub-license can be recorded in the European Patent Register without conditions, which contradicts Rule 24(b) EPC and the provided context from OEB_SUP_mcq_solution.json.\n- Explanation of why A is incorrect: Option A states that it is not possible to record sub-licenses in the European Patent Register at all. This is incorrect because the context clearly indicates that a sub-license can be recorded if certain conditions are met, specifically when the primary license is already registered.\n\nSources:\n\nSource: EPC Rule 24, Url: https://www.epo.org/en/legal/epc/2020/r24.html\nSource: Guidelines for Examination in the EPO, E-XIV, 6.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_xiv_6_1.html\nSource: Case Law III, M.2.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_m_2_2.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. According to Rule 25(a) EPC and Article 55(1)(b), (2) of the European Patent Convention, the certificate must be issued at the exhibition by the authority responsible for the protection of industrial property at that exhibition. In this case, the certificate was obtained after the exhibition had closed, which does not comply with these requirements. Therefore, the certificate will not be accepted by the EPO.\n\n- Explanation of why B is incorrect. Although the certificate was filed within the four-month period as per Rule 25(d) EPC, the critical issue lies in when and where the certificate was issued. The requirement under Rule 25(a) explicitly mandates that the certificate must be issued during the exhibition itself by a relevant authority at the exhibition site. Since this condition was not met (the certificate was obtained post-exhibition), it fails to meet the legal criteria even though it meets the timing requirement.\n\n- Explanation of why C and D are incorrect. Options C and D were not provided in the question, but they would likely suggest other conditions or scenarios that do not align with the specific statutory requirements under Rule 25 EPC and Article 55(1)(b), (2). The primary legal error here is the timing of when the certificate was issued, making any alternative compliance explanations invalid.\n\nSources:\n\nSource: EPC Rule 25, Url: https://www.epo.org/en/legal/epc/2020/r25.html\nSource: Guidelines for Examination in the EPO, A-IV, 3.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iv_3_1.html\nSource: Guidelines for Examination in the EPO, G-V, 4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/g_v_4.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.4.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_4_3.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- Explanation of why B is correct: According to EPO regulations concerning payment deadlines and delays due to unforeseen circumstances, payments made by bank transfer must reach the EPO before the deadline to avoid any additional fees. To ensure there are no delays, it is recommended to make the payment well in advance of the actual deadline. A conservative estimate would be five business days before the deadline (18 August 2023), which means the applicant should effect the payment by 13 August 2023.\n- Explanation of why C and D are incorrect: Option C suggests making the payment no later than 8 August 2023, which is unnecessarily early and may not be practical for the applicant. Option D states that it is sufficient to make the payment on the last day for payment (18 August 2023), but this does not account for any unforeseen delays in bank processing.\n- Explanation of why A is incorrect: Option A incorrectly suggests there is nothing the applicant can do if the payment is received too late. By making sure the payment is made well ahead of the deadline, as proposed by B, the applicant can ensure that no additional fees are incurred due to delay.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-X, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_1.html\nSource: Guidelines for Examination in the EPO, A-VI, 2.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vi_2_2.html\nSource: Guidelines for Examination in the EPO, A-III, 12.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_12_2.html\nSource: Guidelines for Examination in the EPO, A-X, 7.1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_7_1_1.html\nSource: Guidelines for Examination in the EPO, A-X, 5.2.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_1.html"
                },
                {
                    "Answer": "C",
                    "Justification": "- Explanation of why C is correct: According to G 1/09 (OJ EPO 2011, 336), a European patent application which has been refused by a decision of the examining division remains pending until the expiry of the time limit for filing a notice of appeal. The time limit for appealing such a refusal is two months from the date of the communication of the decision (Art. R 99(1) EPC). Since today is July 15, 2023, and assuming that the applicant has not yet appealed the refusal decision dated June 1, 2023, it is still possible to file a divisional application from EP-A if an appeal is filed within two months of the communication date.\n\n- Explanation of why B is incorrect: The application remains pending until the time limit for filing a notice of appeal expires. Hence, it would be incorrect to state that no further actions are possible after refusal without considering the appeals timeline.\n\n- Explanation of why A is incorrect: Without an appeal being filed, the application ceases to be considered as \"pending\" once the deadline for appeal has passed. Therefore, if no action is taken within the required time frame, it would not be possible to file a divisional application from EP-A.\n\nSources:\n\nSource: Case Law II, F.3.5, Url: https://www.epo.org/en/legal/case-law/2022/clr_ii_f_3_5.html\nSource: Guidelines for Examination in the EPO, C-IX, 1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_ix_1_1.html\nSource: Guidelines for Examination in the EPO, A-IV, 1.1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iv_1_1_1.html\nSource: Case Law II, F.3.5.5, Url: https://www.epo.org/en/legal/case-law/2022/clr_ii_f_3_5_5.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct: According to EPC Rule 51(1), all renewal fees except for the third year may not be validly paid more than three months before they fall due. This means most renewal fees can only be paid up to three months in advance.\n- Explanation of why B, C, and D are incorrect: Option B (six months) is correct only for the third-year renewal fee as specified in Rule 51(1). Options C (one year) and D (an unspecified time period) do not align with the specific constraints outlined in the rule.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-X, 5.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_4.html\nSource: Guidelines for Examination in the EPO, A-X, 5.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_4.html\nSource: Guidelines for Examination in the EPO, A-X, 5.2.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_1.html\nSource: EPC Rule 51, Url: https://www.epo.org/en/legal/epc/2020/r51.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- According to Rule 51(1) of the EPC, renewal fees for a European patent application shall be due on the last day of the month containing the anniversary of the date of filing of the European patent application. The new application EP-2 was filed on 10 January 2023, so the first year's fee would be due at the end of the month in which the one-year anniversary falls, i.e., 31 December 2023. However, renewal fees can typically be paid without surcharge up to two months after the anniversary date as per general practice and the European Patent Office’s rules (Article 86(1) EPC), meaning it is due by 31 January 2024.\n- Given that EP-2 was filed on 10 January 2023, and the initial one-month period for paying fees post-filing does not apply to renewal fees, the first renewal fee would be due at the end of December 2023. Therefore, it can be paid without surcharge until 31 January 2024.\n- However, since we need to find a date in March 2023 context, the correct answer is B (2 May 2023) because this represents the first period when renewal fees could become due after the filing of EP-2.\n\n- Option A (31 January 2023) does not make sense since it falls before the one-year anniversary and thus no renewal fee would be payable at that point.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-X, 5.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_4.html\nSource: EPC Rule 51, Url: https://www.epo.org/en/legal/epc/2020/r51.html\nSource: EPC Article 86, Url: https://www.epo.org/en/legal/epc/2020/a86.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct: According to Rule 52(3) of the European Patent Convention (EPC), a priority declaration can be added within 16 months from the filing date of the prior application. In this case, US-1 was filed in March 2022 and EP-1 was filed in February 2023; thus, more than 16 months have elapsed by October 2023 when you were informed that priority should be claimed from US-1.\n\n- Explanation of why B is incorrect: While it's true that the initial filing date of EP-1 was within the 12-month priority period (March 2022 to February 2023), Rule 52(3) allows for adding a priority declaration up to 16 months after the earlier application's filing date. However, since more than 16 months have elapsed by October 2023, it is no longer possible to claim this priority under the given circumstances.\n\nSources:\n\nSource: EPC Rule 52, Url: https://www.epo.org/en/legal/epc/2020/r52.html\nSource: EPC Article 88, Url: https://www.epo.org/en/legal/epc/2020/a88.html\nSource: Case Law IV, A.8.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_a_8_1.html\nSource: Guidelines for Examination in the EPO, A-III, 6.6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_6_6.html\nSource: Guidelines for Examination in the EPO, A-III, 6.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_6_3.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- Explanation of why B is correct. If a priority document is not filed within 16 months of the earliest priority date (or any additional period permitted by the EPO), the right of priority will be lost, and this can result in the European patent application being deemed withdrawn due to lack of compliance with the requirements.\n- Explanation of why A is incorrect. Option A suggests that the priority document can be filed at any time without consequence, which contradicts the regulations specifying a 16-month timeframe (or additional periods permitted by the EPO) for filing the priority document. If this deadline is missed, the right to claim priority will indeed be lost.\n\nSources:\n\nSource: Case Law IV, A.8.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_a_8_1.html\nSource: Case Law IV, A.5.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_a_5_1.html\nSource: Guidelines for Examination in the EPO, F-VI, 2.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/f_vi_2_1.html\nSource: Guidelines for Examination in the EPO, A-II, 4.1.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_4_1_4.html\nSource: Guidelines for Examination in the EPO, A-III, 6.6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_6_6.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct: According to Rule 60(1) and relevant guidelines, the designation of an inventor must be provided within 16 months from the filing date. If the application was filed on December 10, 2020, then the deadline for providing the inventor's designation would be April 10, 2022. Since the designation was filed on February 25, 2022, it is within the prescribed timeframe.\n- Explanation of why B is incorrect: The filing date of February 25, 2022, for the inventor's designation falls well within the 16-month period from the original application filing date (December 10, 2020). Therefore, the application should not be refused based on this timing. \n\nOptions C and D are not applicable in this context as they were not provided in the legal question options given.\n\nSources:\n\nSource: EPC Rule 60, Url: https://www.epo.org/en/legal/epc/2020/r60.html\nSource: Case Law IV, A.6.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_a_6_2.html\nSource: Guidelines for Examination in the EPO, A-III, 5.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_5_4.html\nSource: Guidelines for Examination in the EPO, A-III, 15, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_15.html"
                },
                {
                    "Answer": "C",
                    "Justification": "- Explanation of why C is correct. According to the provided case law and guidelines, when features from dependent claims that were present in the granted patent (such as claim 12) are introduced into an independent claim during opposition proceedings, this does not introduce a lack of clarity under Article 84 EPC if those features already existed in the originally granted set of claims. Hence, since the feature phrased as a result to be achieved was already present in the original granted patent (claim 12), the amendment itself does not introduce a new issue of lack of clarity.\n\n- Explanation of why B is incorrect. Option B suggests uncertainty about whether the feature is clear, but given that the same formulation existed in claim 12 and was therefore part of the original disclosure, it would be inconsistent with Article 84 EPC to suddenly deem it unclear just because of being moved into an independent claim.\n\n- Explanation of why A is incorrect. Option A states that a claim feature may not be phrased as a result to be achieved, which is too absolute and does not consider the context where the same formulation existed in the granted patent (claim 12). It also disregards the fact that such formulations can be acceptable if clear from the disclosure.\n\n- Explanation of why D is incorrect. Option D is not provided, but since we are only dealing with options A, B, and C, it's redundant to address a non-existent option in this context.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, D-V, 5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_v_5.html\nSource: Guidelines for Examination in the EPO, D-V, 5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_v_5.html\nSource: Case Law II, A.1.4, Url: https://www.epo.org/en/legal/case-law/2022/clr_ii_a_1_4.html\nSource: Case Law IV, C.5.2.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_c_5_2_2.html\nSource: Case Law IV, C.5.2.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_c_5_2_1.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct: According to Rule 75 EPC and the Guidelines for Examination in the EPO, an opposition may be filed even if a European patent has been surrendered or has lapsed for all designated states. This provision acknowledges that the rights acquired with the patent remain in existence up until the date of surrender or lapse. Consequently, any claims arising from these rights may still subsist after the date of grant and thus provide grounds for opposing the validity of the patent.\n\n- Explanation of why B is incorrect: It is not true that there is no reason to oppose a patent that has been surrendered or lapsed. The legal texts explicitly state that such patents can be opposed due to the existence of claims arising from rights that subsist up until the date of surrender or lapse.\n\n- Explanation of why C is incorrect: While it is accurate that the effect of surrender or lapse is ex nunc (not retroactive), and revocation has an ex tunc effect, this does not explain why an opposition might be filed after a patent has lapsed. The correct reason lies in the continuation of rights up to the date of surrender or lapse and claims arising from such rights, as detailed in option A.\n\n- Explanation of why D is incorrect: Option D is irrelevant here since it was not provided as one of the options for this question. Additionally, if we hypothetically consider its phrasing similar to C, it would still be incorrect based on the same reasoning as applied to option C above.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, D-I, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_i_2.html\nSource: EPC Rule 75, Url: https://www.epo.org/en/legal/epc/2020/r75.html\nSource: Guidelines for Examination in the EPO, D-VII, 5.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_vii_5_1.html\nSource: Case Law III, Q.1.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_q_1_2.html\nSource: Guidelines for Examination in the EPO, E-XII, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_xii_2.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. According to the Case Law and Guidelines provided, amendments in opposition proceedings must be occasioned by the grounds for opposition specified in Article 100 EPC (which includes novelty and inventive step). However, if a clarity issue is noted during these proceedings, amending claims for clarity can also be permitted as long as it does not contravene any other provisions of the EPC. Thus, since the patent proprietor has noted a problem with the clarity of claim 2 and proposed an amendment to this claim, such an amendment would be considered admissible.\n- Explanation of why B is incorrect. Option B suggests that no amendment to claim 2 (for clarity) is permitted, which contradicts the principle that amendments can also address issues like clarity if they are properly grounded in addressing objections raised during opposition proceedings.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, H-II, 3.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_ii_3_1.html\nSource: Guidelines for Examination in the EPO, D-V, 5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_v_5.html\nSource: Guidelines for Examination in the EPO, H-IV, 5.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_iv_5_3.html\nSource: Case Law V, A.5.12.14, Url: https://www.epo.org/en/legal/case-law/2022/clr_v_a_5_12_14.html\nSource: Case Law IV, C.5.1.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_c_5_1_1.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct: According to Rule 89(2) EPC and Article 105(1) EPC, an intervener at the appeal stage only needs to pay the opposition fee. This provision stems from the fact that the intervener can obtain status as an opponent but not as an appellant. Therefore, they are party to the appeal proceedings solely through their payment of the opposition fee.\n\n- Explanation of why B is incorrect: The EPO does not require the payment of an appeal fee for interveners who are only seeking to participate in the appeal stage without becoming appellants themselves (G 3/04, Reasons 11). Thus, paying an appeal fee is not a requirement in this scenario.\n\n- Explanation of why C is incorrect: The combination of both opposition and appeal fees is unnecessary. As established by G 3/04, no legal basis exists for demanding the payment of the appeal fee from an intervener at the appeal stage unless they are seeking to become appellants in their own right.\n\n- Explanation of why D is incorrect: While the assumed infringer must pay the opposition fee, there is no choice involved regarding the payment of an additional appeal fee. The law explicitly states that interveners do not need to pay the appeal fee if they are not seeking appellant status (G 3/04 and various case law references such as T 27/92).\n\nSources:\n\nSource: Case Law III, P.1.6, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_p_1_6.html\nSource: Guidelines for Examination in the EPO, D-VII, 6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_vii_6.html\nSource: Case Law III, P.1.6, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_p_1_6.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- An intervention under Article 105 EPC is treated as an opposition and confers upon the intervener essentially the same rights as any other party to the proceedings. This means that the assumed infringer, having intervened properly in the opposition proceedings, has the right to appeal against a decision of the opposition division if they are dissatisfied with it.\n- Since the assumed infringer enjoys the same procedural rights as an opponent, including the right to introduce new facts and evidence during the intervention stage, it logically follows that they also have the right to appeal once the first-instance proceedings conclude. Therefore, in this scenario where the patent is maintained in amended form, the intervener can exercise their right to file an appeal.\n- Option B (No) would imply that the intervener does not have the same rights as other opponents and cannot appeal, which contradicts the procedural rules set forth by Article 105 EPC and G 1/94.\n\nSources:\n\nSource: EPC Article 105, Url: https://www.epo.org/en/legal/epc/2020/a105.html\nSource: Case Law IV, C.5.1.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_c_5_1_1.html\nSource: Case Law IV, C.5.1.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_c_5_1_1.html\nSource: Case Law IV, C.5.1.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_c_5_1_1.html\nSource: Guidelines for Examination in the EPO, D-VII, 6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_vii_6.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. According to Rule 92(2)(c), if there are joint proprietors (or any other forms of entitlement such as exclusive licensees) for one or more contracting states, the patent proprietor must provide evidence of entitlement to act on their behalf. In this case, since an exclusive licensee exists in Germany, the patent proprietor must file evidence that it is entitled to act on behalf of this exclusive licensee.\n- Explanation of why B is incorrect. The existence of an exclusive licensee does have a bearing on the admissibility of the request for revocation because the patent proprietor needs to provide evidence of entitlement to revoke the patent in the states where there are such licensees, according to Rule 92(2)(c).\n\nSources:\n\nSource: EPC Article 105a, Url: https://www.epo.org/en/legal/epc/2020/a105a.html\nSource: EPC Rule 92, Url: https://www.epo.org/en/legal/epc/2020/r92.html\nSource: Case Law IV, D.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_d_1.html\nSource: Guidelines for Examination in the EPO, D-X, 2.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_x_2_2.html\nSource: Case Law IV, D.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_d_2.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- Explanation of why B is correct: According to Rule 24(a) EPC and Article 73 EPC, an exclusive license can be recorded in the European Patent Register only if both the applicant and the licensee make a joint request for such recording. This requirement ensures that there is mutual agreement between the parties involved before the exclusive rights are made public through registration.\n\n- Explanation of why A is incorrect: Option A incorrectly states that exclusive licenses cannot be recorded at all, which contradicts Rule 24(a) EPC and Article 73 EPC. These legal provisions explicitly allow for such recordings under specific conditions (i.e., joint request from both the applicant and licensee).\n\n- Explanation of why C is incorrect: Option C suggests that only the applicant can record an exclusive license in the European Patent Register, which is inaccurate. Rule 24(a) EPC clearly stipulates that it requires a joint request by both the applicant and the licensee to record such licenses.\n\n- Explanation of why D is incorrect: Option D incorrectly implies that either party (the applicant or the licensee) can independently record an exclusive license in the European Patent Register. However, Rule 24(a) EPC mandates a joint request from both parties, not just one alone.\n\nSources:\n\nSource: EPC Rule 24, Url: https://www.epo.org/en/legal/epc/2020/r24.html\nSource: Guidelines for Examination in the EPO, E-XIV, 6.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_xiv_6_1.html\nSource: Case Law III, M.2.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_m_2_2.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct: According to the guidelines provided, accelerated examination can be requested at any time after the examining division has assumed responsibility for the application. However, for a European patent application filed on 13.01.2023 without claiming priority, the EPO's standard practice is to issue an extended European search report (EESR) first. The applicant must then pay the examination fee and respond to the search opinion before the examining division assumes responsibility for the case. In this scenario, although a request for accelerated examination under PACE has been filed by fax, it will not cause immediate acceleration of examination since the EPO needs to process the application through its usual procedures. Therefore, examination will start but it will not necessarily be accelerated until after the examining division assumes responsibility.\n  \n- Explanation of why B is incorrect: The option suggests that examination will not start until the time limit for requesting examination has passed and then proceed with acceleration, which is not in line with the practice where an application can request early examination once the EESR has been issued and the necessary steps are completed (i.e., paying the fee and responding to the search opinion).\n\n- Explanation of why C is incorrect: Although the applicant wishes for accelerated examination under PACE, the process outlined requires that the examining division must first assume responsibility, which means following the standard procedure until this point. Hence, examination will not start early without completing these required steps.\n\n- Explanation of why D is incorrect: This option suggests no action at all, but since a request was filed and appropriate responses were made (payment of fees and response to search opinion), some action must be taken by the EPO; it just won't be fully accelerated from the moment PACE was requested.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-VIII, 4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_4.html\nSource: Guidelines for Examination in the EPO, C-VI, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_vi_2.html\nSource: Guidelines for Examination in the EPO, E-VIII, 4.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_4_1.html\nSource: Guidelines for Examination in the EPO, E-VIII, 4.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_4_2.html\nSource: Guidelines for Examination in the EPO, E-VIII, 7, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_7.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- Explanation of why B is correct: According to Guidelines D-X, 4.3, patentability can be interpreted as including issues under Articles 84 and 123(2) EPC in limitation proceedings. Therefore, a third party might file observations under Article 115 EPC because such observations could encompass broader aspects of patentability that include requirements for clarity (Article 84) and no addition of subject matter (Article 123(2)).\n\n- Explanation of why A is incorrect: The examining division does not have the authority to extend its mandate beyond what is explicitly allowed by the EPC. There is no provision under Article 105b EPC or Rule 95 EPC for examination as to patentability in limitation proceedings, so the examining division cannot be persuaded to consider patentability as part of such proceedings.\n\n- Explanation of why C is incorrect: It is not accurate to state that there is \"no point\" in filing observations on patentability because they will not be taken into consideration. Observations filed under Article 115 EPC, which can include issues related to Articles 84 and 123(2) EPC as part of the broader concept of patentability, can still have a bearing on the outcome of limitation proceedings.\n\n- Explanation of why D is incorrect: The option D is not provided in the original question options but if hypothetically it were an incorrect statement along similar lines to C (e.g., suggesting observations are never considered), then it would be equally incorrect for the reasons stated above.\n\nSources:\n\nSource: Case Law III, N.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_n_1.html\nSource: EPC Article 115, Url: https://www.epo.org/en/legal/epc/2020/a115.html\nSource: Case Law III, N.2.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_n_2_2.html\nSource: Case Law III, N.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_n_1.html"
                },
                {
                    "Answer": "D",
                    "Justification": "- Explanation of why D is correct: According to the provided context, an application remains pending until (but not including) the date that the European Patent Bulletin mentions the grant of the patent. In this case, the decision states that the mention of the grant will be published on 24 May 2023. Therefore, the last day a divisional application may be filed is 23 May 2023.\n\n- Explanation of why B and C are incorrect: The date of the decision to grant (28 April 2023) or any arbitrary date within this timeframe like 8 May 2023 do not mark the end of an application's pending status. These dates do not represent when the European Patent Bulletin will mention the grant, which is the critical date for determining when an application ceases to be pending.\n\n- Explanation of why A is incorrect: Filing required translations and paying the grant fee on 2 April 2023 are steps in completing the process towards patent grant but do not directly determine when a divisional application may no longer be filed. The critical date for filing a divisional remains until the European Patent Bulletin publishes the mention of the grant.\n\n- Note: Option E is incorrect as well since the application ceases to be pending once the mention of grant appears in the bulletin, so 24 May 2023 would already be post-pending status.\n\nSources:\n\nSource: Case Law II, F.3.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_ii_f_3_2.html\nSource: Guidelines for Examination in the EPO, E-VIII, 1.6.2.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_viii_1_6_2_3.html\nSource: Guidelines for Examination in the EPO, A-IV, 1.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iv_1_2.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct: According to the Guidelines A-X, 9.2.1 and A-X, 9.2.2, the language reduction under Rule 6(3) EPC applies if certain conditions are met (Rule 6(4), Rule 6(6), and Rule 6(7)). This means that applicants entitled to a fee reduction under Rule 6(3) also benefit from this reduction for the additional fee related to pages in excess of 35.\n- Explanation of why B is incorrect: Answer B states that the fee reduction does not include the additional fee for pages in excess of 35, which contradicts the Guidelines. The language reduction under Rule 6(3) EPC applies comprehensively and includes the additional page fees as specified in A-X, 9.2.1 and 9.2.2.\n\nThe other options (C and D) are not applicable since there were only two provided choices (A and B).\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-III, 13.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_13_2.html\nSource: Guidelines for Examination in the EPO, A-II, 5.6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_5_6.html\nSource: Guidelines for Examination in the EPO, A-III, 13.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_13_2.html\nSource: Guidelines for Examination in the EPO, A-II, 6.8, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_6_8.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct: According to Article 123(2) EPC, any amendment made to a patent application should not extend beyond the content of the application as filed. In this scenario, removing asbestos from the list of fillers does not introduce new subject matter; it merely restricts the claimed invention to what was already disclosed in the original application. The removal of asbestos is permissible under Article 123(2) EPC because the amended claim still falls within the scope of the originally filed disclosure.\n\n- Explanation of why B is incorrect: Answering \"No\" would imply that removing asbestos from the list of fillers violates Article 123(2) EPC. However, this is not true since the removal of asbestos does not add new subject matter and aligns with the original disclosure in the application.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, H-V, 3.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_v_3_3.html\nSource: Case Law II, E.2.4.13, Url: https://www.epo.org/en/legal/case-law/2022/clr_ii_e_2_4_13.html\nSource: Guidelines for Examination in the EPO, B-VIII, 1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_viii_1.html\nSource: Case Law I, C.6.3.3, Url: https://www.epo.org/en/legal/case-law/2022/clr_i_c_6_3_3.html\nSource: Guidelines for Examination in the EPO, B-III, 3.11, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_iii_3_11.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- Explanation of why B is correct: According to the provided context from \"OEB_SUP_mcq_solution.json\", corrections under Rule 139 EPC can only be made up to the time the decision (to grant) is handed over to the EPO's internal postal service. This clearly indicates that once the decision has been dispatched internally, no further requests for correction of errors in documents filed by a patent applicant or proprietor can be entertained.\n  \n- Explanation of why A and C are incorrect: \n  - Option A suggests that corrections under Rule 139 EPC could be made up until the time when the decision to grant is received by the applicant or their representative. This contradicts the legal framework, as once the decision is handed over internally within the EPO, it becomes final and cannot be modified further.\n  - Option C proposes that corrections can be made up to the expiry of the time limit for replying to a communication under Rule 71(3) EPC. However, this timeframe pertains to replies in examination proceedings rather than to correction requests under Rule 139. The specific deadline for making such requests is clearly defined as up to the moment when the decision is handed over internally within the EPO. \n\nThus, B correctly identifies the final opportunity to request corrections under Rule 139 before a decision on grant becomes final and internal dispatch occurs.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-V, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_v_3.html\nSource: Guidelines for Examination in the EPO, A-V, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_v_3.html\nSource: Guidelines for Examination in the EPO, H-VI, 3.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_vi_3_1.html\nSource: EPC Rule 139, Url: https://www.epo.org/en/legal/epc/2020/r139.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct: According to the provided legal context and guidelines, once the decision to grant a European patent application has been issued under Rule 71a(1) EPC, the applicant cannot seek corrections for typographical errors in claims under either Rule 139 or Rule 140 EPC. Rule 139 EPC only allows correction of documents on which the patent is granted while proceedings are still pending, and once the decision to grant has been issued, such proceedings would typically be concluded. Additionally, Rule 140 EPC only applies to linguistic errors, transcription errors, or obvious mistakes in EPO decisions themselves, not to content corrections in granted patents.\n- Explanation of why B is incorrect: Rule 140 EPC specifically does not cover the correction of typographical errors in claims. It only addresses linguistic and transcriptional errors within EPO decisions. Hence, seeking correction under Rule 140 EPC would be inappropriate for a significant typographical error in claim 1.\n- Explanation of why C is incorrect: Rule 139 EPC permits corrections to documents on which the patent is granted while proceedings are pending. However, since the decision to grant has already been issued and received by the applicant, the opportunity to correct under Rule 139 EPC would have passed as the proceeding is now concluded.\n- Explanation of why D is incorrect: Since there is no option D provided in the legal question's options, this choice does not apply. The valid choices are A, B, or C, and only A (None) correctly reflects the inability to correct a typographical error under the given circumstances.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, H-VI, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_vi_3.html\nSource: EPC Rule 140, Url: https://www.epo.org/en/legal/epc/2020/r140.html\nSource: Guidelines for Examination in the EPO, H-VI, 3.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_vi_3_1.html\nSource: Case Law III, L.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_l_2.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. According to G 3/97 and G 4/97, it is permissible for a party to file an opposition on behalf of another entity without being directly named in the filing. In this case, a European patent attorney can act as a representative to file the opposition on behalf of Company X, thus ensuring that the EPO will accept such a filing.\n- Explanation of why B and C are incorrect. Option B is incorrect because there is no prohibition against an attorney or another party acting on behalf of an entity when filing an opposition. The case law explicitly allows for this scenario to occur. Option C is incorrect as it introduces an unnecessary condition (the patentee's objection) that does not apply in the context of permissible representation by a legal professional like a European patent attorney.\n- Explanation of why D is incorrect. Since there are only three options provided, and we have addressed A, B, and C, this option can be disregarded as it was not given among the choices to consider.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, D-I, 4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/d_i_4.html\nSource: Case Law IV, C.2.1.4, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_c_2_1_4.html\nSource: Case Law IV, C.2.1.3, Url: https://www.epo.org/en/legal/case-law/2022/clr_iv_c_2_1_3.html\nSource: Case Law III, Q, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_q.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- Explanation of why B is correct. According to the guidelines and case law provided, changing the category from a method claim defining therapeutic operation of the device to a product (device) claim would broaden the scope of protection and contravene Article 123(3) EPC. The features in the original method claim depend on circumstances such as \"while a person is exercising,\" which cannot be simply converted into physical characteristics of the pacemaker without broadening the claim.\n- Explanation of why A is incorrect. Option A suggests that changing the category from a method to a device is permissible, but this would contravene Article 123(3) EPC by extending the scope of protection beyond what was originally disclosed and claimed in the patent application. The provided case law (T 426/89) illustrates that such an amendment would be impermissible as it broadens the original claim.\n\nSources:\n\nSource: Case Law II, E.2.7.5, Url: https://www.epo.org/en/legal/case-law/2022/clr_ii_e_2_7_5.html\nSource: Case Law II, E.2.7.5, Url: https://www.epo.org/en/legal/case-law/2022/clr_ii_e_2_7_5.html\nSource: Guidelines for Examination in the EPO, H-V, 7, Url: https://www.epo.org/en/legal/guidelines-epc/2024/h_v_7.html\nSource: EPC Rule 80, Url: https://www.epo.org/en/legal/epc/2020/r80.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct: According to Article 11(b) of the Rules relating to Fees (RFees), if a European patent application is withdrawn after substantive examination has begun but before the expiry of the time limit for replying to the first communication from the examining division, 50% of the examination fee can be refunded. In this scenario, since the applicant decides not to proceed further and actively withdraws the application, they would qualify for a partial refund as specified.\n  \n- Explanation of why B is incorrect: Option B suggests that no refund would be available in this situation, which contradicts Article 11(b) RFees. The rules clearly state that a 50% refund can be obtained if the applicant withdraws before the expiry of the time limit for replying to the first communication from the examining division after substantive examination has begun.\n\n- Options C and D are not applicable in this context as there are only two options provided (A and B).\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-VI, 2.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vi_2_5.html\nSource: Guidelines for Examination in the EPO, C-VI, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_vi_3.html\nSource: EPC RFees 11, Url: https://www.epo.org/en/legal/epc/2020/f11.html\nSource: EPC RFees 9, Url: https://www.epo.org/en/legal/epc/2020/f9.html"
                },
                {
                    "Answer": "C",
                    "Justification": "- Explanation of why C is correct. According to Rule 16bis PCT, if fees are paid late, the receiving Office can subject them to a late payment fee which is equal to 50% of the international filing fee (excluding page fees). Given that the applicant has missed the due date but has still made the payment within a short period after the deadline, they will likely receive an invitation from the receiving Office requiring them to pay this additional late payment fee. This aligns with the scenario where the application is not withdrawn but requires payment of the late fee.\n\n- Explanation of why B is incorrect. The statement that \"the fees will be accepted as if they had been paid within the one-month period\" is based on a specific condition provided in OEB_SUP_mcq_solution.json, which states that if it's extremely unlikely for an invitation to be issued by a certain date (11 December 2023), then late payments can be considered timely. However, in this scenario, the payment was made after the specified date and hence does not meet the condition for being accepted as timely.\n\n- Explanation of why A is incorrect. The international application will not automatically be withdrawn simply because fees were paid slightly late. Rule 16bis PCT outlines a process where an invitation to pay the original fees plus a late payment fee can be issued, which prevents automatic withdrawal and gives applicants a chance to rectify their mistake.\n\n- Explanation of why D is incorrect. Since \"D\" was not provided as an option in the question, it cannot be considered correct. However, based on the context, if there were another option suggesting immediate application withdrawal without any invitation or late payment fee notice, this would also be incorrect for the reasons explained above regarding Rule 16bis PCT.\n\nSources:\n\nSource: PCT Rule 12, Url: https://www.wipo.int/pct/en/texts//rules/r12.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.3.5.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_3_5_3.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- According to Rule 90bis.1 PCT, an applicant may withdraw an international application at any time prior to the expiry of 30 months from the priority date. However, if there are multiple applicants, all must sign the notice of withdrawal as per the rules. Since only one of the two joint applicants signed the letter requesting the withdrawal, it does not comply with the requirement for both applicants' signatures.\n- Therefore, the application will **not** be withdrawn based on a single signature.\n\n**Justification:**  \n- Explanation of why B is incorrect: The international application cannot be considered withdrawn because only one of the two joint applicants signed the notice. Both must sign in accordance with Rule 90bis.1 PCT and the associated guidelines.\n- There are no options C or D provided, so there is nothing to explain about them being incorrect.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-IX, 2.9.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_9_1.html\nSource: Case Law VI, 3.2.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_vi_3_2_1.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_2.html\nSource: Guidelines for Examination in the EPO, A-VIII, 1.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_viii_1_4.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct: According to Article 21.5 PCT and PCT Applicant's Guide International Phase 11.048, applicants can prevent publication if the international application is withdrawn before the technical preparations for publication have been completed. The technical preparations for publication are deemed complete by the 15th day prior to the date of publication (PCT Applicant's Guide International Phase 9.014). Therefore, withdrawing the application on or before this date prevents its publication.\n- Explanation of why B is incorrect: Although it might seem that withdrawing any time prior to publication would prevent it from being published, Article 21.5 PCT specifies a precise deadline related to the completion of technical preparations for publication, which occurs 15 days before the scheduled publication date. Therefore, just any time prior to publication does not suffice.\n- Explanation of why C is incorrect: The timeframe mentioned in option C (the end of the day five weeks before the end of the 18th month from the priority or filing date) does not align with the specific requirements provided by Article 21.5 PCT and its related guidelines, which focus on the technical preparation timeline rather than a fixed period relative to the 18-month mark.\n- Explanation of why D is incorrect: There is no option D in the given question options, hence it is irrelevant to this context.\n\nSources:\n\nSource: PCT Article 23, Url: https://www.wipo.int/pct/en/texts//articles/a23.html\nSource: PCT Rule 30, Url: https://www.wipo.int/pct/en/texts//rules/r30.html\nSource: PCT Article 21, Url: https://www.wipo.int/pct/en/texts//articles/a21.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. Correcting inventorship details in the international phase is preferable because no consent from the wrongly named inventor (Mr Black) is required according to Rule 92bis.1 PCT. This can simplify and expedite the correction process, avoiding potential delays or complications later.\n\n- Explanation of why B, C, and D are incorrect.\n    - Option B suggests waiting until after entry into the EPO regional phase, which would require the consent of Mr Black (Rule 21(1) EPC). This can be cumbersome if Mr Black is uncooperative or difficult to locate.\n    - Option C implies that there is no difference between the two options. However, the requirement for consent in the EPO regional phase versus the lack thereof during the international phase creates a significant difference in ease and potential speed of correction.\n    - Since option D does not exist within the given choices, it cannot be considered or explained as incorrect.\n\nBy correcting inventorship details in the international phase (Option A), you ensure that the process is smooth without the need for additional consents, reducing risk and maintaining efficiency.\n\nSources:\n\nSource: Case Law VI, 3.2.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_vi_3_2_2.html\nSource: Guidelines for Examination in the EPO, C-III, 1.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_iii_1_3.html\nSource: Case Law VI, 3.2.4, Url: https://www.epo.org/en/legal/case-law/2022/clr_vi_3_2_4.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. Observations can be filed online using ePCT for international applications and this approach ensures that the observations will be considered by multiple offices where the application enters the national or regional phase, thus saving time and cost.\n- Explanation of why B, C, and D are incorrect. Option B (sending a letter to the receiving office or International Bureau) and option C (filing observations by letter) do not utilize the streamlined ePCT process that is designed for efficient handling across multiple jurisdictions. Option D states it is not possible to file such observations, which is incorrect since there are established procedures like ePCT for filing observations on international applications.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, B-VI, 4.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_vi_4_1.html\nSource: Guidelines for Examination in the EPO, B-XI, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_xi_2.html\nSource: Guidelines for Examination in the EPO, E-VI, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_vi_3.html\nSource: Case Law III, N.5, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_n_5.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- According to the legal texts provided, Rule 58 sets out that where deficiencies such as those outlined must be rectified within a non-extendable period of two months from the date of the communication inviting the applicant to do so. The invitation in this case was dated and mailed on September 22, 2023. Therefore, the deadline for responding would logically extend exactly two months from that date, which is November 22, 2023.\n- Option B (November 27, 2023) is incorrect because it extends beyond the two-month period.\n- Option C (December 3, 2023) and D (December 4, 2023) are also incorrect as they both exceed the exact two months from September 22, 2023. \n- It's important to note that while the applicant may have received the invitation on October 2, 2023, this does not affect the calculation of the deadline, which is based solely on the date the EPO mailed the communication (September 22).\n\nSources:\n\nSource: Guidelines for Examination in the EPO, B-VIII, 3.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_viii_3_2.html\nSource: Guidelines for Examination in the EPO, A-VII, 1.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_1_4.html\nSource: Guidelines for Examination in the EPO, A-III, 16.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_16_2.html\nSource: Guidelines for Examination in the EPO, B-VIII, 4.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_viii_4_2.html\nSource: Guidelines for Examination in the EPO, B-VIII, 3.2.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_viii_3_2_1.html"
                },
                {
                    "Answer": "D",
                    "Justification": "- Explanation of why D is correct: According to the guidelines for examination in the EPO and relevant legal texts, if an applicant misses the 12-month priority period unintentionally but can demonstrate that they were unable to meet the deadline despite taking all due care, they may still restore their claim to priority. This aligns with the \"due care criterion\" mentioned in Rule 49ter of the PCT and Article 122 of the EPC.\n\n- Explanation of why B is incorrect: Requesting further processing under Rule 159(1) EPC or Rule 160(1) does not specifically address the issue of restoring a missed priority claim. It only pertains to extending time limits for entering into the European phase, which is different from actually restoring the right of priority.\n\n- Explanation of why C is incorrect: While unintentionally missing the deadline may be part of the context under Rule 49ter PCT (for international phase), the EPO specifically applies a \"due care criterion\" (Rule 49ter.1(b) PCT). Therefore, merely stating that the date was missed unintentionally does not suffice; demonstrating due care is necessary.\n\n- Explanation of why A is incorrect: The question involves whether restoration can be sought and granted if specific conditions are met, rather than simply declaring the priority claim impossible to restore based on a missed deadline. Under certain circumstances (such as meeting the \"due care\" requirement), the priority claim can indeed still be restored.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-III, 6.6, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_6_6.html\nSource: Case Law VI, 3.2.5, Url: https://www.epo.org/en/legal/case-law/2022/clr_vi_3_2_5.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.3.5.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_3_5_3.html"
                },
                {
                    "Answer": "C",
                    "Justification": "- Explanation of why C is correct. According to Rule 160(2) EPC and Article 121(1) PCT, if the 31-month period for entering the regional phase before the EPO has expired (which it has in this case as the international filing date was 14 March 2022), entry can still be made by using provisions for further processing. The 31-month deadline would have been on or around 14 December 2024, which is past.\n\n- Explanation of why A and B are incorrect.\n    - Option A states that it is not possible to enter the regional phase because the 31-month period has expired; however, this overlooks the possibility of using further processing provisions as per Rule 160(2) EPC.\n    - Option B suggests withdrawing priority from US-1. Withdrawing the priority claim would not affect the time for entering into the regional phase since the international filing date remains unaffected by such a withdrawal and is still used to calculate deadlines.\n\nThus, use of further processing provisions allows entry even after the expiration of the 31-month period.\n\nSources:\n\nSource: Case Law VI, 3, Url: https://www.epo.org/en/legal/case-law/2022/clr_vi_3.html\nSource: Case Law VI, 1, Url: https://www.epo.org/en/legal/case-law/2022/clr_vi_1.html"
                },
                {
                    "Answer": "D",
                    "Justification": "- Explanation of why D is correct. According to Rule 51(2) and the guidance provided by the EPO, for an international patent application (PCT) entering the regional phase at the European Patent Office (EPO), the renewal fee in respect of the third year should be paid before the end of the month following the corresponding anniversary date of the filing. Since PCT-1 was filed on 16 June 2019, the due date for payment without surcharge would generally be 30 June 2022. However, considering the EPO regional phase entry took place after 18 months (on 26 December 2021), there is a grace period until January 2022 to pay this fee as per the notice from the EPO concerning amendments to Rule 51(2). Therefore, the correct payment date without surcharge would be by 31 January 2022. However, given that options A through D must be strictly adhered to and considering the closest option to this grace period is 17 January 2022 (Option D), it is selected as the most appropriate answer.\n  \n- Explanation of why B, C, and A are incorrect. Options A (30 June 2021) and B (26 December 2021) are before the relevant third-year anniversary date for payment. Option C (2 January 2022) is outside the grace period granted under Rule 51(2).\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-X, 5.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_4.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.3.12, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_3_12.html\nSource: Guidelines for Examination in the EPO, A-X, 5.2.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_x_5_2_4.html\nSource: EPC Rule 51, Url: https://www.epo.org/en/legal/epc/2020/r51.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- Explanation of why B is correct: According to Article 153(5) EPC and Rule 165 EPC, an international application (PCT-1), if it was filed earlier than the priority date or filing date of a subsequent European patent application (EP-1), will be part of the state of the art within the meaning of Article 54(3) EPC. PCT-1 was published on 8 July 2021, which is later than the priority date of EP-1 (20 June 2021). Therefore, it cannot fall under Article 54(2) but will be part of the state of the art under Article 54(3).\n  \n- Explanation of why A and C are incorrect: \n  - Option A is incorrect because PCT-1 has an earlier filing date than EP-1 (filed on 5 January 2020), meaning it meets the criteria to be part of the state of the art.\n  - Option C is incorrect because Article 54(2) EPC pertains to disclosures made prior to the filing date or priority date of an application, and PCT-1's publication (8 July 2021) occurred after the claimed priority date of EP-1 (20 June 2021). Therefore, it is not considered part of the state of the art according to Article 54(2) EPC.\n\nSources:\n\nSource: Case Law I, C.2.4.4, Url: https://www.epo.org/en/legal/case-law/2022/clr_i_c_2_4_4.html\nSource: Case Law II, F.3.5.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_ii_f_3_5_2.html\nSource: Case Law I, C.2.4.1, Url: https://www.epo.org/en/legal/case-law/2022/clr_i_c_2_4_1.html\nSource: Case Law VI, 1, Url: https://www.epo.org/en/legal/case-law/2022/clr_vi_1.html"
                },
                {
                    "Answer": "C",
                    "Justification": "- Explanation of why C is correct. According to Article 153(7) and Rule 164(2), after entry into the European regional phase, if an objection of lack of unity was raised during the international search and no additional search fees were paid for non-searched inventions, an applicant can still pay additional search fees within two months of receiving a notification from the EPO (which invites payment). This allows them to have their claims examined without having to file a divisional application initially.\n\n- Explanation of why B is incorrect. The time period mentioned in option B (within two months of entry into the European regional phase) does not align with the prescribed procedure under Rule 164(2), which requires payment within two months from notification by the EPO.\n\n- Explanation of why A is incorrect. Filing a divisional application for claim 10 can be done, but it is an additional cost and effort beyond what is required at this stage to simply pay an additional search fee as per Rule 164(2).\n\n- Explanation of why D is incorrect. There was no option labeled \"D\" provided in the question.\n\nSources:\n\nSource: Case Law II, B.6.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_ii_b_6_2.html\nSource: Guidelines for Examination in the EPO, F-V, 7.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/f_v_7_4.html\nSource: Guidelines for Examination in the EPO, B-II, 4.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/b_ii_4_5.html\nSource: Guidelines for Examination in the EPO, C-III, 3.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_iii_3_1.html\nSource: Guidelines for Examination in the EPO, F-V, 7.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/f_v_7_1.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct: According to the provided guidelines, oral proceedings must be held if any party requests them, with one specific exception being a request for further oral proceedings before the same department where the parties and the subject of the proceedings are the same. There are no other explicit exceptions mentioned in the provided legal texts that would allow the EPO to refuse a request for oral proceedings.\n\n- Explanation of why B is incorrect: The receiving section does not have the authority to refuse requests for oral proceedings as per the guidelines; the general rule is that if any party requests oral proceedings, they must be held unless it falls under one of the limited exceptions mentioned (such as further oral proceedings before the same department).\n\n- Explanation of why C is incorrect: Similarly, there is no indication in the provided guidelines that the opposition division has the authority to refuse a request for oral proceedings. The general principle is that requests for oral proceedings must be honored unless they are for further oral proceedings with the same parties and subject.\n\n- Explanation of why D is incorrect: There is also no specific mention allowing the Legal Division to refuse a request for oral proceedings according to the provided guidelines. The overarching rule remains that any party's request for oral proceedings must be accommodated, barring the exception regarding further requests before the same department with unchanged circumstances.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-III, 4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_iii_4.html\nSource: Guidelines for Examination in the EPO, E-III, 3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_iii_3.html\nSource: Guidelines for Examination in the EPO, E-III, 1.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_iii_1_3.html\nSource: Guidelines for Examination in the EPO, E-III, 1.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_iii_1_4.html\nSource: Guidelines for Examination in the EPO, C-V, 4.7.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/c_v_4_7_1.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct: According to Rule 159(1) EPC and Case Law II, B.6.2., early entry into the European phase requires compliance with all conditions specified in Rule 159(1), including payment of the filing fee. Since PCT-1 consists of only 20 pages (less than 35 pages, thus no additional page fees apply) and does not require an additional search by EPO (since it was already searched as ISA), the required fee is just the basic filing fee.\n  \n- Explanation of why B is incorrect: The examination fee must be paid if the period under Rule 70(1) has expired. Since PCT-1 was filed 28 months ago, it's not yet time to pay the examination fee at this stage unless the applicant wishes to expedite the process further.\n  \n- Explanation of why C is incorrect: In addition to B's reasoning, renewal fees are due for the third year from the filing date; however, given that PCT-1 was filed 28 months ago, no such renewal fee would be due yet. Thus, this option overestimates the necessary payments.\n  \n- Explanation of why D is incorrect: This option includes a claims fee and other unnecessary fees (such as examination and renewal). Since there are no extra pages or additional search requirements specified by EPO in this scenario, only the filing fee must be paid to effect early entry into the European phase.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-IX, 2.1.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_1_1.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.8, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_8.html\nSource: EPC Rule 159, Url: https://www.epo.org/en/legal/epc/2020/r159.html\nSource: Case Law II, B.6.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_ii_b_6_2.html"
                },
                {
                    "Answer": "A",
                    "Justification": "- Explanation of why A is correct. According to the guidelines and relevant rules, restoration of priority rights under Rule 49ter PCT must be requested within one month from the expiry of 31 months from the filing date of the priority right to be restored when entering the EPO regional phase.\n- Explanation of why B is incorrect. The requirement in option B refers to satisfying the requirements of Rule 159(1) EPC, which pertains to various procedural deadlines but does not specifically align with the deadline for requesting restoration of the priority right under Rule 49ter PCT.\n- Explanation of why C is incorrect. Two months from the date on which the requirements of Rule 159(1) EPC are satisfied (option C) would not align with the specific one-month requirement mentioned in Rule 49ter PCT for requesting restoration at the EPO.\n- Explanation of why D is incorrect. While option D specifies a timeframe related to the filing date of the international application, it does not adhere to the correct deadline under Rule 49ter PCT which requires a request within one month from the expiry of 31 months from the priority right’s filing date.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-IX, 2.3.5.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_3_5_3.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.3.5.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_3_5_3.html\nSource: Case Law VI, 3.2.5, Url: https://www.epo.org/en/legal/case-law/2022/clr_vi_3_2_5.html"
                },
                {
                    "Answer": "C",
                    "Justification": "- Explanation of why C is correct. No translation of the priority document is required unless the validity of the priority claim becomes relevant to patentability (Rule 51bis.1(e)(i) PCT; PCT Applicant's Guide National Phase 5.010). This means that a Korean utility model application, as long as its priority claim does not become relevant for assessing patentability, would not require translation upon entry into the European regional phase.\n- Explanation of why B is incorrect. Option B incorrectly suggests that a translation into one of the official EPO languages must be provided within two months after entering the EPO regional phase, which is not required unless the validity of the priority claim affects the patentability of the invention.\n- Explanation of why A is incorrect. Option A also incorrectly states that a translation is required into the language of the proceedings within two months of the end of the 31-month period for entering the EPO regional phase. This requirement does not exist unless the validity of the priority claim becomes relevant to patentability.\n- Explanation of why D is incorrect. While option D mentions that no translation is needed if a declaration stating that the European application is a complete translation of the priority document is submitted, this situation is not generally required at entry into the regional phase and only becomes necessary when the EPO invites for it based on relevance to patentability.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-IX, 2.5.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_5_1.html\nSource: Guidelines for Examination in the EPO, A-II, 5.4.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_ii_5_4_4.html\nSource: Guidelines for Examination in the EPO, A-VII, 3.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_3_3.html\nSource: Guidelines for Examination in the EPO, A-III, 6.8, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_iii_6_8.html"
                },
                {
                    "Answer": "B",
                    "Justification": "- Explanation of why B is correct: According to the Guidelines for Examination in the EPO, if the translation of an international application into one of the official languages of the European Patent Office (EPO) is not filed within the required time frame after entry into the EPO regional phase, the applicant can remedy this by filing the translation along with a request for further processing and paying the corresponding fee under Rule 135 EPC. This must be done within two months of notification from the EPO regarding the missed deadline.\n\n- Explanation of why A is incorrect: The option suggesting reinstatement of rights under Rule 49.6 PCT does not apply in this context because Rule 49.6 PCT deals with situations where a communication from an international authority or designated Office was not received by the applicant due to postal delay, and it pertains more to PCT procedures rather than EPO-specific remedies for filing deficiencies after entry into the European phase.\n\n- Explanation of why C and D are incorrect: There were no options C and D provided in the question, so these cannot be directly addressed. However, if there were any other hypothetical alternatives (such as waiting for a communication before taking action or some other procedural step), they would generally be deemed less preferable or inappropriate given the specific guidance that immediate remediation within two months of notification is required under EPO rules to prevent abandonment of the application.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, A-VII, 1.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/a_vii_1_4.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.1.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_1_3.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.1.3, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_1_3.html"
                },
                {
                    "Answer": "C",
                    "Justification": "- Explanation of why C is correct. Applicants based outside an EPC contracting state, such as those from Japan, can themselves comply with Rule 159(1) EPC for the translation requirements. This means they can directly handle certain procedural acts like filing translations.\n\n- Explanation of why A and B are incorrect. While it is true that a professional representative must be appointed in most proceedings, especially after certain formal steps have been taken (such as requesting examination), applicants themselves can fulfill the requirement under Rule 159(1) EPC regarding translations prior to such appointments.\n\n- Explanation of why D is not applicable since it was not provided as an option. However, similar to A and B, appointing a professional representative or legal counsel would be necessary for broader proceedings but not specifically for complying with Rule 159(1).\n\nSources:\n\nSource: Guidelines for Examination in the EPO, E-IX, 2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2.html\nSource: Guidelines for Examination in the EPO, E-IX, 2.3.1, Url: https://www.epo.org/en/legal/guidelines-epc/2024/e_ix_2_3_1.html\nSource: Case Law III, V.2.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_iii_v_2_2.html"
                },
                {
                    "Answer": "C",
                    "Justification": "- Explanation of why C is correct. FP1 includes subject-matter A and was filed ten months before FP2. Since FP1 is still pending, it will be published after a 18-month period from its filing date unless withdrawn earlier. Therefore, when EP1 is filed ten months after the filing of FP2 (which itself is filed ten months after FP1), the priority claim to FP1 for subject-matter A becomes invalid because FP1 would have been disclosed publicly before EP1's effective date if it claims a later priority from FP2. As per Article 87(1) and F-VI, 1.4 of the Guidelines for Examination in the EPO, FP2 cannot be considered as the first application since FP1 already discloses subject-matter A.\n- Explanation of why B is incorrect. Option B suggests that only the priority from FP1 is invalid, but it does not account for FP1 becoming prior art and rendering claim 1 non-novel under Article 54(2).\n- Explanation of why A is incorrect. This option implies both priority claims are valid, which would be true if neither application had any overlap in disclosure timing, but since FP1's contents would become public before the effective date of EP1 (if EP1 only claimed FP2 as priority), this scenario contradicts Article 87(1) and F-VI, 1.4.\n- Explanation of why D is incorrect. Since \"D\" was not an option given in the initial question and the correct answer is C, there’s no need to explain it further.\n\nSources:\n\nSource: Guidelines for Examination in the EPO, F-VI, 1.5, Url: https://www.epo.org/en/legal/guidelines-epc/2024/f_vi_1_5.html\nSource: Guidelines for Examination in the EPO, F-VI, 2.4.2, Url: https://www.epo.org/en/legal/guidelines-epc/2024/f_vi_2_4_2.html\nSource: Case Law I, C.2.4.2, Url: https://www.epo.org/en/legal/case-law/2022/clr_i_c_2_4_2.html\nSource: Guidelines for Examination in the EPO, F-VI, 1.4, Url: https://www.epo.org/en/legal/guidelines-epc/2024/f_vi_1_4.html"
                }
            ]
        }
    ]
}